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ABSTRACT OF THE DISSERTATION

Organization of the Streptococcal ExPortal and its Interaction with Cationic
Antimicrobial Peptides
By
Luis Alberto Vega
Doctor of Philosophy in Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2012
Professor Michael G. Caparon, Chairperson
Streptococcus pyogenes and other Gram-positive pathogens are highly dependent
on secreted virulence proteins for their ability to colonize a host and evade the immune
effectors that act on pathogens to prevent this. Unlike eukaryotes and Gram-negative
bacteria, all Gram-positive pathogens lack a cellular compartment dedicated to folding
and processing secreted proteins once they have been translocated across the cytoplasmic
membrane. S. pyogenes and other Gram-positive organisms overcome this challenge by
clustering the secretory translocons at a defined anionic lipid microdomain of the
cytoplasmic membrane that is enriched for accessory factors needed for protein
biogenesis, referred to as the ExPortal. The manner in which S. pyogenes achieves and
maintains spatial coordination of the factors that constitute the ExPortal is not
understood. Given the importance of secreted virulence proteins to streptococcal
pathogenicity, the ExPortal is an attractive target for the development of therapeutics that
can efficiently counter streptococcal infections. I investigated the interaction of cationic
antimicrobial peptides with the streptococcal ExPortal to provide insights into how this
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secretory organelle is organized and how it may be targeted by this mechanism of innate
immunity.
Cationinc antimicrobial peptides (CAPs) targeted the anionic lipid microdomain
of the ExPortal. Traditionally regarded as membrane permeabilizing compounds, CAPs
interacted with the streptococcal membrane at concentrations that did not porate the
membrane. Rather, exposure of S. pyogenes to sub-lethal CAP concentrations resulted in
concomitant redistribution of anionic lipids, translocons and accessory factors to
peripheral regions of the membrane. In addition, CAPs inhibited secretion of important
virulence proteins, including the pathogenically relevant SpeB protease and Streptolysin
O (SLO) cytolysin. One of the CAPs investigated also targets the lipid II precursor of
extracellular peptidoglycan, suggesting the influence of CAPs on ExPortal organization
extended beyond their affinity for negatively charged membrane lipids and that the
streptococcal cell wall is involved in organizing the ExPortal.
Removal of extracellular peptidoglycan also resulted in redistribution of anionic
lipids and ExPortal protein, indicating the cell wall is required for maintaining proper
localization of both lipid and protein components of the ExPortal. Exposure of
streptococci to lantibiotics that preferentially bind and sequester lipid II in the
cytoplasmic membrane disrupted ExPortal organization and secretory function in a
manner similar to CAP activity. Given that both CAPs and lantibiotics target lipid
components of the cytoplasmic membrane, it appears that lipid segregation in the
membrane is central to organization of the ExPortal. Establishment or maintenance of
this lipid segregation could involve interaction with petidoglycan synthesis in the
streptococcal membrane, as two membrane-localized synthetic enzymes, one integral
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(MraY), the other membrane-associated (MurN), that are required for lipid II production
are localized in the same anionic lipid microdomain to where secretory translocons of the
ExPortal are targeted to. This provides a potential model for the mechanism(s) organizing
the ExPortal. Cytoskeletal proteins and cell wall biogenesis components which are
observed to interact with cytoplasmic membrane structures to organize membrane
localized processes required for cell growth and division influence the segregation of
anionic lipids in the membrane, and by extension, where and how the ExPortal is
organized.
Testing of this model by genetic and molecular approaches that target components
of cell division and peptidoglycan will provide both further insights into how Grampositive bacteria coordinate protein biogenesis with secretion as well as reveal novel
potential targets for the development of effective therapeutics against pathogens like S.
pyogenes.
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Chapter I

ExPortal Secretion, Cell Wall Biogenesis and Cationic Antimicrobial Peptide
Involvement in Streptococcus pyogenes Pathogenesis
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SCOPE OF THESIS
Streptococcus pyogenes and other Gram-positive bacteria circumvent the lack of a
specialized cellular compartment for folding secreted proteins following their
translocation by clustering the Sec translocons at a defined microdomain of the
cytoplasmic membrane that is also enriched in anionic lipids and accessory factors for
protein biogenesis, referred to as the ExPortal. The function of this secretory organelle
appears to be that of spatially coupling secretion with protein maturation, but the
mechanisms organizing the ExPortal are still poorly understood. In order to further
knowledge of how spatial coordination of protein secretion and processing is achieved
and maintained in streptococci, examination of cationic antimicrobial peptide (CAP)
interaction with the anionic lipid-enriched membrane microdomain of the ExPortal was
undertaken. Two CAPs, the therapeutically important polymyxin B and physiologically
relevant human neutrophil peptide 1 (HNP-1), preferentially targeted the ExPortal at sublethal, non-porating concentrations. This non-permeabilizing interaction with the
membrane resulted in disruption of ExPortal organization, as observed by the
redistribution of ExPortal anionic lipids, the secretory translocon ATPase SecA and the
chaperone protease HtrA into the peripheral membrane. Redistribution was associated
with inhibition of secretion of certain toxins, including the SpeB cysteine protease and
the Streptolysin O (SLO) cytolysin, but not SIC, a protein that protects S. pyogenes from
CAPs. These data suggest a novel function for CAPs in targeting the ExPortal and
interfering with secretion of factors required for infection and survival. This report also
contributed to literature indicating CAPs can kill their bacterial targets in the absence of
pore formation, exerting their lethal effect by interfering with the dynamic function of
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lipid-associated complexes, such as the ExPortal, by a so-called “sand in a gearbox”
mechanism.
Previous research showed that interaction of HNP-1 with the bacterial membrane
is not limited to anionic lipids, since the peptide also binds the lipid II peptidoglycan
precursor. As an emerging literature indicates that cell wall biogenesis components
interact with cytoplasmic membrane structures to organize membrane-localized
processes, involvement of the streptococcal cell wall in organizing and maintaining the
ExPortal was investigated. Removal of extracellular peptidoglycan by the action of a
streptococcal phage lysin resulted in redistribution of both lipid and aforementioned
protein components of the ExPortal, suggesting the cell wall is required for maintaining
proper localization of the secretory organelle. Exposure to a lipid II-targeting lantibiotic
also concomitantly disrupted localization of anionic lipids and ExPortal proteins, as well
as secretion of the streptococcal virulence factors observed to be affected by CAPs. These
results support the hypothesis that lipid localization in the membrane is central to
organization and maintenance of the ExPortal. Given that lantibiotic activity disrupts cell
wall synthesis by binding lipid II and sequestering it away from the sites of peptidoglycan
biogenesis, it was of interest to determine whether lipid II production and ExPortal
secretion are spatially coordinated processes. Fluorescent tagging of MraY and MurN,
two proteins involved in the membrane-associated steps of lipid II synthesis, revealed
these to localize at foci in the streptococcal membrane that coincide with the anionic lipid
microdomain and secretory translocons of the ExPortal. These results suggest a model for
ExPortal organization in which peptidoglycan synthesis co-localizes with the ExPortal,
influences its establishment and is required for its maintenance.
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INTRODUCTION
Streptococcus pyogenes Pathogenesis
S. pyogenes is a gram-positive pathogen that can cause numerous diseases in
humans that range from superficial infection of the skin and mucous membranes
(impetigo, pharyngitis), to highly invasive and life-threatening diseases (necrotizing
fasciitis), as well as serious post-infection sequelae (rheumatic fever, glomerulonephritis,
reviewed in [1]). Annually, Group A streptococcus (GAS) infections account for an
estimated 700 million cases of mild, non-invasive infections worldwide, of which
approximately 650,000 progress to severe, invasive (at a sterile site) infections with an
associated mortality of approximately 25% [2].
This ability to cause disease is dependent on the secretion of an extensive network of
virulence proteins (Figure 1) [1, 3]. Among these are the proteases ScpC (SpyCEP),
ScpA, EndoS and SpeB; surface-bound Protein F (SfbI) and M protein adhesins or
polymeric structures such as pili; host-targeted cytotoxins such as Streptolysin O (SLO),
streptococcal NAD glycohydrolase (SPN) and Streptolysin S (SLS); polypeptides like
streptococcal inhibitor of complement (SIC) and extracellular DNAses that directly
inhibit immune effectors [3, 4]. Extracellular DNAses degrade chromatin and break down
the neutrophil extracellular traps (NETs) extruded by neutrophils to trap pathogens and
subject them to microbicidal effectors, thus helping streptococci evade neutrophil killing
[5, 6]. SIC is one of multiple defenses streptococci have developed against such
microbicidal effectors. As its name indicates, SIC was first identified as a secreted
polypeptide that can inhibit membrane attack complex of complement by preventing
uptake of C5b67 complement complexes on bacterial membranes [7, 8]. SIC however,
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also interacts with and inhibits multiple host microbicidal proteins, including lysozyme,
cathelicidin LL-37, human neutrophil peptide-1 (HNP-1) and human beta-defensins
(hßD1, -2, -3) [9-11]. Proteins bound to the streptococcal surface also play a major role in
the evasion of phagoyctic cells and their effectors [3]. Specifically, M protein inhibits
opsonophagocytosis of streptococci by binding multiple host proteins [12-14] and
promotes colonization alongside SfbI by interacting with extracellular matrix components
and adhering to host epithelial cells [15-17]. Additionally, similar to other pathogenic
bacteria, S. pyogenes assembles multimeric proteinaceous fibres on its surface known as
pili, which are involved in the adhesion of the bacterium to host epithelia [18].
Like all Gram positive bacteria, Group A streptococci lack the specialized secretory
systems and the accompanying host cell cytosol-targeted effectors that are necessary for
virulence in some gram-negative pathogens (e.g. Type III secretion of Salmonella
enterica [19]). However, the cytolysin SLO and NAD glycohydrolase SPN constitute a
unique mechanism for specifically translocating the latter into the host cell via so-called
cytolysin mediated translocation (CMT) [20]. The cholesterol-dependent cytolysin SLO
oligomerizes to form large pores in host cell membranes and can thus acts on its own to
induce cell death [21].

However, this pore-forming capacity is not required for the

translocation of SPN by CMT [22] and mutations to SLO that do not interfere with poreforming activity, or modifications to SPN that do not affect NAD-glycohydrolase activity
render these proteins incompetent for CMT [23, 24]. The precise mechanism by which
CMT of SPN occurs then is an area of active research, but it is clear that CMT is
important for pathogenesis [20, 25], and that the process involves interaction of
streptococci with the host cell surface as well as between SPN and SLO. Another
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secreted toxin of streptococci, SLS, is cytolytic to erythrocytes, leukocytes and
subcellular organelles [26-28], promotes evasion of phagocytic killing via its cytolytic
activity on neutrophils [29] and inhibits neutrophil recruitment during the early stages of
streptococcal infection [30].

Figure 1. Virulence factors secreted by Streptococcus pyogenes. These factors include
proteases (ScpA, ScpC, EndoS, SpeB, Mac1/IdsE), surface-bound adhesins (SfbI, M protein,
Protein H) host-targeted cytotoxins (SLO, SLS), extracellular DNAses (Sda1) immunity effectortargeted polypeptides (SIC). A majority of these virulence factors are involved in the evasion of
phagocytic killing [3].
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The secreted proteases of Group A streptococci (GAS) serve to inactivate all kinds
of proteins involved in host immunity. ScpC cleaves and inactivates interleukin-8 (IL-8)
[31] and ScpA acts as an endopeptidase to cleave the C5a polypeptide fragment of the
complement cascade [32]. EndoS hydrolyzes the chitobiose core of the asparagine-linked
glycan on Immunoglobulin G (IgG) to prevent recognition of IgG by phagocyte Fc
receptors, while SpeB cleaves IgA, IgM, IgD and IgE antibodies as well [33]. In fact,
SpeB degrades a myriad of host proteins, including extracellular matrix components,
cytokine precursors and antimicrobial peptides [34, 35]. The protease activity of SpeB
extends to extracellular and surface-associated streptococcal proteins, including M
protein [36], various superantigens [37], streptokinase [38], SLO [39] and SIC [40].
Given such a variety of virulence-associated targets, the precise role of SpeB in
streptococcal pathogenesis is still unclear and an area of active investigation.
The SpeB cysteine protease is one of the most intensively researched virulence factors of
GAS, and these efforts have revealed that production of enzymatically active SpeB is a
complex process involving a variety of regulatory controls and multiple accessory factors
post-translation (reviewed in [41]). Expression of SpeB is growth phase dependent and
influenced by environmental factors including pH [42], NaCl concentration [43] and
nutrient availability [44]. Peptide transport also affects SpeB expression as was
determined by the mutational inactivation of the oligopeptide permease (Opp) and
dipeptide permease (Dpp) systems responsible for peptide acquisition [45, 46]. Multiple
regulatory proteins influence speB expression by either directly activating (RopB, CcpA
[47-49]) or indirectly inducing (Mga, CodY, SagP, LuxS [50-52]) or repressing
(CovR/CovS, Srv, LacD.1, Nra, Vfr [53-58]) transcription; something that reflects the
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variety of inputs that affect SpeB production and suggests that timely and appropriate
synthesis of this protease is of great importance to streptococcal pathogenesis. The speB
transcript is translated into a 40kDa zymogen, that through either inter- or intramolecular
autocatalytic processing at nine reported cleavage sites is proteolytically processed into a
28kDa active enzyme [59-61]. Prior to this processing however, the SpeB zymogen is
modified by the peptidyl-prolyl cis-trans isomerases (PPIase) RopA and PrsA [47, 62].
The PPIases isomerize one or more of the 13 proline residues in the SpeB zymogen and
this activity is required for proteolytic processing of the polypeptide. Dysregulation of
PrsA adversely affects both SpeB activity and pathogenicity of GAS [63]. Interestingly,
the PPIase activity of RopA is dispensable for secretion of the SpeB zymogen, but loss of
RopA expression inhibits secretion of SpeB [47], suggesting that aside from its
processing role RopA is an accessory factor for secretion of the protease. Another
accessory factor of SpeB secretion and processing is the serine protease HtrA. This
extracellular membrane-anchored protease is involved in the folding and maturation of
secreted proteins as well as the degradation of proteins misfolded during secretion in
Lactococcus lactis [64]. In GAS functional HtrA is required for the efficient conversion
of secreted SpeB zymogen into its active form [65], although HtrA does not directly
process SpeB in vitro [66]. Additionally, mis-localization of HtrA out of the cytoplasmic
membrane results in altered maturation kinetics of SpeB [67]. Given the multitude of
stretptococcal and host proteins SpeB acts on, it is not surprising that its biogenesis is a
highly regulated process involving many factors. It is possible though that other secreted
virulence proteins of streptococci that have not been as well characterized as SpeB also
require the interaction of multiple accessory factors for their production. Most
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importantly, existing research has demonstrated that loss or inhibition of these secreted
proteins’ activity results in reduced virulence [5, 68-71], highlighting the importance of
understanding the mechanism(s) by which these proteins are secreted and processed into
their active forms.

Figure 2. Secretion systems of Gram-positive bacteria. In gram-positive bacteria (Monoderm,
as the figure states), secreted proteins can be (i) anchored to the CM (i.e. lipoproteins); (ii)
attached to the CW either covalently (i.e. LPXTG proteins) or non-covalently (i.e. by LysM, GW,
CWBD1, CWBD2, SLHD or WXL motifs); (iii) part of cell-surface appendages, such as pili
(whose subunits are secreted via Sec), competence pseudo-pili (assembled via FPE) or flagella
(assembled via FEA); (iv) released into the extracellular milieu via Sec, Tat, holin or Wss; or (v)
translocated into a host cell after secretion via Sec of a cholesterol-dependent cytolysin, which
integrates into the membrane of a host cell to permit transport of secreted effectors via cytolysinmediated translocation (CMT). Black arrows show routes of proteins targeted to CM exhibiting
an N-terminal signal peptide, blue arrows routes used by proteins lacking a signal peptide. Red
arrows relate to secretion, and violet arrows refer to integration of membrane proteins (IMP).
Secreted proteins are blue. Abbreviations: Cyto, cytoplasm; CM, cytoplasmic membrane; CW,
cell wall; Ext, extracellular milieu; FPE, fimbrilin-protein exporter; FEA, flagella export
apparatus [72]. S. pyogenes possesses only the Sec secretory pathway.
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Secreted protein biogenesis and the ExPortal of GAS
In bacteria, the most conserved route of protein translocation across the
cytoplasmic membrane is the general secretory (Sec) pathway (for a detailed review see
[73]). The membrane-embedded enzyme complex that constitutes the translocase is
composed of a molecular motor, the peripheral adenosine triphosphatase (ATPase) SecA
[74] and a trimeric protein complex that acts as the conducting channel. This channel is
formed by the SecY [75], SecE [76] proteins that together associate with the integral
membrane subunit SecG [77], or with another heterotrimeric complex composed of the
SecD, SecF and YajC proteins encoded in the secD operon [78, 79]. S. pyogenes however
expresses the SecYEG complex, SecA and YajC proteins, but its genome does not
encode genes for SecDF [80]. Studies in Escherichia coli and Bacillus subtilis reveal that
YajC is a membrane protein with a single transmembrane segment and a large cytosolic
domain that, except for the observation that it associates with SecDF, is not needed for
protein translocation or viability [81, 82]. Therefore, given that streptococci lack SecDF,
the precise function of YajC in GAS remains unknown.
Proteins destined for secretion via the Sec pathway are synthesized as preproteins
that are targeted to the Sec translocons by an 18 to 30 amino acid N-terminal signal
sequence containing a positively charged N-terminal domain, a hydrophobic core and a
more polar C-terminal domain [83]. This signal is cleaved off by a signal peptidase, a
membrane bound protease that acts on the cleavage site in the C-domain of the signal
peptide during the translocation reaction. Proteins thus produced can either be posttranslationally or co-translationally translocated, and the mechanism in GAS for directing
the latter process is the signal recognition particle (SRP) pathway. In bacteria the SRP is
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a complex composed of a 4.5S RNA and the GTPase Ffh [84] that interacts with the
signal sequence of nascent preproteins as they emerge from the ribosome [85]. This socalled ribosome nascent chain (RNC) complex bound to SRP in a GTP-dependent
manner interacts with a membrane bound receptor, FtsY [86]. It is this complex that,
upon GTP hydrolysis by both FtsY and SRP, transfers the RNC to the translocase to
initiate export of the polypeptide [87]. For many bacteria the SRP pathway is essential to
survival, but, as described in the Appendix, in GAS it was found to be dispensable for
growth under in vitro conditions, yet necessary for virulence and the production of certain
secreted virulence factors, including SLO, SPN and SpeB, the latter in a nutrientdependent manner. [88].
The secreted proteins of streptococci that remain surface-bound are anchored to
either the outer leaflet of the cytoplasmic membrane or to the streptococcal cell wall via
sortases. These enzymes function to covalently join secreted surface factors to cell wall
peptidoglycan or to polymerize the proteins that constitute multimeric structures like pili
into their functional fibrous form (for a detailed review see [89]). Though not virulence
effectors themselves, the role sortases play in targeting surface factors required for
virulence like those previously described means sortases are crucial for pathogenesis. The
known sortases that act on cell wall-anchored substrates all function as cysteine
transpeptidases, joining proteins containing a cell wall sorting signal to an acceptor
amino group on the outer cell surface [90]. The sorting signal consists of an LPXTG
motif (X standing for any amino acid), followed by a segment of hydrophobic amino
acids and a tail of predominantly positively charged residues. The enzymatic reaction
carried out by these sortases consists of breaking the threonine and glycine peptide bond
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in the LPXTG motif to form a substrate-sortase complex in order to transfer the surface
protein to the peptidoglycan precursor lipid II, thus generating an isopeptide linked
protein-lipid II product [91]. The transglycosylation and transpeptidation reactions that
synthesize the cell wall then incorporate the lipid-II bound surface protein into the
peptidoglycan polymer. The gram-positive sortases characterized to date are categorized
into six different classes based on sequence homology and functionality [89]. Two of
these classes are represented in S. pyogenes. One is the class commonly referred to as the
‘housekeeping’ Class A sortases, whose enzymatic activity anchors a diverse array of
surface proteins to the cell wall, including M protein, SfbI and ScpA [92]. The other is
the Class B sortases exemplified by Sortase C, which is involved in the assembly of the
adhesive pili required for streptococcal biofilm formation and adhesion to host epithelia
[93].
S. pyogenes lack all of the other known secretion systems of Gram-positive bacteria,
diagrammed in Figure 2 [72, 80]; thus all secreted virulence proteins of GAS are
exported via the Sec pathway. Sreptococci however, like all Gram-positive bacteria, lack
a specialized cellular compartment for folding secreted proteins following their
translocation across the membrane by the Sec system. This problem is circumvented in
S. pyogenes and several other species of Gram-positive cocci by clustering the Sec
translocons and secretory accessory factors at a defined microdomain of the cytoplasmic
membrane that has been termed the ExPortal [67, 94-97]. In S. pyogenes, secretion of the
SpeB protease occurs at a unique site on the streptococcal surface, as does secretion of a
non-native Sec pathway substrate (PhoZ) expressed from a plasmid [94]. This site of
SpeB secretion coincides with the membrane localization of the SecA ATPase and of the
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HtrA serine protease [67, 94]. Likewise SrtC, the sortase required for the polymerizatioin
of pili in Enterococcus faecalis, co-localizes with SecA in the enterococcal membrane,
and loss of SrtC expression resulted in accumulation of pilus subunits (EbpA, EbpC) at
unique foci on the bacterial surface [95]. Other examples of this coordination of Sec
translocons and accessory proteins include the co-localization of SecA and the cell wall
protein–anchoring Sortase A at unique foci in the membrane of Streptococcus mutans
[97], whereas in replicating Streptococccus pneumoniae cells HtrA and SecA were
observed to oscillate between septal and polar membrane microdomains [98]. The
membrane microdomain to which SpeB secretion localizes to in S. pyogenes is also
enriched in anionic lipids [99], while in S. pneumoniae, cells devoid of the cardiolipin
synthase encoding gene cls failed to localize SecA to septal membrane microdomains
[98]. A similar mutation in GAS did not affect secretion of SpeB, suggesting that in S.
pyogenes it is the more abundant phosphatidylglycerol that localizes to the ExPortal [99].
Moreover, additional evidence from both enterococci and GAS indicates that sorting of
cell wall-anchored virulence factors occurs in the immediate vicinity of their site of
secretion and coincides with the site of de-novo peptidoglycan synthesis [95, 97, 100,
101]. Altogether, this suggests that a function of the ExPortal is to spatially couple
secretion with protein maturation, and that this coordination could involve membrane
lipid organization and cell wall synthesis as well.
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Bacterial lipid membrane microdomains
As mentioned, the ExPortal of S. pyogenes has been shown to have an asymmetric
lipid content enriched in anionic phospholipids [99] that may contribute to the
preferential retention of certain proteins at the ExPortal vs. the peripheral membrane [95].
Other bacterial membranes have been known to contain localized microdomains enriched
for specific phospholipds, as was shown

in the case of cardiolipin and

phophatidylethanolamine-rich septal membrane domains of B. subtilis [102, 103]. These
domains were absent in mutants disrupted in the cardiolipin synthase-encoding gene clsA
[102] and in the genes encoding phosphatidlyserine carboxylase (psd) and
phophatidylserine synthase (pssA) [103]. Interestingly, the majority of the lipid synthases
localize

to

the

septal

membrane

region

at

which

cardiolipin

and

phosphatidylethanolamine are retained [103]. Membrane lipid spirals detected along the
long axis of cells in B. subtilis co-localized with GFP protein fusions of MinD, thus
hinting at possible involvement of lipid membrane microdomains in cell division [104].
Anionic lipids also play a multitude of roles in organizing the protein components
of the bacterial membrane, including targeting secretory proteins by their signal
sequence, directing membrane proteins via the SRP pathway, facilitating the interfacial
insertion of peripherally attached protein domains, influencing or even determining the
correct topology of transmembrane segments, and promoting efficient formation of
protein complexes in the membrane (reviewed in [105]). Particularly with respect to
protein secretion, phosphatidylglycerol is involved in optimal protein translocation via
the Sec pathway by influencing interaction of the SecA ATPase with the SecYEG
translocon [106-108], as well as interacting with pre-protein signal sequences during
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protein translocation [109], and with the FtsY component of the SRP pathway, enhancing
its GTPase activity [110]. Thus, bacterial membrane lipids play a vital role in the
organization and functionality of the bacterial cell’s secretory processes. However, in
gram-positive bacteria secretion is one of several important cellular processes occurring
at the surface for which lipid organization appears to be of particular importance. Another
such process, as described below, is cell wall synthesis.

Figure 3. Gram-positive cell wall biogenesis. The enzymatic steps of cell wall synthesis in
Staphylococcus aureus, a representative gram-positive pathogen, are shown. The cytoplasmic
conversion of UDP-GlcNAc to the soluble precursor UDP-MurNAc-pentapeptide is carried out
by sequential action of the MurA to MurF enzymes. The membrane-associated synthesis of lipid
II by MraY and MurG involves conjugation of MurNAc-pentapeptide to undecaprenyl-phosphate
(C55-P) and addition of GlcNAc. Addition of the interpeptide crosslinker (5 x Gly) is catalyzed by
the FemXAB transferases just prior to translocation of the lipid II precursor across the
cytoplasmic membrane. Extracellular transglycosylation (TG) and transpeptidation (TP) reactions
carried out by penicillin binding proteins (PBPs) assemble lipid II precursors into the cell wall
peptidoglycan polymer [111].
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Gram-positive cell wall synthesis
The cell wall of Gram-positive pathogens is an extracellular organelle that plays a
multitude of roles essential to both survival and virulence (for a review see [112]). A
rigid peptidoglycan exoskeleton made up of polymers of alternating N-acetylglucosamine
(GlcNAc) and N-acetylmuramic acid (MurNAc) glycan units cross-linked via peptide
bridges, its main purpose is to preserve cellular integrity against osmotic forces from
without and within the bacterial cell [113]. The structural rigidity required for this is
balanced by the flexibility necessary to allow for changes in cell shape during growth and
division. This plasticity results from the combined activities of penicillin binding proteins
(PBPs) and cell wall hydrolases. PBPs are the enzymes that carry out the
transglycosylation reactions involved in the polymerization of disaccharide units to
produce the individual strands of peptidoglycan, as well as the transpeptidation reactions
that crosslink these strands via peptide bridges [114]. Their name stems from the fact that
they are the targets of the ß-lactam class of antibiotics to which penicillin belongs to.
PBPs are classified as high molecular weight (HMW) Class A PBPs, which are
bifunctional proteins with both glycosyltransferase and transpeptidase activity, HMW
Class B PBPs with transpeptidase activity and low molecular weight PBPs with
carboxypeptidase or endopeptidase activity [115]. Along with enterococci and other
streptococci, GAS morphologically fit into the class of so-called ovococci, referring to
gram-positive bacteria that are not true cocci due to their ellipsoid shape and divide in the
same single plane perpendicular to the long axis of the cell, thus forming chains of cells
[114]. To accomplish this most ovococci utilize a common set of PBPs: three class A
PBPs (PBP1a, 1b and PBP2a), two class B PBPs (PBP2b and 2x) and a LMW PBP
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(PBP3); GAS encodes all of the above with the exception of PBP2b. The hydrolases
involved in modifying peptidoglycan during cell wall synthesis include Nacetylmuramidases and N-acetylglucosaminidases that digest the glycan backbone,
amidases that cleave the peptide cross-links, and lytic transglycosylases [116]. In S.
pyogenes these enzymes have remained largely uncharacterized; however a secreted
protein containing a cysteine and histidine-dependent aminohydrolase/peptidase (CHAP)
domain [117] common to N-acetylmuramidases was recently identified as a functionally
active peptidoglycan hydrolase required for virulence [118]. Disrupting expression of this
protein, termed CdhA (CHAP-domain containing and chain forming cell wall hydrolase),
resulted in severe growth defects, including the inability to form chains, suggesting a role
in coordinating cell division plane recognition and cell wall synthesis in streptococci. It is
known that ovococci synthesize the cell wall mostly at the division site mid-cell, the new
hemispheres of the daughter cells being synthesized between the parting parent
hemispheres [119, 120]. The precise coordination of PBPs and other cell wall synthesis
factors (i.e. hydrolases and cell division proteins) in order to achieve this is an area of
active investigation and the organization of cell wall biogenesis appears to result largely
from underlying cytoplasmic membrane organization and the positioning of cell division
machinery [104, 121-123].
Synthesis of the cell wall by PBPs requires the production and translocation
across the cytoplasmic membrane of peptidoglycan subunits in the form of undecaprenylpyrophosphoryl-MurNAc-(petapeptide)-GlcNAc (lipid II). The final steps of lipid II
biogenesis occur at the inner leaflet of the cytoplasmic membrane (Figure 3) and involve
membrane-associated (MraY, MurG) as well as cytosolic proteins (FemABX; for a
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review see [124]). MraY is an integral membrane protein that carries out the first
membrane-associated step in the synthesis of lipid II by catalyzing the transfer of the
phospho-MurNAc-pentapeptide

from

the

soluble

cytoplasmic

UDP-MurNAc-

pentapeptide substrate to the membrane embedded undecaprenyl-phosphate (C55-P)
acceptor [125, 126], thus producing undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide
(lipid I), the immediate precursor of lipid II. The subsequent step involves the extrinsic
membrane transferase MurG, which catalyzes the transfer of the GlcNAc moiety from
UDP-GlcNAc to lipid I in order to produce lipid II [127]. The peptidoglycan structure of
many gram-positive bacteria contains an additional peptide cross-link between the
pentapeptide chain and the cross-linked strand, something that requires the addition of
interchain residues to the pentapeptide of the lipid II intermediate [128]. Cytosolic nonribosomal peptidyltransferases carry out this reaction in Staphylococcus aureus
(FemABX [129, 130]), E. faecalis, S. pneumoniae and S. pyogenes (MurMN [131, 132])
on the inner leaflet of the cytoplasmic membrane prior to translocation of lipid II across
the membrane [124]. In S. aureus synthesis of these peptide bridges is required for the
sortase-mediated attachment of surface virulence factors to the cell wall [133] and their
loss results in reduced virulence [134].
The dynamic quality of the cell wall is also important for its function as an
attachment site for extracellular factors that interact with the host environment, which
aside from surface virulence proteins also includes lipoteichoic and teichoic acids. Given
the role of sortases in processing the former, most research into the interaction of grampositive secretion with cell wall biogenesis to date, particularly in the case of
streptococci, has focused on the characterization of sortase function [89], rather than the
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the coordination between secretion and cell wall synthesis, an area that holds great
potential for important discoveries. The cellular processes described thus far (i.e. proteins
secretion, membrane lipid segregation and cell wall synthesis) are clearly linked to one
another in a variety of ways; whether it is that molecular substrates of one process (e.g.
secreted surface factors) are inputs for another (cell wall assembly), or the organization of
one (membrane lipid segregation) appears to inform the functionality of another (protein
secretion). It follows then that certain disruptive influences on any one of these processes
could have deleterious consequences on the others and, by extension, the most effective
antimicrobials will be those that can influence any one of these processes in such a way
as to affect the others as well. Such antimicrobial compounds exist in nature, are the
subject of active investigation and a summary of their known properties and activities is
given below.
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Cationic antimicrobial peptides
Cationic antimicrobial peptides (CAPs) are gene-encoded peptides produced by
nearly all known life-forms as part of an ancient nonspecific innate immune system that
is the main defense mechanism during the initial stages of infection against many
organisms (for a review see [135]). They display a broad range of activity across a range
of pathogens, including bacteria, fungi, metazoans, parasites and viruses [136], and some
are even active against cancerous cells [137]. Some are systemically expressed while
others are localized to specific cells or tissue types most susceptible to infection by
pathogens (e.g. histatins in human saliva [138]). In mammalian hosts, their contribution
to overall immunity varies between different tissue sites (skin, oral, gastrointestinal and
respiratory epithelia) within a host and from one organism to another [139].
Though they display a broad range of activity, have limited sequence homology and
a wide range of secondary structures, the great majority of CAPs share similar physical
properties. In general, they derive from larger precursors by proteolytic processing, are
12 to 50 amino acids in size, carry a net cationic charge (+2 to +11), possess a nearly
50% hydrophobic residue composition and are able to adopt an amphipathic structure in
contact with lipid membranes [140]. Structurally, the majority of CAPs fall into either of
two categories: amphipathic α- helices, and amphipathic β-sheets. The former group is
made up of the majority of CAPs known so far, which are short linear cationic α-helical
peptides (e.g. magainins, cathelicidins, cecropins [141-143]). The amphipathic β-sheets
on the other hand present a defined number of β-strands organized in a common
amphipathic manner, with relatively few or no helical domains, and constrained either by
disulfide bonds (e.g. defensins, protegrins) or by cyclization of the peptide backbone

20

(gramicidin S or polymyxin B). The defensins make up most of the cysteine-containing
peptides and are frequently formed by several antiparallel β-strands stabilized by a series
of up to six disulfide bonds [144]. They are expressed by neutrophils and epithelial cells
of humans and other mammals, functioning both as broad-spectrum microbicides and as
modulators of the immune response by influencing epithelial cell proliferation, enhancing
wound healing, regulating production of pro-inflammatory cytokines, and directing
chemotaxis of several types of leukocytes [139, 145].
As described previously, the conjugation of lipids with proteins in supramolecular
complexes is central to multiple biological processes. Thus, it is not surprising that the
lipid membrane of pathogens is the principal target of CAP activity. It is generally
accepted that the primary mechanism of antibacterial activity of CAPs involves
interactions of their charged and hydrophobic residues with the hydrophilic charged head
groups and the fatty acyl chains of phospholipids in the bacterial membrane. The
consequences of this interaction include the dissipation of the electrochemical potential
and lipid asymmetry, loss of important metabolites and cellular components due to the
destruction of membrane permeability and eventual bacterial cell death [146-148]. The
membrane-CAP interaction typically involves initial adsorption and binding of peptides
to the membrane, followed by the accumulation of bound peptides that upon reaching a
threshold level results in conformational transitions that permit peptide insertion into the
membrane in order to exert their membranolytic activity [135]. Given their variety in size
and structure, there is no unique mode by which all CAPs permeabilize bacterial
membrane, rather a variety of mechanisms shared amongst different CAPs, as illustrated
in Figure 4.
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Figure 4. CAP membranolytic mechanisms. The principal models proposed for the poreforming activity of CAPs are shown. Following binding to the outer surface of the cytoplasmic
membrane (top-left), peptides can oligomerize and form pores according to the barrel-stave
model (A), aggregate on the membrane surface in a detergent-like manner as in the carpet model
(B) or distort the membrane to form lipid/peptide-lined pores as in the toroidal pore model (C). In
the molecular electroporation model (D), lipid-bound CAPs promote an electrical potential
difference across the membrane that induces transient poration. The sinking raft mechanism (E)
proposes that peptide aggregation on the outer leaflet causes a mass imbalance between the two
leaflets. The ensuing curvature gradient causes peptides to ‘sink’ into the membrane and form
transient pores that permeabilize the cell and promote translocation of CAPs to the inner leaflet
[135].
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The membranolytic mechanisms of CAP activity include the formation of stable
pores (barrel-stave and toroidal pore models), membrane thinning (via molecular
electroporation or the sinking raft model) and micellization of membranes in a detergentlike manner (carpet model). In the barrel stave model (Figure 4A), peptide helices form a
bundle in the membrane with a central lumen that constitutes the pore, a mechanism
observed for alamethicin and zervamicin peptides [149, 150]. It is interesting to note that
the formation of cytolytic pores by SLO and other cholesterol-dependent cytolysins like it
involves a similar mechanism of oligomerization and protein conformational changes of
the cytolytic polypeptide [151]. The toroidal pore model (Figure 4C) involves similar
partitioning of peptides into the membrane, with the additional effect of inducing bending
of the membrane leaflets such that the resulting pore is lined by both the inserted peptides
and lipid head groups [148]. The molecular electroporation model (Figure 4D) describes
the pore-forming activity of annexin V and consists of the aggregation of CAPs at the
membrane surface with sufficient charge density to generate an electrical field that
induces the formation of pores similar in size to those of polymyxin B and melitin
peptides in the absence of overall membrane disruption [152, 153]. Another membrane
thinning mechanism, the sinking raft model (Figure 4E), was described only recently for
an α-helical peptide and involves an imbalance in mass ratio of the membrane due to
binding of a particular lipid microdomain [154, 155]. This results in the formation of
transient pores following translocation of the peptide and dissipation of the peptide
induced membrane leaflet mass imbalance. The carpet model (Figure 4B), as its name
implies, consists of adsorption of CAPs to the membrane such that the bilayer surface is
‘carpeted’ by the peptides. At the critical threshold concentration, peptides that act via
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this mechanism (e.g. ovispirin, dermaseptin, magainins [156, 157]) will form toroidal
pores lined by the peptide, allowing further access to the inner leaflet of the membrane by
the CAP, and resulting in membrane disintegration through the formation of micelles in a
detergent-like manner.
Recent studies however, suggest that many CAPs have multiple targets and/or much
more complicated mechanisms of action than membrane poration alone (reviewed by
[158]). In particular, some peptides can produce significant membrane perturbation by
forming lipid-peptide domains, lateral phase segregation of zwitterionic lipids from
anionic lipids and even inducing non-lamellar phases under physiologically relevant
conditions [135]. A more in depth discussion of such CAP activity on bacterial
membranes can be found in Chapter IV, especially as it relates to the effect of CAPs on
ExPortal organization. Peptide-induced lipid segregation of anionic components has
mainly been observed in gram-positive model membranes that are enriched in
phosphatidylglycerol [159-162], the principal anionic lipid of S. pyogenes and other
gram-positive pathogens [99, 163]. Another aspect of the peptide-pathogen interaction
that was not often examined but is now of increasing interest is the effect CAPs have on
their bacterial targets at levels below their minimum inhibitory concentrations. One
studied effect is the induction of regulatory responses involved in resistance to CAPs.
Bacteria have developed multiple factors to resist killing by CAPs, and expression of
these factors is activated by regulatory mechanism responsive to sub-lethal amounts of
CAPs. Researchers have exploited this to uncover previously unknown resistance
mechanisms, by treating bacteria with sub-lethal peptide amounts and performing
transcriptional analyses of the ensuing responses. Examples of this include studies on
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Bacilllus cereus resistance to enterocin [164], Aspergillus niger responses to caspofungin
and fenpropimorph [165], and characterization of SigB-mediated antibiotic resistance in
Listeria monocytogenes [166], to name a few. In the case of GAS responses to CAPs,
sub-inhibitory concentrations of cathelicidin LL-37 stimulate expression of the S.
pyogenes hyaluronic acid capsule synthesis operon (hasABC), which results in a more
invasive phenotype [167]. This is a regulatory effect apparently exclusive to LL-37
among all the CAPs tested and involves direct sensing of the extra-cellular concentration
of the LL-37 peptide by the CsrRS (CovRS) two-component regulatory system [167,
168]. Replacement of three acidic amino acids with uncharged residues in the
extracellular domain of the CsrS (CovS) sensor-kinase abrogated induction of the
hasABC operon by LL-37 [168], providing strong evidence of a close relationship
between CAPs and streptococcal virulence. Mutagenic approaches combined with
exposure to CAPs have conversely uncovered the regulatory networks controlling CAP
resistance, as was the case in S. aureus with the identification of a two component
regulatory system (GraRS) as the controller of key determinants of staphylococcal
surface charge (mprF and dlt) required for resistance to multiple CAPs (HNP-1,
polymyxin B) [169]. Another actively investigated effect of sub-lethal exposure to CAPs
is the inhibition of antibiotic resistance factors produced by pathogens. For example, sublethal amounts of designer analogs of the CAP pyrrhocoricin inhibited the activity of the
TEM-1 ß-lactamase by targeting the heat-shock protein DnaK, thus restoring amoxicillinsensitivity to ß-lactam resistant strains of E. coli [170]. Also at sub-lethal levels, the
enterocin peptide modifies the ion permeability of bacteria, dissipating the membrane
proton motive force; this impairs the activity of multidrug efflux systems in Listeria
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innocua, rendering it susceptible to traditional antibiotics [171], a potentially useful
therapeutic tool given the troubling rise in multidrug resistance amongst pathogens.
Certain CAPs have additionally been demonstrated to act on intracellular targets
or by non-permeabilizing mechanisms [172]. Examples include, activation of bacterial
proteases by indolicidin [173], inhibition of DNA replication by PR-39 or microcin B17
[174, 175], or protein synthesis inhibition by pleurocidin [176]. However, the best
characterized and most effective CAPs with additional non-permeabilizing activity are a
class of lipid II-targeting bacterial defense peptides commonly referred to as lantibiotics
(for a review, see [177]). The term lantibiotic designates gene-encoded peptides that
contain the thioether amino acids lanthionine or methyllanthionine, which are formed by
post-translational modifications that introduce intramolecular cyclic structures. The most
representative lantibiotic, nisin, specifically binds lipid II in a defined stoichiometry in
order to form pores that efficiently permeabilize bacterial membranes [178, 179]. More
importantly however, non-porating variants of nisin have been shown to efficiently kill
bacteria using an alternative mechanism by which lipid II is clustered into patches in the
cytoplasmic membrane away from the regions where cell wall peptidoglycan synthesis
occurs [180]. Other lantibiotics such as gallidermin, epidermin and mutacin have been
observed to act via this alternative mechanism [180-182], thus inhibiting cell wall
synthesis and causing bacterial cell death without permeabilizing the cytoplasmic
membrane.
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Characterizing ExPortal organization and its interaction with CAPs
Recent studies have shown that multiple human CAPs are lethal to GAS in vitro
[183, 184], and that the CAP cathelicicin LL-37 is highly expressed in severe soft tissue
infection in humans at sites coinciding with high tissue burdens of S. pyogenes [185].
Several studies have highlighted the important role of CAPs in innate immune defenses
against S. pyogenes.

These include the observation that soft tissue infection by S.

pyogenes in mice deficient in a major CAP of the cathelicidin family (CRAMP) was
significantly exacerbated [186] and that overexpression of a cathelicidin in murine skin
provides enhanced protection [187]. It is not surprising then, that much recent research
has been directed at identifying streptococcal factors that subvert the lethal effects of
CAP activity [10, 167, 188].
The signature ability of CAPs to bind to the cytoplasmic membrane, offers
numerous targets whose functions could be affected at sub-inhibitory concentrations.
The cytoplasmic membrane is of particular importance to S. pyogenes since, as described
previously, its pathogenicity relies on an extensive network of virulence proteins. Due to
their cationic nature, CAPs predominantly bind to anionic phospholipids in bacterial
membranes [147]. The ExPortal of S. pyogenes has been shown to have an asymmetric
lipid content enriched in anionic phospholipids [99] that may contribute to the
preferential retention of certain proteins at the ExPortal vs. the peripheral membrane [95].
These observations suggest that the ExPortal may thus be uniquely sensitive to the action
of CAPs.
This presented the unique opportunity to expand understanding of the interaction of
a strictly human pathogen like S. pyogenes with an important component of the innate

27

immune response, such as CAPs are, and of the mechanisms underlying the coordination
of protein secretion and processing by the ExPortal in an organism as dependent as GAS
are on secreted virulence factors. Thus, I investigated the interaction of CAPs at sublethal concentrations with S. pyogenes and the effects of said interaction on ExPortal
organization and function. Given that lipid II-targeting CAPs can disrupt cell wall
synthesis absent effects on membrane permeability and the potential for the ExPortal as a
target for CAPs, this work was also designed to determine whether a link exists between
cell wall biogenesis and organization of the secretory organelle that is the ExPortal.
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ABSTRACT
Although they possess a well-characterized ability to porate the bacterial
membrane, emerging research suggests that cationic antimicrobial peptides (CAPs) can
influence pathogen behavior at levels that are sub-lethal. In this study, we investigated
the interaction of polymyxin B and human neutrophil peptide (HNP-1) with the human
pathogen

Streptococcus

pyogenes.

At

sub-lethal

concentrations,

these

CAPs

preferentially targeted the ExPortal, a unique microdomain of the S. pyogenes membrane,
specialized for protein secretion and processing. A consequence of this interaction was
the disruption of ExPortal organization and a redistribution of ExPortal components into
the peripheral membrane. Redistribution was associated with inhibition of secretion of
certain toxins, including the SpeB cysteine protease and the Streptolysin O (SLO)
cytolysin, but not SIC, a protein that protects S. pyogenes from CAPs. These data suggest
a novel function for CAPs in targeting the ExPortal and interfering with secretion of
factors required for infection and survival. This mechanism may prove valuable for the
design of new types of antimicrobial agents to combat the emergence of antibioticresistant pathogens.
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INTRODUCTION
Cationic antimicrobial peptides (CAPs) are gene-encoded antibacterial peptides
produced by nearly all known life-forms. A group of these, the defensins, are expressed
by neutrophils and epithelial cells of humans and other mammals, functioning both as
broad-spectrum microbicides and as modulators of the immune response [1]. It is
generally accepted that the antibacterial activity of CAPs involves interactions of their
charged and hydrophobic residues with the hydrophilic charged head groups and the fatty
acyl chains of phospholipids in the bacterial membrane.

The consequence of this

interaction is the destruction of membrane permeability and bacterial cell death [2, 3].
However, more recent studies have suggested that many of these peptides may have
multiple targets and/or much more complicated mechanisms of action (reviewed by [4]).
In particular, one aspect of the peptide-pathogen interaction that is not often examined is
the manner in which CAPs act on their bacterial targets at levels below their minimum
inhibitory concentrations.
Interaction with CAPs plays an important role in host-pathogen interactions for
infections caused by Streptococcus pyogenes (group A streptococcus).

This Gram-

positive pathogen can cause numerous diseases in humans that range from largely
superficial infection of the skin and mucous membranes (impetigo, pharyngitis), to highly
invasive and life-threatening diseases (necrotizing fasciitis), as well as, serious postinfection sequelae (rheumatic fever, glomerulonephritis, reviewed in [5]). Recent studies
have shown that multiple human CAPs are lethal to S. pyogenes in vitro [6, 7], and that
the CAP cathelicicin LL-37 is highly expressed in severe soft tissue infection in humans
at sites coinciding with high tissue burdens of S. pyogenes [8]. Several studies have

43

highlighted the important role of CAPs in innate immune defenses against S. pyogenes.
These include the observation that soft tissue infection by S. pyogenes in mice deficient
in a major CAP of the cathelicidin family (CRAMP) was significantly exacerbated [9]
and that overexpression of a cathelicidin in murine skin provides enhanced protection
[10]. It is not surprising then, that much recent research has been directed at identifying
streptococcal factors that subvert the lethal effects of CAP activity [11-13].
The signature ability of CAPs to bind to the cytoplasmic membrane, offers
numerous targets whose functions could be affected at sub-inhibitory concentrations.
The cytoplasmic membrane is of particular importance to S. pyogenes, as its ability to
cause disease is dependent on the secretion of an extensive network of virulence proteins
[14]. Lacking other known secretion systems, these virulence proteins are exported by the
general secretory [15] pathway, which is highly conserved between Gram-positive and –
negative bacteria and eukaryotes (for a review see [16]). However, unlike these latter
two classes, Gram-positive bacteria lack a specialized cellular compartment for folding
proteins following their translocation across the membrane by the Sec system. A solution
to this problem used by S. pyogenes and several other species of Gram-positive cocci, is
to cluster the Sec translocons at a defined microdomain of the cytoplasmic membrane
that has been termed the ExPortal [17-21]. The ExPortal is also highly enriched with
accessory factors for protein biogenesis, including sortases, and HtrA. The former are
involved in the covalent attachment of proteins to the cell wall, while the latter is a multifunction protease and chaperone that is required for the biogenesis of the active form of
the SpeB protease. These data suggest that one function of the ExPortal is to spatially
couple secretion with protein maturation [17-19, 22, 23]. This is supported by the
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observation that mutations causing the mis-localization of HtrA or sortase C outside of
the ExPortal microdomain result in a highly reduced efficiency for maturation of secreted
proteases and pili, in S. pyogenes and Enterococcus faecalis, respectively [18, 19].
Due to their cationic nature, CAPs predominantly bind to anionic phospholipids in
bacterial membranes [3]. Of interest, the ExPortal of S. pyogenes has been shown to have
an asymmetric lipid content enriched in anionic phospholipids [22] that may contribute to
the preferential retention of certain proteins at the ExPortal vs. the peripheral membrane
[19]. These observations suggest that the ExPortal may be uniquely sensitive to the
action of CAPs. In the present study, we examined the interaction between several CAPs
and S. pyogenes and report that CAPs preferentially interact with the ExPortal when
examined at sub-lethal concentrations and that this results in a re-distribution of ExPortal
components into the peripheral membrane. Furthermore, this disruption is associated
with an inhibition of secretion of the SpeB cysteine protease and the Streptolysin O
(SLO) cytolysin.
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RESULTS
Polymyxin B binds to a single, unique site on the S. pyogenes membrane. To test the
hypothesis that CAPs may interact with the ExPortal, we examined how the CAP
polymyxin B interacts with the S. pyogenes membrane at sub-lethal concentrations.
Readily available and well-characterized in its ability to bind anionic lipids [24],
polymyxin B is a cyclic CAP antibiotic that is highly active against Gram-negative, but
not most Gram-positive bacteria [25]. However, S. pyogenes is an exception and is
highly susceptible to polymyxin B (see below), which likely reflects that unlike many
other Gram-positive species its genome does not contain mprF [26], which encodes an
enzyme that modifies the negative charge of phosphatidyl glycerol via lysinylation to
reduce its affinity for binding CAPs [27, 28]. The interaction of polymyxin B with S.
pyogenes was therefore examined using a biotin-labeled derivative of polymyxin B to
treat cultures of the M1 serotype S. pyogenes strain SF370 in a “challenge assay.” In this
assay (see “Experimental Procedures”), polymyxin B was added to cultures in the late
logarithmic phase of growth (time = 0 h) and samples harvested for analysis after cultures
had entered stationary phase (Fig. S3). The concentrations of polymyxin B used had no
effect on viability in this assay and did not result in significant poration of membranes
(see “Experimental Procedures” and Fig. S1). Bound polymyxin B was detected using a
streptavidin-gold conjugate and examined by electron microscopy.

This analysis

revealed that rather than a uniform pattern of circumferential staining, cells consistently
exhibited a single intense focus of gold particles at a discrete location adjacent to the
membrane (Fig. 1A). An identical pattern was observed following treatment of the M14
serotype S. pyogenes strain HSC5 (data not shown) and minimal staining with the
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streptavidin conjugate was observed in the absence of treatment with biotin-labeled
polymyxin B (data not shown).

Polymyxin B targets the ExPortal. The pattern of polymyxin B binding was then
examined following treatment with a fluorescent derivative of polymyxin B (dansylpolymyxin B) at sub-inhibitory concentrations. Treatment with <60 µM polymyxin B
under our challenge assay conditions (see “Experimental Procedures”) did not alter the
viability of cultures at the end of the period of incubation as determined by enumeration
of colony forming units (Fig. S1A). Examination of cultures treated with a fluorescent
probe that is excluded by intact membranes (Live/Dead®) confirmed the viability of
polymyxin B treated cultures and demonstrated that most cells had membranes that were
not porated (Fig. S1B). Examination by fluorescent microscopy revealed that when
treated at concentrations <15 µM the fluorescent CAP typically localized to a single
discrete site of the membrane (Fig. 1B, C, D, E). Some cells with staining at multiple foci
or with a more diffuse distribution around the circumference of the cell were also
observed (data not shown). However, when examined quantitatively, the number of cells
with single foci exceeded 60% and was significantly higher than that observed for any
other staining pattern (P<0.0001, Fig. 1F). To assess whether polymyxin B was targeting
the ExPortal, co-staining was conducted to determine if these foci corresponded to the
site of secretion of the SpeB cysteine protease, a signature feature of the ExPortal [17,
18].

This was conducted using an assay that employs a protease substrate that is

intramolecularly quenched but becomes active when cleaved to visualize the site of
secretion of active SpeB protease in cells that have been embedded in agarose [17, 29].
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Figure 1. Focal binding of Polymyxin B to the S. pyogenes surface: The distribution of
polymyxin B on the surface of S. pyogenes SF370 following sub-lethal challenge was revealed:
(A) by treatment with biotinylated polymyxin B (1:10,000) and immunogold electron microscopy
using staining with a streptavidin-gold conjugate (scale bar = 200nm) and (B, C, D, E) by
fluorescent microscopy following challenge with dansyl-polymyxin B alone (B) at the
concentration indicated in the Figure (scale bar = 1µm) or in cells counterstained with Nile Red
(C), fluorescent vancomycin (D) or wheat germ agglutinin Alexa Fluor 488 conjugate (E).
Staining patterns following challenge with dansyl-polymyxin B were quantitated as described in
the Experimental Procedures (F). Data represents the mean and standard error of the mean (SEM)
derived from at least 3 independent experiments and examination of a minimum of 1000 stained
cells. The number of cells with a single focus was significantly higher than any other staining
pattern (P < 0.0001).
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When a sub-inhibitory concentration of dansyl-polymyxin B (5 µM or 10 µM) was
included in this assay about 50% of the cells showed staining with both reagents.
However, when co-stained (Fig. 2), the coincidence of the membrane site recognized by
dansyl-polymyxin B and the site of SpeB secretion approached 100% (out of at least 200
co-stained cells observed).

Figure 2. The site of polymyxin B binding is coincident with the site of SpeB secretion. Cells
of S. pyogenes SF370 were challenged with dansyl-polymyxin B (10 µM), fluorescent
vancomycin stained to visualize cell wall and subjected to the red protease assay, which monitors
cleavage of BODIPY TR-X-casein by the SpeB protease. Stained cells were then examined by
fluorescent microscopy. Panels are as follows: (A, E) fluorescent vancomycin, (B, F) BODIPY
TR-X-casein, (C, G) Dansyl-polymyxin B and (D, H) Merge of Panels A, B and C. Scale bar =
1µm.
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Polymyxin B disrupts ExPortal Lipids.

The data above suggest that at sub-lethal

concentrations, polymyxin B preferentially targets the ExPortal. The consequence of this
interaction was then examined using higher, but still sub-lethal concentrations of the
CAP. ExPortal integrity was assessed by staining with 10-nonyl acridine orange (NAO),
a fluorescent membrane probe that preferentially binds anionic phospholipids [22, 30]. In
the absence of polymyxin B, NAO stained cells at single foci (Fig. 3A), which were
previously shown to be co-incident with the ExPortal [22]. Following treatment with 30
µM polymyxin B, most cells had either multiple foci or a more diffuse staining pattern
(Fig. 3B), while this latter pattern predominated following treatment with 60 µM
polymyxin B (Fig. 3C). This result suggested that the CAP was altering the organization
of ExPortal-associated anionic phospholipids. Consistent with this, treatment with a
higher, but still sub-lethal concentration of biotin-labeled polymyxin B resulted in cells
stained at multiple foci or more diffusely around the membrane when examined by
electron microscopy, rather than staining at single foci as was observed at lower
concentrations (compare Fig. 3E with Fig. 1A,). Similarly, treatment with a higher
concentration of dansyl-polymxin B resulted in a majority of cells stained at multiple foci
(compare Fig. 3F, G to Fig. 1B, D, E). This shift was examined quantitatively (Fig. 3H),
revealing that the number of cells stained at multiple foci was significantly higher than
other staining patterns observed. Stressing membranes by subjecting cells to a condition
known to induce the heat shock response (42oC, 30 mins.; [18]) did not alter the focal
pattern of NAO staining (Fig. 3; compare panels 3D, 3A). Similarly, heat shock did not
alter the focal binding pattern of a low sub-lethal concentration of bodipy-labeled
polymyxin B (10 µM, Fig. S2C,D), which contrasts with the disruption observed at a
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Figure 3. Sub-lethal challenge with polymyxin B alters the distribution of anionic membrane
lipids. Cultures of S. pyogenes SF370 were stained with NAO following challenge with 0 µM
(A), 30 µM (B) or 60 µM (C) polymyxin B or heat shock at 42˚C (D) and examined by
fluorescent microscopy (scale bar = 1µm). The distribution of polymyxin B following higher, but
still sub-lethal challenge, was revealed by treatment with biotinylated polymyxin B (1:500) and
immunogold electron microscopy using staining with a streptavidin-gold conjugate (scale bar =
200nm) (E) and by fluorescent microscopy following challenge with dansyl-polymyxin B alone
at the concentration indicated in the Figure (scale bar = 1µm) (F) or costained with fluorescent
vancomycin (G). Staining patterns following challenge were quantitated as described previously
(H). Data represents the mean and SEM derived from at least 3 independent experiments and
examination of a minimum of 1000 stained cells. The number of cells with multiple foci was
significantly higher than any other staining pattern (P < 0.0001) at this polymyxin B
concentration.
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higher sub-lethal concentration (45 µM, Fig. S2E,F). Thus, these data suggest that
disruption of the ExPortal-associated anionic lipid domain is specific to high sub-lethal
concentrations of polymyxin B and does not result from a general membrane stress
response.

Polymyxin B disrupts ExPortal Organization. There is evidence to suggest that the
asymmetric lipid content of the ExPortal contributes to the retention of some ExPortalassociated membrane proteins [19]. This suggests that the polymyxin B-mediated
disruption of ExPortal lipid structure observed above could result in an overall disruption
of ExPortal organization. To test this, the distribution of several proteins known to be
enriched at the ExPortal was examined in cells of strain SF370 exposed to a sub-lethal
concentration of polymyxin B. The concentrations tested (30-60 µM) were those that
produced a high frequency of cells with multiple NAO- or polymyxin B-stained foci (see
above). Consistent with prior studies [17, 18], in the absence of polymyxin B, the
translocon ATPase SecA localized to a single membrane site in a majority of cells when
examined by immunogold electron microscopy (Fig. 4A). Similarly, the membraneassociated HtrA serine protease [18] localized to a single membrane site in a majority of
cells when examined by immunogold electron microscopy (Fig. 4D) and by
immunofluoresent microscopy (Fig. 4G, H). Adding polymyxin B at concentrations <30
µM did not alter this pattern for either SecA or HtrA. However, polymyxin B
concentrations of of 30 µM through 60 µM resulted in redistribution of SecA (Fig. 4B,C)
and HtrA (Fig. 4E,F, I, J) as demonstrated by a more circumferential staining pattern and
a significant increase in the number of cells demonstrating multiple stained foci (Fig. 4K;
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Figure 4. Redistribution of ExPortal proteins following sub-lethal polymyxin B challenge.
The distribution of SecA (A, B, C) and HtrA (D, E, F) on S. pyogenes SF370 was assessed by
immunogold electron microscopy following challenge with polymyxin B at the concentrations
indicated in the Figure (scale bar = 200nm). The distribution of HtrA was also assessed by
immunofluorescent microscopy in the absence of (G, H) and following challenge with polymyxin
B at 47 µM (I, J) and was quantitated as described previously (scale bar = 500nm) (K). Data
represents the mean and SEM derived from at least 3 independent experiments and examination
of a minimum of 1000 stained cells. In untreated cultures, the number of SF370 or HSC5 cells
with a single focus was significantly higher than any other staining pattern (P < 0.05), whereas in
polymyxin B-treated cultures, the number of streptococcal cells with multiple foci was
significantly higher (P < 0.05).
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P<0.05). Similar results were observed with the unrelated strain HSC5 (data not shown).
Analysis of culture fractions indicated that the levels of SecA protein were unchanged in
peptide-challenged streptococci and that the protein was retained in the same fractions in
treated and untreated cells (Fig. S3A), suggesting that only localization of SecA at the
membrane is affected. These data demonstrate that sub-lethal polymyxin B treatment can
result in a disruption of ExPortal organization.

Polymyxin B inhibits ExPortal-mediated secretion of SpeB. Disruption of ExPortal
organization could have a deleterious effect on protein secretion. Particularly vulnerable
would be those proteins that require the ExPortal to coordinate the activities of multiple
secretion and biogenesis factors. A prominent example of this class is the SpeB cysteine
protease, which requires numerous accessory factors, including the ExPortal-localized
HtrA, for its secretion and conversion of its 43 kDa zymogen into the 28 kDa mature
form [18, 31-34]. In addition, because the gene encoding SpeB is expressed at the onset
of the stationary phase of culture [35-37], its expression would provide a sensitive
assessment of the effect of prior challenge with a CAP at the late logarithmic phase of
growth. Treatment of strain SF370 with various sub-lethal concentrations of polymyxin
B resulted in a dose-dependent reduction in the amount of cysteine protease activity in
culture supernatant (Fig. 5A), to a level less than 20% of that observed in the absence of
the CAP (Fig. 5A, 60 µM). This reduction correlated with a dose-dependent decrease in
the amount of SpeB polypeptide that was detected in treated culture supernatants (Fig.
5B). Secretion of SpeB in strain HSC5 was inhibited at lower concentrations of
polymyxin B (Fig. S3B) and challenge with 60 µM polymyxin B
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Figure 5. High sub-lethal challenge with polymyxin B inhibits secretion of SpeB and SLO,
but not SIC. Expression of the SpeB protease in cultures of S. pyogenes SF370 was determined
following challenge with the indicated concentrations of polymyxin B by quantitation of cysteine
protease activity in culture supernatant (A), by real-time RT-PCR analysis of speB transcript
abundance (A, inset) by Western blot analysis of culture supernatant (B) in whole cell lysates (C)
and following overnight culture on protease indicator plates containing (+) or lacking (-) 150 µM
polymyxin B (D). Expression of SpeB results in a zone of clearing around colonies. Western
blotting was also used to analyze the amount of SLO (E) and SIC (F) present in culture
supernatant following challenge with the indicated concentrations of polymyxin B. All samples
for SpeB analysis were harvested at 3 hrs post-challenge; samples for SLO and SIC were
harvested 2hrs post-challenge. Open and filled triangles indicate the migration of the zymogen
and mature form of SpeB, respectively. The migration of the SLO and SIC polypeptides are also
indicated.
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resulted in a >95% inhibition of SpeB activity (data not shown). Several lines of evidence
indicated that inhibition was not caused by an effect on growth, induction of stress or by
suppression of speB transcription. Firstly, at the time of analysis of SpeB in culture
supernatants (3 hrs post-challenge, Fig. S3C), the speB transcript was as abundant or
present at higher levels as compared to untreated cultures (Fig. 5A, inset). Secondly,
when transcription of speB was de-repressed and partially uncoupled from its growth
phase-dependent control by mutation of the regulatory gene vfr [34, 38], polymyxin B
challenge resulted in the same profile of inhibition of SpeB secretion that was observed
for the wild type strain (Fig. S3D). Thirdly, sublethal polymyxin B did not induce a
general stress response, as treatment had no effect on levels of the HtrA protease (Fig.
S3E). Fourthly, while treatment reduced the amount of SpeB present in supernatants, the
SpeB polypeptide was still produced and could be detected in cell lysates (Fig. 5C).
Finally, incorporation of polymyxin B into protease indicator plates at concentrations that
did not reduce numbers of CFU’s, did inhibit expression of protease activity, as indicated
by an absence of zones of clearance around colonies on treated media following
overnight culture (Fig. 5D), although some activity was evident upon a prolonged period
of incubation (not shown).

Taken together, these data indicate that polymyxin B

challenge inhibits SpeB expression at the level of secretion.

Polymyxin B inhibits secretion of SLO but not SIC. The Sec pathway delivers
presecretory proteins to the translocons via either the post-translational pathway or the
co-translational signal peptide recognition (SRP) pathway. While SpeB can be secreted
via the post-translational pathway, the cytolysin SLO is targeted via the SRP pathway
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[33]. Given that expression of this cytolysin begins during the early logarithmic phase of
growth, the challenge assay was slightly modified (see Experimental Procedures) in order
to detect SLO that was secreted post-challenge. Comparison of supernatant harvested
from peptide-challenged and untreated cultures of SF370 revealed a dose-dependent
decrease in the amount of SLO protein detected in treated cultures (Fig. 5E); an effect
that was more pronounced in HSC5 (data not shown). Similar to speB, slo transcript
levels in polymyxin B-challenged cultures were as abundant as in untreated cultures at
the time of analysis (Fig. S3F). A prominent difference between SF370 and HSC5 is that
the former possesses the Streptococcal Inhibitor of Complement (SIC), which has been
shown to enhance the resistance of S. pyogenes to CAPs [13, 39]. In contrast to SLO, no
apparent differences in secreted SIC polypeptide was observed between culture
supernatants from untreated and challenged cultures of SF370 (Fig. 5F). Thus, inhibition
of toxin secretion is selective for certain toxins and is not a universal feature of sub-lethal
polymyxin B treatment.

Human Defensin HNP-1 also disrupts the S. pyogenes ExPortal. In order to assess if
human CAPs could also disrupt ExPortal function, cultures were challenged with sublethal concentrations of the α-defensin HNP-1, the ß-defensins hBD-1 and hBD-2, and
the cathelicidin LL-37. A Western blot analysis of culture supernatant revealed that of
these, only HNP-1 noticeably inhibited secretion of SpeB at the CAP concentrations
tested (<50 µM for all CAPs tested), and did so at concentrations lower than those
required for similar inhibition by polymyxin B (Fig. 6A). Examination of the staining
pattern of a fluorescent derivative of HNP-1 (5-FAM-HNP1) revealed that while staining
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Figure 6. Focal localization and inhibition of SpeB expression by HNP-1. Cultures were
challenged with HNP-1 or by 5-FAM-HNP-1 at the concentrations indicated. Expression of SpeB
was evaluated by a Western blot analysis (A) and binding to the S. pyogenes surface was assessed
using fluorescent microscopy (B, C, D). Presented are overlays of fluorescent and phase images
(B, C) or the fluorescent image alone (D) (scale bar = 1µm). Staining patterns were quantitated
as described previously (E). Data represents the mean and SEM derived from at least 3
independent experiments and examination of a minimum of 1000 stained cells. At minimal
concentration the number of cells with single foci is significantly higher than all other staining
patterns, whereas multiple foci and hemisphere staining predominated significantly at higher
peptide concentrations (P < 0.05).
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was observed on a small population of cells at low concentration (5 µM, Fig. 6B), that
these predominantly stained at discrete single or multiple foci (Fig. 6E). Increasing
concentrations (15 µM) resulted in a higher percentage of cells with multiple foci (Fig.
6C, 6E), while at even higher concentrations (30 µM) the CAP primarily localizes to one
hemisphere of the cell (Fig. 6D). Finally, localization of HtrA by immunofluorescence
demonstrated that similar to polymyxin B, treatment with HNP-1 at sub-lethal
concentrations that inhibited SpeB secretion also significantly decreased the number of
cells exhibiting HtrA at discrete foci (P<0.0001, Fig. 7). These results suggest that a
CAP to which S. pyogenes may be exposed to inside a human host can disrupt the
organization and function of the ExPortal.
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Figure 7. Challenge with HNP-1 results in redistribution of HtrA. Cultures of S. pyogenes
HSC5 were challenged with the indicated concentrations of HNP-1 and subjected to
immunofluorescent microscopy to assess the distribution of HtrA (A, B). Cell walls were
visualized by staining with fluorescent vancomycin (scale bar = 1µm). Staining patterns were
quantitated as described previously (C). Data represents the mean and SEM derived from at least
3 independent experiments and examination of a minimum of 1000 stained cells. Challenge with
the peptide significantly decreased the number of SF370 or HSC5 cells exhibiting HtrA at single
foci (P<0.0001) and resulted in a significant increase in the number of multiple foci (P<0.0001)
in the SF370 strain.
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DISCUSSION
The ability of S. pyogenes to cause a wide range of diseases has been linked to its
production of virulence factors that neutralize or subvert innate mechanisms of immunity,
including the lethal effects of CAPs (for review, see [14, 40, 41]). However, by showing
that sub-lethal concentrations of CAPs are able to disrupt the secretory ExPortal, the
results of this study suggest that interaction with CAPs may play a more intimate role in
S. pyogenes pathogenesis, serving to modulate virulence factor expression at both the
transcriptional and post-transcriptional levels. Finally, the observation that disruption of
ExPortal organization is associated with a defect in secretion of certain toxins provides
additional support for the concept that the ExPortal serves a functional role in facilitating
protein secretion.
A literature is emerging indicating that individual CAPs have a considerable
diversity in how they interact with and kill bacteria using both lytic and non-lytic
mechanisms (reviewed in [42-44]). However, an initial step common to all pathways
analyzed to date, involves the binding of the CAP to anionic lipids in the membrane.
While little is currently known about the mechanism(s) by which sub-lethal
concentrations of CAPs may affect bacterial physiology, the data presented here indicate
that disruption of ExPortal organization and inhibition of SpeB and SLO secretion were
also associated with membrane binding by the CAPs. Most models of CAP action
postulate that at low sub-lethal concentrations, the peptides bind in a parallel orientation
relative to the lipid membrane and begin to aggregate as concentrations increase, until a
lethal concentration is reached and the peptides reorient to attack the membrane
(reviewed by [4, 43]). The observation that CAP binding to the ExPortal leads to
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redistribution of anionic lipids in the absence of pore formation contrasts with CAP
behavior in model membranes, where they typically cluster anionic lipids (reviewed in
[45]). Additionally, this redistribution of anionic lipids does not appear to induce or result
from generalized disruption of the cytoplasmic membrane, as our data show that the
integrity of the membrane is not compromised. Furthermore, numerous functions that
depend on membrane integrity are also not compromised, including energy-dependent
processes such as gene transcription and cell-growth, the latter of which also requires the
assembly of macromolecular complexes at the membrane. The binding of polymyxin B to
the membrane appears to only affect the physical location of anionic lipids and SecA
within the membrane relative to each other and to accessory factors like HtrA. This
suggests that the initial binding and/or aggregation of the CAPs is sufficient to disrupt the
factor(s) that maintains ExPortal organization. If the anionic character of these lipids
plays a fundamental role in organization, then it is possible that CAP binding serves to
neutralize their charge to promote disruption. Alternatively, the interaction of CAPs with
ExPortal lipids may disrupt the insertion or translocation of factors that function to
maintain ExPortal lipid organization.

The redistribution of ExPortal-associated

membrane proteins may then occur subsequent to disruption of lipid structure, as analysis
of a bitopic membrane protein (sortase C) has suggested that interaction between anionic
lipids and a high density of positive charge in the cytoplasmic tail of its transmembrane
helix is responsible for its localization at the ExPortal [19].
Many bacterial pathogens segregate charged lipids into microdomains (reviewed
in [46, 47]) and these support the function of several multi-enzyme complexes required
for secretion, membrane protein biogenesis and cell division [48-50]. Since some CAPs
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can kill in the absence of pore formation and can also target charged lipids, it has been
proposed that they exert their lethal effect by interfering with the dynamic function of
these lipid-associated complexes, referred to as the “sand in a gearbox” mechanism [51].
This concept is supported by the observation that these CAPs can elicit enhanced
expression of some components of these complexes [51]. By documenting the physical
disruption of a multi-component organelle in the absence of poration, the results of the
present study provide strong support for this mechanism. Furthermore, they extend this
emerging concept to show that disruption can also occur at sub-lethal exposure to CAPs,
and as a consequence, significantly influence how the bacterium interacts with its
environment.
To date, modulation of signaling via the CovRS (CsrRS) two-component
transcription regulator has been the most widely studied consequence of sub-lethal S.
pyogenes-CAP interaction. Analysis of this mechanism has shown that from among a
large panel of CAPs that included HNP-1, only human LL-37 functioned to induce
signaling [12]. Similarly, ExPortal targeting was not a property that was shared by all the
CAPs tested in the present study, including LL-37. While the reason for this is not
known, it was not unexpected, as the considerable diversity of CAP structure is reflected
in differences in selectivity, binding efficiency, mechanism of killing and the physical
conditions required for optimum activity (reviewed by [42]).

Furthermore, these

behaviors have not been extensively investigated at sub-lethal concentrations for any
CAP.
Of the human-derived CAPs tested in the present study, HNP-1 proved more
potent that polymyxin B in ExPortal disruption. This α-defensin is expressed
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constitutively in the azurophilic granules of neutrophils [1] and can be detected at
concentrations of up to 63 µM [52] in secretions from nasopharyngeal tissue, a niche that
can be colonized by S. pyogenes. Thus, it is likely that S. pyogenes encounters HNP-1
during infection.

Also, while HNP-1 targets anionic lipids, it may have additional

targets, including the lipid II molecule involved in cell wall synthesis [53]. Binding to
lipid II likely explains why higher concentrations of HNP-1 produced more heterogenous
patterns of staining, including a tendency for staining one hemisphere of the cell. In
“ovococci” like S. pyogenes, which divide in successive parallel planes perpendicular to
their long axis, this pattern is consistent with the pattern of new cell wall synthesis
(reviewed by [54]).
The ability of S. pyogenes to secrete numerous toxins likely plays a central role in
its ability to cause disease [55]. Thus, inhibition of SpeB and SLO may represent a
physiologically relevant property of sub-lethal CAP concentrations. Since secretion of
essential proteins will be required to support viability, it is unlikely that sub-lethal CAP
treatment would produce a global blockade of protein secretion.

It is known that

biogenesis of SpeB requires secretion factors that are not required for other Sec-secreted
proteins [31-34]. Similarly, as an SRP substrate [33] SLO’s secretion requires
coordination between FtsY, the membrane receptor for the SRP, and the Sec translocons
[56]. In contrast SIC secretion in the SF370 strain was unaffected by CAP treatment, a
result that suggests that its secretion may not require additional factors in addition to Sec.
If the ExPortal functions to coordinate interactions between various secretion
components, then disruption of ExPortal organization could lead to the secretion defect.
Alternatively, it has been shown that some CAPs can act on internal targets (reviewed by
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[4]), raising the possibility that sub-lethal CAPs may interfere with secretion factors in
the cytoplasmic compartment of the streptococcal cell.
Interestingly, analysis of the recently introduced antibiotic daptomycin has
suggested that it principally targets regions of membrane enriched in anionic
phospholipids [57], suggesting that these domains can be exploited for the development
of even more potent antibiotics. Thus, further analysis of CAP-ExPortal interaction will
be valuable for uncovering the fundamental organizing principles of the ExPortal, how
the ExPortal informs the coordination of protein secretion and maturation and the
importance of modulation of secretion in response to host factors during infection.
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EXPERIMENTAL PROCEDURES
Strains, plasmids, media and growth conditions: As indicated, experiments utilized S.
pyogenes HSC5 [58] or SF370 [26]. Localization of HtrA was analyzed in HSC5
following transformation by pHtrA-HA, which expresses a HA-tagged derivative of HtrA
[18]. Strain GCP682 contains an in-frame deletion (vfrΔ15-289) in vfr (SPy_0887) (G. Port
and M. Caparon in preparation). Routine culture was at 37°C in Todd-Hewitt broth
(BBL) supplemented with 0.2% yeast extract (Difco) (THY medium). Functional assays
utilized cultures grown in unmodified C medium as described previously [59]. To
produce solid media, Bacto Agar (Difco) was added to a final concentration of 1.4%.
Expression of the secreted SpeB cysteine protease was evaluated on skimmed milk agar
medium [31]. Liquid cultures were grown without agitation in closed containers and solid
cultures were incubated under anaerobic conditions using a commercial gas generator
(GasPak, cat. #260678, BBL) as described [59]. The SpeB protease was inhibited in
cultures used to analyze the abundance of secreted streptococcal proteins by including the
cysteine protease inhibitor E64 [31]. In selected experiments, media were supplemented
with CAPs, including polymyxin B (cat. #P0972-50MU, Sigma), Human Neutrophil
Peptide-1 (HNP-1, cat. #60743, AnaSpec), Human ß-defensin 1 (hßD-1, cat. #072-53,
Phoenix Pharmaceuticals), Human ß-defensin 2 (hßD-2, cat.#072-48, Phoenix
Pharmaceuticals), and Human cathelicidin LL-37 (LL-37, cat. #61302, AnaSpec) at the
concentrations indicated in the text.

Challenge with CAPs: Unless otherwise indicated, bacteria were cultured overnight in
liquid THY medium, diluted 1:100 in fresh C medium and then cultured to the late-
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logarithmic phase of growth (Fig. S3C, 0h). The CAPs were then added to the various
final concentrations indicated in the text and incubation continued until cultures reached
stationary phase (3 hrs post-treatment, Fig. S3C) as determined by monitoring optical
density (OD600). Control cultures were grown in parallel, but were not treated with any
CAPs; control and treated cultures entered stationary phase at approximately the same
time (Fig. S3C). For this challenge assay, the minimum concentration of polymyxin B
and HNP-1 that resulted in a greater than one-log reduction in the number of SF370
viable cells (determined by enumeration of colony forming units as described below)
were 145 µM and 67 µM, respectively. This assay differs from a conventional assay for
determining the minimal inhibitory concentration, which employs an inoculum of
stationary phase cells from an overnight culture at a low cell density. As expected, SF370
was more sensitive to polymyxin B in the conventional assay (22 µM). In contrast, SF370
was more resistant to polymyxin B on protease indicator medium (see Fig. 5), which is
likely due to its increased lipid content. For analysis of proteins whose expression begins
in early logarithmic phase, the challenge assay was modified in order to remove proteins
secreted into the supernatant prior to challenge as follows: cultures were grown to midlogarithmic phase (Fig. S3C), harvested by centrifugation, immediately resuspended in an
equivalent volume of warm fresh medium and then challenged with CAPs as indicated in
the text. Samples were collected and processed for assessment of viability, for
microscopy and for analysis of protein secretion, as described below. Data presented are
representative of those obtained over the range of sub-lethal concentrations of CAPs.
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Analysis of Viability: At selected time points following challenge with CAPs, aliquots
were removed from cultures and viability assessed by determination of CFUs following
brief sonication to disrupt streptococcal chains, serial dilution in PBS and plating on C
medium agar as described previously [60]. Viability was also assessed by staining with a
fluorescent vital dye (LIVE/DEAD®, BacLighttm) as recommended by the manufacturer
(Invitrogen). Viability was quantitated by examination using a fluorescent microscope
(Leica model DM IRE 2) with enumeration of the percentage of live bacteria in randomly
chosen microscopic fields totaling >1000 cells for each condition examined. Data
reported represent the mean and standard error of the mean derived from a minimum of 3
independent experiments. Differences between calculated means were evaluated for
significance using a one-way Analysis of Variance (ANOVA).

Cellular staining and fluorescent microscopy: Streptococcal cultures were challenged
with various CAPs as described above, stained with various fluorescent reagents and then
analyzed by fluorescent microscopy as follows: Analysis of the location and integrity of
a membrane microdomain enriched in anionic phospholipids was assessed by staining
with 10-nonyl acridine orange (NAO, cat. #A7847 Sigma) as described [22].
Localization of the discrete membrane site of secretion of the SpeB cysteine protease was
conducted using the red protease assay [17]. Analysis of CAP binding involved the
substitution of native CAPs in the challenge assay with sub-lethal concentrations of
fluorescent derivatives, including dansyl-polymyxin B (5, 10, 15 and 47µM, cat.
#P13238, Invitrogen), polymyxin B BODIPY®FL conjugate (10 and 45µM, cat.
#P13235, Invitrogen) or 5-FAM-HNP-1 (5, 15 and 30µM, custom synthesis by
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AnaSpec). Samples were examined using a Leica model DM IRE 2 fluorescent
microscope and images captured using a QImaging Retiga 1350 EX charged-coupled
device camera and Openlab software (Improvision). Where indicated, simultaneous
treatment with 2 reagents was conducted in order to assess co-localization of staining. In
these experiments streptococcal cells walls were visualized by staining with fluorescent
vancomycin (1 µg ml-1, cat. #V34850, Invitrogen), or wheat germ agglutinin Alexa Fluor
488 conjugate (5 µg ml-1, cat. #W11261, Invitrogen) and neutral membrane lipids were
visualized by staining with Nile Red (2.5 ug ml-1, cat. #N1142, Invitrogen). Focal
localization in images of cells was quantitated as described in detail elsewhere [19] and
scored as staining at a unique focus, multiple foci, or non-specifically (staining was of
homogeneous intensity around the cellular circumference). Co-localization in the red
protease assay was quantitated as the percentage of vancomycin-stained cells that
exhibited focal staining with each individual reagent where the two foci were
superimposable. Data presented for each condition represents the mean and standard
error of the mean derived from at least 3 independent experiments and examination of a
minimum of 1000 stained cells. Images were processed for publication using Adobe
Photoshop CS3.

Immunofluorescent microscopy: The localization of native and HA-tagged HtrA protein
(in SF370 and HSC5, respectively) was detected by immunofluorescent microscopy, as
described [18]. Aliquots from untreated or CAP-treated (47 µM polymyxin B or 29 µM
HNP-1) challenge assay cultures (see above) were treated with PlyC lysin (prepared as
described, [61]) and fixed according to the method of Raz and Fischetti [23]. Antisera
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used included a polyclonal rabbit anti-HtrA antiserum (a gift from Mark Walker,
University of Wollongong, Australia) used at a dilution of 1:100 that was detected using
an AlexaFluor 594-lableled goat anti-rabbit IgG (Invitrogen) at 1:500 and an AlexaFluor
594-conjugated rabbit IgG anti-HA epitope antiserum (Invitrogen) used at 1:500. Wheat
germ agglutinin (WGA)-AlexaFluor 488 (Invitrogen) at a final concentration of 5 µg ml-1
was used to visualize the streptococcal cell walls. Slides were mounted in an anti-fade
reagent (Prolong Gold, Invitrogen) and images captured and staining patterns quantitated
as described above. Differences between means were analyzed for significance using a
two-tailed Student’s t-test.

Immunogold electron microscopy: Localization of polymyxin B binding was examined
by electron microscopy, as follows:

Cultures in the assay described above were

challenged with biotin-conjugated polymyxin B (HyCult Biotechnologies) at the various
dilutions indicated in the text.

At 1 hr post-challenge, aliquots were removed and

prepared for immunoelectron microscopy as described [17, 18]. Sections were stained
using a streptavidin-gold conjugate (20nm, BBI International) and examined by electron
microscopy as detailed [17, 18]. Localization of SecA and HtrA following treatment in
the challenge assay with the concentrations of polymyxin B indicated in the text was
determined at 2 hr post-challenge by immunogold electron microscopy [17, 18]. Focal
staining was defined and quantitiated as described in detail elsewhere [19].

Analysis of protein expression and secretion: Expression of the transcript for the SpeB
cysteine protease was determined at various time points following challenge with
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polymyxin B by real time RT-PCR as described [59, 62]. Data represents the mean and
standard error of the mean derived from 3 independent experiments conducted on
different days, with each sample analyzed in quadruplicate. Supernantant fractions from
cultures challenged with polymyxin B were analyzed for SpeB proteolytic activity as
previously described [18] via the relative increase in fluorescence generated by the
cleavage of fluorescein isothiocyanate-casein (cat. #C3777, Sigma). Supernatant, cell
wall and protoplast fractions from cultures challenged with CAPs were prepared and
analyzed for the presence of SpeB and HtrA by Western blotting as described [33]. Blots
were developed using a Chemidoc XRS imager (BioRad) and relative protein
concentrations determined using Quantity One software (BioRad, version 4.6.7). Data
are expressed relative to untreated cultures and were derived from a minimum of 3
independent experiments. Differences between means were evaluated for significance
using one-way ANOVA.
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SUPPLEMENTARY FIGURES

Figure S1. Validation of sub-lethal polymyxin B challenge. Cultures of S. pyogenes SF370
were treated with the indicated concentrations of polymyxin B in the challenge assay and viability
assessed by (A) determining the number of colony forming units (CFU) following serial dilution
and plating on C medium and (B) fluorescent microscopy of cells following staining with
reagents that distinguish between cells with intact membranes and those whose membranes have
become porated (LIVE/DEAD BacLighttm, Invitrogen). Samples for both viability assays were
harvested following 2 hrs of treatment, and numbers of CFU determined following 24 hrs of
incubation. Numbers of cells with porated membranes were derived from examination of at least
1000 stained cells. All data presented represents the mean and standard error of the mean derived
from at least 3 experiments. Differences between mean values were evaluated for significance by
a one-way ANOVA, which revealed no significant differences between any treated vs untreated
cultures. Identical results were obtained from performing these same analyses on S. pyogenes
strain HSC5 (data not shown).
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Figure S2. Focal localization of anionic lipids is unaffected by heat stress. Cultures of S.
pyogenes HSC5 (A, C, E) and SF370 (B, D, F) were challenged in the standard assay as follows:
Cultures were challenged with 10µM bodipy-labeled polymyxin B (Invitrogen) and incubated for
30 min at 37oC (A, B) or subjected to heat shock (42o C, 30 min.) (C, D) or challenged with an
ExPortal-disrupting concentration of bodipy-labeled polymyxin B (45µM) (E, F). Samples were
then analyzed by microscopy and each individual field was examined using fluorescence or phase
contrast modes (left and right of each panel, respectively). Scale bar = 1µm.
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Figure S3. Validation of secretion-inhibitory effects in streptococci of sub-lethal polymyxin
B levels. (A). Expression of the secretory translocon ATPase SecA in cultures of S. pyogenes
SF370 was determined 2 hrs post-challenge with the concentrations of polymyxin B indicated in
the Fig. A Western blot analysis of cell protoplasts is shown. (B) Western blot analysis of SpeB
in culture supernatants of S. pyogenes HSC5 following sub-lethal polymyxin B challenge. Open
and filled triangles indicate the migration of the zymogen and mature form of SpeB, respectively.
(C). Growth of S. pyogenes in the absence or presence of the indicated amounts of polymyxin B.
Arrows indicate the point at which cultures were challenged (0 h, Mid-log) and the subsequent
time points where samples were harvested for the various analyses described in the text. (D). A
Vfr- mutant of HSC5 (GCP682) was cultured to the time of challenge (Mid-log) and then treated
with the indicated concentrations of polymyxin B. Shown is a Western blot analysis of SpeB in
culture supernatant. (E). A Western blot analysis of HtrA in lysates of S. pyogenes SF370 that
were prepared 3 hrs post-challenge with the indicated concentrations of polymyxin B. (F). Realtime RT-PCR analysis of slo transcript abundance following challenge of S. pyogenes HSC5 with
the indicated concentrations of polymyxin B. Data shown represent the mean and SEM derived
from at least three independent experiments conducted on different days and each sample was
analyzed in triplicate.
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ABSTRACT
S. pyogenes and other Gram-positive bacteria circumvent the lack of a specialized
cellular compartment for folding secreted proteins following their translocation by
clustering the Sec translocons at a defined microdomain of the cytoplasmic membrane
that is also enriched in anionic lipids and accessory factors for protein biogenesis,
referred to as the ExPortal. The function of this secretory organelle appears to be that of
spatially coupling secretion with protein maturation, but the mechanisms underlying
ExPortal organization and maintenance are still poorly understood. Emerging literature
suggests that cell wall biogenesis components interact with cytoplasmic membrane
structures and the cell division machinery to organize membrane localized processes. In
the present study we examined the role the streptococcal cell wall and peptidoglycan
synthesis in the cytoplasmic membrane play in organizing and maintaining the ExPortal
and report that extracellular peptidoglycan is required for maintaining proper localization
of both lipid and protein components of the ExPortal. Treatment with a lipid II-targeting
lantibiotic disrupted localization of anionic lipids and ExPortal proteins, as well as
secretion of ExPortal substrates in a manner similar to what was observed previously
with cationic antimicrobial peptides at sub-lethal concentrations. Furthermore, proteins
responsible for the membrane-associated steps of lipid II synthesis localize to foci in the
streptococcal membrane that coincide with the anionic lipid microdomain and secretory
translocons of the ExPortal, suggesting that localization of peptidoglycan synthesis
coincides with the ExPortal and influences its organization.
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INTRODUCTION
Streptococcus pyogenes is the causative agent of numerous diseases in humans that
range from largely superficial infection of the skin and mucous membranes (impetigo,
pharyngitis), to highly invasive and life-threatening diseases (necrotizing fasciitis), as
well as, serious post-infection sequelae (rheumatic fever, glomerulonephritis, reviewed in
[1]. A gram-positive pathogen, its ability to cause disease is dependent on the secretion of
an extensive network of virulence proteins [1, 2]. In the absence of other known secretion
systems, these virulence proteins are exported by the general secretory [3] pathway (for a
review see [4]. S. pyogenes and other Gram-postive pathogens circumvent the lack of a
specialized cellular compartment for folding secreted proteins following their
translocation, a feature shared by all Gram-positive bacteria, by clustering the Sec
translocons at a defined microdomain of the cytoplasmic membrane referred to as the
ExPortal [5-9]. The ExPortal is also highly enriched with accessory factors for protein
biogenesis at the extracellular leaflet of the membrane, including the sortases involved in
covalent attachment of proteins to the cell wall, and the multi-function protease and
chaperone HtrA that aids in the biogenesis of the active form of the SpeB protease [5-7,
10, 11]. These studies suggest the function of the ExPortal is to spatially couple secretion
with protein maturation, but the mechanisms underlying the organization and
maintenance of this secretory organelle are still poorly understood.
The ExPortal of S. pyogenes has been shown to have an asymmetric lipid content
enriched in anionic phospholipids [10] that may contribute to the preferential retention of
certain proteins at the ExPortal vs. the peripheral membrane [7]. Research into the
interaction between S. pyogenes and cationic antimicrobial peptides (CAPs), which bind
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to negatively charged membranes, showed that sub-lethal concentrations of certain
peptides disrupt both localization of anionic lipids and retention of HtrA and the Sec
translocon ATPase SecA at the ExPortal microdomain, and in doing so inhibit its
secretory activity [12]. Interestingly, this study also revealed that one of these CAPs,
human neutrophil peptide 1 (HNP-1), localizes to the bacterial cell surface which
overlaps to regions of new cell wall synthesis in streptococci at the sub-lethal, ExPortaldisrupting concentrations tested. It has been previously demonstrated that HNP-1 targets
the peptidoglycan precursor lipid II in bacterial membranes [13], much like other
defensins for which a similar affinity for the lipid II molecule has been observed [14, 15].
This finding suggests that CAPs can interfere with ExPortal function by disruption of
lipid II in addition to anionic lipids.
The best characterized lipid II-targeting molecules known belong to a class of
small bacterial defense peptides commonly referred to as lantibiotics (for a review, see
[16]. The best characterized of these, nisin, specifically binds lipid II in a defined
stoichiometry in order to form pores that efficiently permeabilize bacterial membranes
[17, 18]. More importantly however, non-porating variants of nisin have been shown to
efficiently kill bacteria using an alternative mechanism by which lipid II is clustered into
patches in the cytoplasmic membrane away from the regions where peptidoglycan
synthesis occurs [19]. Other lantibiotics such as gallidermin, epidermin and mutacin have
also been observed to act via this alternative mechanism [19-21], thus inhibiting cell wall
synthesis and causing bacterial cell death without permeabilizing the cytoplasmic
membrane. The fact that lipid II-targeting molecules can disrupt cell wall synthesis
without compromising membrane permeability, combined with the observation that a
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CAP shown to interact with lipid II can similarly target and disrupt the ExPortal hint at a
possible link between cell wall biogenesis and organization of this secretory organelle.
The cell wall of Gram-positive pathogens is an extracellular organelle that plays a
multitude of roles essential to both survival and virulence (for a review see [22]. A rigid
exoskeleton made up of polymers of alternating N-acetylglucosamine (GlcNAc) and Macetylmuramic acid (MurNAc) glycan units crosslinked via peptide bridges, its main
purpose is to preserve cellular integrity against osmotic forces from without and within
the bacterial cell [23]. The cell wall is also the attachment site for extracellular factors
that interact with the host environment, which include surface-associated virulence
proteins, lipoteichoic and teichoic acids. Since cell wall-anchored proteins are covalently
attached by sortases to their peptidoglycan acceptor immediately following their
secretion, most research into the relationship between gram-positive secretion and cell
wall biogenesis, particularly in the case of streptococci, has focused on the
characterization of sortase function (reviewed in [24]. In contrast, our present study
corresponds to an emerging literature on how the organization of cell wall biogenesis
relates to underlying cytoplasmic membrane structures and cell division machinery [2528] by examining the possibility of a more direct relationship between protein secretion
and cell wall synthesis in streptococci, particularly in terms of the organization of these
processes. The final steps of cell wall peptidoglycan biogenesis occur at the inner leaflet
of the cytoplasmic membrane. In gram-postive species including Streptococcus
pneumoniae, Staphylococcus aureus and Enterococcus faecalis, these involve cytosolic,
as well as membrane-intrinsic and extrinsic proteins (for a review see [29]. The cellular
localization of these proteins relative to the ExPortal microdomain of Streptococcus
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pyogenes has not been documented and could reveal a great deal as to whether
peptidoglycan biogenesis influences ExPortal organization. Thus, our current study also
examined those proteins involved in the first and last of the membrane-associated steps of
cell wall synthesis. MraY is a membrane intrinsic protein that carries out the first
membrane-associated step in the synthesis of the lipid II precursor by catalyzing the
transfer of the phospho-N-acetylmuramoyl(MurNAc)-pentapeptide from the soluble
cytoplasmic UDP-MurNAc-pentapeptide substrate to the membrane embedded
undecaprenyl-phosphate (C55-P) acceptor, thus producing undecaprenyl-pyrophosphorylMurNAc-pentapeptide (lipid I), the immediate precursor of lipid II. MurN, on the other
hand, is a cytosolic polypeptide belonging to the family of FemABX peptidyl transferases
that attach the amino acids constituting the peptide cross-links between peptidoglycan
subunits in the cell wall structure of many gram-positive bacteria [30]. This is the final
synthetic step occurring on the inner leaflet of the cytoplasmic membrane prior to
translocation of lipid II across the membrane. In S. aureus synthesis of these peptide
cross-links is required for the sortase-mediated attachment of surface virulence factors to
the cell wall [31]. Moreover, evidence indicates that sorting of surface virulence factors
occurs in the immediate vicinity of their site of secretion and coincides with the site of
de-novo peptidoglycan synthesis [7, 9, 11, 32]. These data further suggest that
peptidoglycan biogenesis and ExPortal-mediated secretion may be spatially coordinated
in the streptococcal membrane.
Thus, in the present study we examined the role the streptococcal cell wall and
peptidoglycan synthesis in the cytoplasmic membrane play in organizing and maintaining
the ExPortal and report that cell wall peptidoglycan is required for maintaining proper
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localization of both lipid and protein components of the ExPortal at their membrane
microdomain. Treatment with a lipid II-targeting lantibiotic disrupted localization of
anionic lipids and ExPortal proteins, as well as secretion of ExPortal substrates in a
manner similar to what was observed previously with other CAPs at sub-lethal
concentrations [12]. Furthermore, proteins responsible for the membrane-associated steps
of lipid II synthesis localize to foci in the streptococcal membrane that coincide with the
anionic lipid microdomain and secretory translocons of the ExPortal, suggesting that
localization of peptidoglycan synthesis coincides with targeting and organization of the
ExPortal.
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RESULTS
Cell Wall Peptidoglycan is required for maintenance of the ExPortal anionic lipid
microdomain. In order to characterize the involvement of cell wall biogenesis in
ExPortal organization we first determined whether the cell wall is necessary to maintain
ExPortal integrity. To that end we examined the localization of anionic lipids in the
cytoplasmic membrane in protoplasts devoid of extracellular peptidoglycan. Treatment
with purified PlyC bacteriophage lysin of logarithmic and stationary phase streptococcal
cultures resuspended in either raffinose buffer or glycerol-supplemented media removed
all surface peptidoglycan from the majority of streptococci, as monitored by the
breakdown of streptococcal chains into individual protoplasts and the absence of either
FL-Vancomycin or Wheat Germ Agglutinin (WGA) labeling on the protoplast surface
(Fig. 1). The loss of cell-wall labeling in PlyC-treated streptococci coincided with a
redistribution of labeled polymyxin B from unique foci to the entirety of the bacterial
cell’s surface, giving the protplasts a “halo” appearance (Fig. 1A, B, H), distinct from the
focal localization of the labeled peptide observed in intact streptococci (Fig. 1C and D)
and PlyC-treated streptococci in which not all of the cell wall peptidoglycan was
removed, as evidenced by the presence of FL-Vancomycin or WGA label on their surface
(Fig. 1A, top of panel). The distribution of labeled polymyxin B in protoplasts also
coincided with the distribution of neutral lipid-binding dye Nile Red (compare Fig. 1H
and I), suggesting that in the absence of cell wall peptidoglycan, integrity of the anionic
lipid microdomain of the ExPortal is lost and anionic lipids are uniformly distributed in
the streptococcal membrane in a manner similar to neutral lipids. Staining streptococcal
protoplasts with a fluorescent vital dye (LIVE/DEAD BacLightTM) indicated that the
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Figure 1. Surface peptidoglycan is required for maintenance of the ExPortal anionic lipid
microdomain. The distribution of anionic lipids on the surface of S. pyogenes SF370 and HSC5
protoplasts was revealed by fluorescent microscopy. Loss of cell wall labeling by FL-vancomycin
in SF370 protoplasts coincided with redistribution of anionic lipid labeling by dansyl-polymyxin
B from focal sites in intact bacteria (A, top) to the entire protoplast membrane surface (A,
bottom). Similar redistribution of dansyl-polymyxin B to the entire surface was observed in
HSC5 protoplasts (B), compared to focal localization in intact bacteria (C). Localization of
dansyl-polymyxin B (D, H) and neutral lipids (E, I) in WGA-stained (F,J) HSC5 intact cells (DG) and protoplasts (H-K) further confirmed redistribution of anionic lipids to the entire
membrane surface. Fluorescent (A, right; D-F, H-J), phase (B, top), and merged images (A, left;
B,C,G,K) are shown. FL-vancomycin (1µg ml-1, green), Dansyl-polymyxin B (10µM, blue),
WGA (5µg ml-1, green), Nile red (2.5µg ml-1, red). Scale bar = 1µm.
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Figure 2. Loss of anionic lipid segregation at a microdomain is not due to membrane
permeabilization. Membrane permeability of S. pyogenes protoplasts displaying altered anionic
lipid distribution was assessed by fluorescent microscopy following staining with reagents that
distinguish between protoplasts with intact membranes (viable) and those with permeabilized
membranes (LIVE/DEAD BacLighttm, Invitrogen). Fluorescent images of a representative field of
HSC5 protoplasts displaying uniform membrane-staining with dansyl-polymyxin B (A), viable
(B) and permeabilized cell staining (C), as well as corresponding merged image (D) are shown.
Protoplasts generated by PlyC lysin treatment (PlyC+) have non-permeabilized membranes,
indicated by viable cell staining similar to untreated (PlyC-) HSC5 cells (E). A significant
number of protoplasts (PlyC+) displaying uniform membrane labeling with dansyl-polymyxin B
(Halo) had intact membranes (Halo+viable) as opposed to permeabilized membranes
(Halo+permeabilzed)(F). Few intact cells display uniform membrane labeling by dansylpolymyxin B (Halo PlyC-). Numbers of viable, permeabilized protoplasts and intact streptococcal
cells were derived from examination of 1000 stained cells. Data presented represents the mean
and standard error of the mean derived from at least 3 experiments. Differences between mean
values were evaluated for significance by a one-way ANOVA (P<0.0001). Scale bar = 10µm.
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cytoplasmic membranes of the protoplasts examined are not permeabilized (Fig. 2A-D).
Quantitation of protoplasts displaying the uniform membrane distribution of labeled
polymyxin B described above revealed that a significantly large proportion of them had
intact membranes (Fig. 2E and F, P<0.0001). This suggests that the observed
redistribution of anionic lipids resulting from the removal of surface peptidoglycan under
our experimental conditions is not due to perturbation of membrane permeability.

Cell Wall Peptidoglycan is required for ExPortal protein targeting at the membrane.
Previous work demonstrated that localization of ExPortal-associated proteins such as
SecA and HtrA coincided with the anionic lipid microdomain of the ExPortal [6, 10] and
that disruption of the lipid microdomain by CAPs resulted in redistribution of these
proteins in the streptococcal membrane [12]. Thus, we examined whether disruption of
anionic lipid localization in the streptococcal membrane resulting from the absence of
surface peptidoglycan affected the distribution of ExPortal-associated proteins.
Immunofluorescence microscopy of streptococcal protoplasts revealed that the
membrane-associated HtrA protease was distributed uniformly over the entirety of the
membrane (Fig. 3A). Likewise, the translocon ATPase SecA was observed uniformly in
the membrane for the most part, as protoplasts in which multiple foci of SecA labeling
were also observed (Fig. 3B). Removal of cell wall peptidoglycan was confirmed by the
absence of staining with WGA following PlyC treatment and fixation of streptococci.
Again, streptococci in which surface peptidoglycan removal was incomplete following
treatment displayed the unique foci of HtrA (Fig. 3C) and SecA (data not shown)
localization that are commonly observed in streptococci with intact cell walls, consistent
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with prior studies [6, 12]. The observed altered localization of HtrA and SecA further
supports the hypothesis that integrity of an anionic lipid microdomain is central to
targeting of ExPortal-related proteins in the membrane. Moreover, that localization of
lipid and proteinacious ExPortal components is altered in the absence of surface
peptidoglycan suggests that an intact cell wall is necessary for ExPortal organization.

Figure 3. Redistribution of ExPortal proteins following removal of surface peptidoglycan.
The distribution of HtrA (A) and SecA (B) in S. pyogenes HSC5 cells and protoplasts was
assessed by immunofluorescence microscopy. Incomplete removal of surface peptidoglycan from
streptococci following treatment with PlyC lysin does not alter focal localization of HtrA (C).
Merged fluorescence images of intact streptococci (A, left; B, top) and protoplasts (A, right; B,
bottom) are shown. WGA (5µg ml-1, green), HtrA and SecA (red). Scale bar = 1µm.
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The lantibiotic gallidermin disrupts targeting of lipid and proteinaceous ExPortal
components as well ExPortal-mediated secretion. The experimental results previously
described suggest that beyond its role of protecting the membrane from damage from
internal turgor pressure and maintaining cell shape, the streptococcal cell wall might also
play a role in organizing or maintaining organization of the secretory organelle that is the
ExPortal. Disruption of the ExPortal resulting from the loss of extracellular
peptidoglycan does not appear to be due to compromised membrane permeability,
indicating that the cell wall’s involvement in organizing the ExPortal goes beyond that of
maintaining membrane integrity. One possibility is that peptidoglycan synthesis and the
ExPortal are linked, meaning the site of peptidoglycan production at the membrane
coincides with and influences the localization of protein secretion and processing at the
ExPortal. To test this hypothesis we first examined whether compounds known to be
disruptive to cell wall synthesis affect ExPortal organization and function. As mentioned
previously, lantibiotics such as nisin, gallidermin and mutacin have been demonstrated to
possess a high affinity for the peptidoglycan precursor lipid II and to interact with it in
order to porate membranes and disrupt cell wall synthesis. Thus, we monitored the
localization of the anionic lipid microdomain of the ExPortal in the presence of
lantibiotics at concentrations that were not lytic to streptococci. We assessed membrane
permeability using a Live/Dead® stain to quantitate numbers of porated streptococci in
lantibioitc treated cultures and determined lytic concentrations to be those that resulted
<50% viable cells in observed microscopy fields. Examination of either HSC5 or SF370
strain cultures showed that gallidermin and nisin do not compromise streptococcal
membrane integrity at concentrations lower than 2µM and 0.5µM, respectively (Fig. 4A
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Figure 4. The lantibiotic gallidermin disrupts localization of anionic lipids at non-lytic
concentrations. The localization of anionic lipids in S. pyogenes SF370 and HSC5 was assessed
by fluorescence microscopy following challenge with a non-lytic concentration of gallidermin
(1µM). Non-lytic concentrations of the lantibiotics gallidermin (A) and nisin (B) were determined
by fluorescent microscopy of cells following staining with LIVE/DEAD BacLighttm reagents
(Invitrogen). Distribution of anionic lipids in the membrane was monitored by staining with sublethal levels of polymyxin B BODIPY®FL conjugate (10µM) in gallidermin exposed (C) and
untreated streptococci (D). Streptococci treated with anionic lipid microdomain-disrupting
concentrations of polymyxin B BODIPY®FL conjugate (60µM) are shown for comparison (E).
Fluorescent, phase and merged images are shown. Scale bar = 1µm. Samples for analysis of
viability were harvested following 1 hr of lantibiotic treatment and numbers of cells with porated
membranes were derived from examination of at least 1000 stained cells. All data presented
represents the mean and standard error of the mean derived from at least 3 experiments. Numbers
of viable protoplastst (PlyC+) are shown for comparison. Identical results were obtained from
performing these same analyses on S. pyogenes strain SF370 (data not shown).
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and B, data not shown). Fluorescent microscopy using bodipy-labeled polymyxin B to
ascertain the localization of ExPortal-associated anionic lipids revealed that non-lytic
concentrations of gallidermin disrupt the anionic lipid microdomain of the ExPortal (Fig.
4C) in a manner similar to high sub-lethal amounts of polymyxin B (compare, Fig. 4C, D
and E), as observed by the localization of the labeled cationic peptide to multiple foci or
in a more diffuse staining pattern than in untreated streptococci. Nisin had a disruptive
effect on the localization of the fluorescent peptide to unique foci at concentrations
determined to be lytic to streptococci in treated cultures (data not shown), which makes it
difficult to discern whether this effect of nisin was due to its membrane-porating capacity
or to its affinity for lipid II. However, given that the disruptive effect of gallidermin on
anionic lipid localization in the membrane was observed with non-lytic amounts of the
lantibiotic, we examined whether gallidermin also affected the localization of ExPortalrelated proteins. Immunofluorescence microscopy revealed that gallidermin treatment of
streptococcal cultures at a non-lytic concentration resulted in redistribution of HtrA to
either multiple foci or, for the most part, in a diffuse pattern on the streptococcal surface
(compare Fig. 5A and B). Co-labeling with fluorescent polymyxin B confirmed that the
observed localization of HtrA corresponded with a re-distribution of ExPortal-associated
anionic lipids, as identified by the labeled CAP.
Since gallidermin was observed to interfere with the localization of both lipid and
proteinaceous components of the ExPortal, we examined whether the lantibiotic could
inhibit translocation of proteins requiring an intact ExPortal for their secretion, as has
been previously studied with cationic antimicrobial peptides [12]. Treatment of strain
SF370 with a non-lytic concentration of gallidermin resulted in a reduction in the amount
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Figure 5. Redistribution of HtrA following non-lytic gallidermin challenge. The distribution
HtrA on S. pyogenes HSC5 was assessed by immunofluorescent microscopy in the absence of (A)
and following challenge with gallidermin at 1 µM (B). Fluorescent images of cell wall (WGA,
5µg ml-1, green), HtrA (red), anionic phospholipid (dansyl-polymyxin B, 10µM, blue) labeling
and merged fluorescent images (bottom panel) are shown. Scale bar = 1µm.
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of cysteine protease SpeB in culture supernatants as revealed by Western blot analysis
(Fig. 6A). This reduction in the amount of secreted SpeB was similar to that observed in
supernatants from cultures treated with high sub-lethal amounts of polymyxin B and was
observed in supernatants from the HSC5 strain as well (Fig. 6B). Decreased levels of
secreted Streptolysin O (SLO) cytolysin were also observed in gallidermin-treated
cultures of both HSC5 and SF370 strains (Fig. 6 C and D), in the same manner as
resulted from treatment with high sub-lethal amounts of polymyxin B. Protein synthesis
and the capacity to translocate proteins appear to be unaffected as levels of SecA protein
in gallidermin-exposed streptococci are unaltered relative to untreated bacteria as
indicated by Western analysis of streptococcal lysates (Fig. 6E), suggesting the effect of
gallidermin on secretion of ExPortal substrates is due to its disruption of ExPortal
organization. Altogether, these results indicate that the lipid II-targeting activity of a
lantibiotic disrupts the streptococcal ExPortal and support the hypothesis that synthesis of
the peptidoglycan precursor at the membrane influences ExPortal organization.

Synthetic enzymes required for lipid II peptidoglycan precursor biogenesis co-localize
with the ExPortal. As mentioned previously, the final steps of cell wall subunit
biogenesis occur at the cytoplasmic membrane, meaning that lantibiotic interaction with
lipid II likely occurs in the proximity of the membrane site where precursor synthesis
takes place. The disruptive effect of gallidermin on ExPortal organization in the absence
of changes in membrane permeability further supports the possibility that lipid II
synthesis at the membrane affects maintenance of the ExPortal. If peptidoglycan
precursor synthesis and the organization of ExPortal-mediated protein biogenesis and
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Figure 6. Non-lytic challenge with gallidermin inhibits secretion of SpeB and SLO. Secretion
of the SpeB protease in cultures of S. pyogenes was determined following challenge with the
indicated concentrations of gallidermin and polymyxin B by Western blot analysis of culture
supernatant from SF370 (A) and HSC5 strains (B). Western blotting was also used to analyze the
amount of SLO present in culture supernatant following challenge with the indicated
concentrations of gallidermin and polymyxin B of SF370 (C) and HSC5 (D) cultures. Expression
of SecA in HSC5 cultures was determined following challenge with the indicated concentrations
of gallidermin by Western blot analysis of streptococcal lysates (E). All samples for SpeB
analysis were harvested at 2 hrs post-challenge; samples for SLO and SecA were harvested 1hr
post-challenge. Open and filled triangles indicate the migration of the zymogen and mature form
of SpeB, respectively. Migration of the SLO and SecA polypeptides is also indicated.
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translocation are linked in this manner, then lipid II synthesis and the ExPortal are likely
to be spatially coordinated in the streptococcal membrane. To further examine this
hypothesis we monitored the localization of two enzymes involved in the membraneassociated steps of lipid II synthesis, the membrane spanning MraY, which carries out the
first membrane-associated step, and the cytosolic MurN transferase that catalyzes the
final enzymatic step prior to translocation of the peptidoglycan subunits across the
membrane. Both proteins were C-terminally tagged with superfolder GFP (sfGFP) and
their expression examined by Western analysis, fluorescence and electron microscopy
(Fig. 7). Peak expression of MraY and MurN occurred during log phase (Fig. 7A), which
was not unexpected since most peptidoglycan synthesis occurs during cell division and
growth. The membrane intrinsic MraY was observed to predominantly localize to unique
foci in the streptococcal membrane (Fig. 7B-D). Localization of MraY to a membrane
microdomain occurred under all experimental media conditions used in this study,
observed most strongly during log-phase in both cultures grown in C media (Fig. 7B) and
ThyB (Fig. 7C), as determined by fluorescence microscopy. Electron microscopy
analysis of log-phase streptococci confirmed localization of the tagged protein to unique
membrane microdomains, as evidenced by the clustering of immunogold particles at
distinct sites (Fig. 6D). Cytoplasmic MurN was also found at foci in the vicinity of the
streptococcal membrane (Fig. 7E-G), though some localization throughout the
streptococcal cytoplasm was also observed (data not shown). Like MraY, MurN localized
to foci at log phase (Fig. 7E and F) and was ascertained by electron microscopy as well
(Fig. 7G).
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Figure 7. Focal localization of MraY and MurN at the S. pyogenes surface. The expression of
C-terminally sfGFP-tagged MraY and MurN in S. pyogenes HSC5 was confirmed by Western
blot analysis of the indicated streptococcal culture fractions (A). Arrows indicate the expected
size of the fluorescent protein-tagged polypeptides (MraY-sfGFP: 63.5kDa; MurN-sfGFP:
74kDa). Localization of sfGFP-tagged MraY (B-D) and MurN (E-G) in S. pyogenes HSC5 was
revealed by fluorescent microscopy (scale bar = 1µm) (B,C,E and F) and immunogold electron
microscopy using staining with a streptavidin-gold conjugate (scale bar = 500nm) (D and G).
Real color, phase and merged images (B,D; sfGFP, green) are shown, as well as false color
images (C,F; sfGFP red; WGA, 5µg ml-1, green).
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To confirm that the observed localization of the tagged proteins corresponded to
their native localization and not to any effects stemming from expression of the
fluorescent protein tag, we also monitored the localization of C-terminally tagged YajC
protein, which is maintained at the membrane by its single transmembrane segment. In
other bacteria, YajC is considered an auxiliary subunit of the protein translocase by virtue
of its co-expression and interaction with SecD and SecF proteins, but has been found to
be non-essential for both viability and secretion [33]. Additionally, S. pyogenes does not
express SecD and SecF [34] and thus the function of YajC in streptococci remains
unknown. Unlike MraY and MurN, sfGFP-tagged YajC was observed over the entirety of
the streptococcal membrane by both fluorescence (Fig. 8A and B) and electron
microscopy (Fig. 8C) under all conditions tested, suggesting that the observed
localization of MraY and MurN corresponds to their native cellular site.

Figure 8. Distribution of YajC on the S. pyogenes surface. Localization of C-terminally sfGFPtagged YajC in S. pyogenes HSC5 was revealed by fluorescent microscopy (scale bar = 1µm) (A
and B) and immunogold electron microscopy using staining with a streptavidin-gold conjugate
(scale bar = 500nm) (C). Real color, phase and merged images (A; sfGFP, green) are shown, as
well as false color images (B; sfGFP red; WGA, 5µg ml-1, green).
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Next we determined whether focal localization of MraY and MurN corresponds to
the site of the ExPortal. We have previously demonstrated that a fluorescently labeled
cationic animicrobial peptide preferentially targets to the site of the ExPortal lipid
microdomain at low sub-lethal concetrations [12]. Fluorescence microscopy revealed that
MraY (Fig. 9A and C) and MurN (Fig. 9B and D) localization predominantly coincides
with that of labeling by the dansyl-polymyxin B probe, indicating that lipid II synthesis
occurs at the anionic lipid microdomain of the ExPortal. Finally, we confirmed the
targeting of lipid II synthetic machinery to the membrane region of the ExPortal by
determining their localization relative to the Sec machinery translocons. Electron
microscopy showed that immunogold labeling with antibodies against SecA and sfGFPlabeled MurN localized to the same focal site on the streptococcal surface (Fig. 9E),
confirming that peptidoglycan precursor synthesis is spatially coordinated with the
ExPortal.
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Figure 9. The sites of MraY and MurN localization are coincident with the site of the
ExPortal in the streptococcal mmebrane. Localization of sfGFP-tagged MraY (A,C) and MurN
(B,D) relative to the anionic lipid microdomain of the ExPortal in S. pyogenes HSC5 was
revealed by fluorescent microscopy following staining by dansyl-polymyxin B (10µM; scale bar
= 1µm). False color, phase and merged images (A,B: dansyl-polymyxin B, red; sfGFP, green;
C,D: dansyl-polymyxin B, blue; sfGFP, red; WGA, green) are shown. Co-localization of sfGFPtagged MurN and SecA at the ExPortal was revealed by immunogold electron microscopy using
staining with a streptavidin-gold conjugate (E). SecA was labeled with 12nm beads, MurN-sfGFP
with 18nm gold-beads. Scale bar = 500nm.
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DISCUSSION
Understanding the mechanisms involved in the biogenesis of secreted virulence
factors in an organism whose pathogenicity depends highly on secreted effectors is of
great importance to developing therapeutic strategies against infection by these
pathogens. A great deal of research has been devoted to elucidating the regulation and
expression of virulence proteins by S. pyogenes and other related Gram-positive
pathogens [35]. However, knowledge of how these factors get translocated out of the
streptococcal cell and processed into their biologically active forms is sparse and
deserving of further investigation, especially given the emergence of resistance amongst
gram-positive pathogens against clinically used antibiotics targeted at other cellular
processes (e.g. macrolides which target protein synthesis; reviewed in [36]).
The data presented here indicate that biogenesis of the bacterial cell wall is not
only necessary for protection from environmental insults and as a scaffold for the display
of extracellular virulence effectors, but also for the maintenance of the secretory
organelle that is the ExPortal. Examination of peptidoglycan involvement in the
distribution of lipids in the underlying cytoplasmic membrane in Bacillus subtilis
revealed that the cell wall is required for retention of anionic lipids at discrete
microdomains [25]. In the investigation by Muchova et al. removal of surface
peptidoglycan

by

lysozyme

treatment

produced

protoplasts

in

which

phosphatidylglycerol failed to localize in the spiral configuration that had been
previously observed in intact cells using fluorescent lipid dyes [37, 38]. Most
interestingly, inhibition of peptidoglycan production by depletion of the lipid IIsynthesizing enzyme MurG disrupted localization of both phosphatidylglycerol and
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cardiolipin in the membrane [25]. This suggests that peptidoglycan synthesis is necessary
for the establishment of specific lipid domains in B. subtilis or that disruption of lipid II
production causes disassembly of existing domains [25]. Our experimental data confirms
that the presence of extracellular peptidoglycan is necessary for maintaining the
asymmetric distribution of anionic lipids in the cytoplasmic membrane of a gram-positive
pathogen. Additionally, disruption of anionic lipid localization in the membrane
following cell wall removal in GAS resulted in mis-localization of ExPortal proteins,
further supporting the hypothesis that segregation of anionic lipids at a particular
microdomain constitutes a mechanism underlying ExPortal organization.
Our data and the results from Muchova et al indicate the gram-positive cell wall is
involved in restricting lipids and proteins to specific regions of the cytoplasmic
membrane. The bulk of each of the ExPortal proteins examined is found on opposite
sides of the membrane, HtrA extracellularly and SecA intracellularly. Both, however,
were mis-localized to a similar degree in the streptococcal cell membrane in the absence
of the cell wall, even though SecA is unable to interact directly with extracellular
peptidoglycan. Like HtrA in S. pyogenes, sortase localization in E. faecalis coordinates
with that of the secretory translocons in the cytoplasmic membrane [7]. Most importantly,
the cell wall sorting signal (CWS) of SrtC and SrtA sortases in E. faecalis contains a
positively charged tail that was hypothesized to determine topology and mediate targeting
and retention of the sortases within the membrane microdomains at which they were
observed to localize [7]. Mutagenesis of the C-terminal CWS of SrtC to remove the
positively charged tail or reduce its cationic character resulted in mis-localization of SrtC
and reduction of its physiologic activity (pilus assembly), indicating that proper targeting
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of the sortase to the membrane depended on the interaction of its cationic CWS with
anionic components in the membrane [7]. Altogether, this data suggests that the retention
of anionic phospholipids at specific, unique membrane sites constitutes the primary
mechanism for targeting ExPortal proteins to their destination in the membrane, and that
peptidoglycan mediates the site restriction of anionic phospholipids.
The non-membranolytic, lipid II-binding activity of gallidermin also disrupted
localization of both lipid and proteinaceous elements of the ExPortal. The reported
mechanism of lantibiotics like gallidermin that are bactericidal despite not permeabilizing
cytoplasmic membranes is the sequestration of lipid II away from the sites of
peptidoglycan synthesis [19, 20]. The effect of this can be considered to be two-fold:
arresting further growth of the cell wall by starving penicillin binding proteins (PBPs) of
substrate needed for peptidoglycan polymerization at the site of de novo cell wall
synthesis, and depleting the lipid II content of the cell by preventing recycling of C55-P
lipid anchors needed for further lipid II production at the inner leaflet of the cytoplasmic
membrane. The role of the cell wall in organizing the ExPortal may then have more to do
with peptidoglycan synthesis, rather than with the peptidoglycan polymer itself, though it
is apparent that integrity of this macromolecule is essential for lipid segregation in the
membrane.
Previous research indicates that segregation of anionic lipids in bacterial
membranes is also a mechanism for targeting the macromolecular complexes involved in
cell wall synthesis and other essential cellular processes to the sites where their
physiological activity is required. Lipid microdomains identified in B. subtilis can be
isolated together with homologues of eukaryotic Flotillin1 and other proteins involved in
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transport and signaling [39]. In Caulobacter crescentus the dependence of MurG
localization on helical cables of the cytoskeleton protein MreB [40] and the colocalization of the division protein MinD with phosphatidylglycerol lipid spirals in the
cytoplasmic membrane of B. subtilis [28] point to a link between the molecular
machineries of peptidoglycan synthesis, cell division and membrane lipids. Most
recently, examination of cell wall synthesis in growing B. subtilis cells found that MreB
and its isoforms (Mbl, MreBH) assembled with components of the cell wall synthesis
holoenzyme (MreC, MreD, PbpH, PBP2A and RodA) into discrete patches at the
cytoplasmic membrane that moved processively along peripheral tracks perpendicular to
the cell axis [26, 27]. MreC and MreD are transmembrane proteins reported to couple
cytosolic MreB and its isoforms to the extracellular peptidoglycan synthesis machinery,
and RodA an integral membrane protein linked to cell wall elongation and to the PBPs
examined (PbpH and PBP2A; for a review see [41]). Motility of the observed MreBassociated peptidoglycan biosynthetic complexes was driven by cell wall synthesis and
MreB polymers restricted localization of patch components in the membrane and directed
their movement [26, 27]. One possible mechanism then by which peptidoglycan synthesis
in GAS might affect lipid segregation in the cytoplasmic membrane is by association of
cytoskeletal components inside the cell with cell wall synthesis outside the cell, placing
constraints on the distribution of phospholipids in the intervening membrane, thus leading
to the creation and stabilization of lipid domains. However, S. pyogenes lacks homologs
to the cytoskeletal MreB proteins [34], and as a morphologically ovococcoid bacterium,
given its pattern of cell division in successive parallel planes perpendicular to the cell
axis, S. pyogenes does not express the synthetic machinery required for cell elongation in
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rod-shaped bacteria like B. subtilis (RodA, MreC, MreD; reviewed in [42]). Rather, the
macromolecular complex directing cell division and growth in S. pyogenes consists of the
tubulin homologue FtsZ, its accessory divisome proteins (i.e. FtsA, FtsW, EzrA, DivIB,
DivIVA) and a set of high- and low-molecular weight PBPs common amongst
enterococcal and streptococcal species [42]. Thus, although the relevance of
peptidoglycan to the localization of membrane anionic lipids appears to be similar in S.
pyogenes and B. subtilis, the mechanism underpinning this function of cell wall
biogenesis may be different in each species and its elucidation requires characterization
of the role divisome proteins of GAS play in organization of the ExPortal and cell wall
synthesis.
In model membranes, lipids can adopt various fluid and liquid-ordered phases,
characterized by the different spatial arrangement and motional freedom of each lipid
molecule with respect to the surrounding molecules, and dependent on the composition,
structure and environment of the membrane [43]. Different fluid phases can coexist
within a single membrane plane delimited by a plane boundary, resulting in lateral phase
segregation and contributing to the formation of lipid microdomains similar to those
observed in bacterial cytoplasmic membranes. The properties of these lipid phases can
determine the orientation, mobility and interaction of proteins and lipids contained
therein and thus directly influence the biological functionality of the domains [44]. An
alternative, or perhaps contributing mechanism underlying organization of the ExPortal
by membrane lipid segregation may be localization of the C55-P anchor of lipid II in the
membrane. The membrane region at which C55-P is localized, thereby determining the
site at which lipid II synthesis occurs, is different in composition and environment from
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the rest of the membrane and thus determines where anionic lipids segregate in the
membrane. The data we present here demonstrate that in GAS, the membrane-associated
steps of lipid II synthesis are restricted to a unique microdomain of the streptococcal
membrane, since both an integral membrane transferase (MraY) and a cytoplasmic
enzyme (MurN) required for the production of lipid II were predominantly localized at
unique foci in streptococcal cells, as observed by both fluorescent and electron
microscopy. Moreover, this site coincides with the localization of the anionic lipid
microdomain and secretory translocons of the S. pyogenes ExPortal. Restriction of lipid II
synthesis to the site C55-P is found in the membrane could direct localization of
phosphatidylglycerol, the predominant anionic lipid of GAS membranes. Alternative
models in which anionic lipids maintain C55-P localization in the membrane or in which
C55-P and phosphatidylglycerol are equally dependent on each other for localization
cannot be ruled out. Regardless, both existing research and the data presented here are
indicative of spatial coordination between molecules like C55-P and anionic lipids.
Previous work in B. subtilis suggests that the lipids associated with bacterial membrane
microdomains include polyisoprenoids synthesized via pathways involving squalene
synthases, as treatement with zaragozic acid, an inhibitor of squalene synthesis, prevented
the formation of functional lipid microdomains in B. subtilis membranes [39]. Most
interestingly, further characterization of squalene synthesis inhibition by inactivation of a
gene involved in the pathway converting farnesyl pyrophosphate into squalene, inhibited
protein secretion and biofilm formation, but not viability of the bacterium. The C55-P
membrane anchor of lipid II is also a polyisoprenoid synthesized from the condensation
of eight isopentenyl pyrophosphate units to farnesyl pyrophosphate, catalyzed by
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undecaprenyl pyrophosphate synthase (UppS) [45, 46]. Therefore, production of the
essential C55-P isoprenoid could be the key factor for localization of both cell wall
synthesis and the ExPortal. This does not however exclude the possibility that targeting
of C55-P in the cytoplasmic membrane depends on the localization of the UppS
transferase responsible for its production, which in turn may involve the action of
divisome proteins, as these are involved in determining the site of cell wall growth and
septation necessary for the genesis of two daughter cells with their own cell walls from a
single parent cell.
Further characterization of the ExPortal organization will require examining the
involvement of proteins known to coordinate cell division with cell wall synthesis in
other gram-positive bacteria. It will also be useful to examine the effect of compounds
that target different aspects of peptidoglycan and lipid II synthesis on organization and
function of the ExPortal. Recent work revealed that the secretory activity of the
streptococcal ExPortal and its organization are particularly sensitive to the action of
CAPs [12]. Since CAPs are a class of antimicrobial molecules against which bacterial
pathogens have developed limited resistance, it is important to understand how these
peptides target the ExPortal in order to develop novel and more effective therapeutics
against GAS. Conversely, characterizing the mechanisms and specific factors supporting
organization and function of the ExPortal can reveal novel targets to be exploited against
S. pyogenes and other gram-positive pathogens with similar secretory mechanisms.

111

EXPERIMENTAL PROCEDURES
Strains, media and growth conditions: As indicated, experiments utilized S. pyogenes
HSC5 [47] or SF370 [34]. Localization of HtrA was analyzed in HSC5 following
transformation by pHtrA-HA, which expresses a HA-tagged derivative of HtrA [6].
Localization of MraY, MurN, YajC was analyzed in HSC5 strain streptococci expressing
C-terminal SuperFolder GFP protein fusions generated by chromosomal integration of
pLAV5912, pLAV51012 and pGCP477. Routine culture was at 37°C in Todd-Hewitt
broth (BBL) supplemented with 0.2% yeast extract (Difco) (THY medium). Functional
assays utilized cultures grown in unmodified C medium as described previously [48],
supplemented with spectinomycin (100ug ml-1, Sigma #S4014) when indicated. To
produce solid media, Bacto Agar (Difco) was added to a final concentration of 1.4%.
Liquid cultures were grown without agitation in closed containers and solid cultures were
incubated under anaerobic conditions using a commercial gas generator (GasPak, cat.
#260678, BBL) as described [48]. SpeB protease activity was inhibited in cultures used
to analyze the abundance of secreted streptococcal proteins by including the cysteine
protease inhibitor E64 (Sigma #E3132) [49].

In selected experiments, media were

supplemented with the cationic antimicrobial peptide polymyxin B (cat. #P0972-50MU,
Sigma), the lantibiotics nisin (Sigma #N5764), or gallidermin (a generous gift from Dr.
James Smith, Texas A&M University). Protoplasts were generated by treating
streptococci with PlyC lysin (5U ml-1, 10 minutes) in 30% (wt/vol) raffinose solution
supplemented with 5mM EDTA. For visualization of lipid and protein localization,
protoplasts were resuspended in either ThyB or C media supplemented with 5-8% (v/v)
glycerol, as indicated.
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DNA techniques: Plasmid DNA was isolated via standard techniques and used to
transform S. pyogenes as described previously [50]. Restriction endonucleases, ligases
and polymerases were used according to manufacturer’s recommendations.

Fluorescent protein-tagged constructs: All fluorescent-tagged proteins examined in this
study were expressed in the HSC5 strain by chromosomal integration of the C-terminal
tags. Cloning primers are detailed in Table 1. To generate GFP-tagged constructs, the
coding sequence for SuperFolder GFP (sfGFP) was first amplified from pET28sfGFP (a
kind

gift

from

Geoff

Waldo

at

Los

Alamos

http://www.lanl.gov/projects/gfp/index.shtml

National

Laboratory
and

http://www.theranostech.com/products.htm) using primers GP526 and GP527. The
amplified sfGFP sequence was then directly cloned by overlap extension PCR cloning
using Phusion DNA polymerase (Finnzymes) as previously described [51] into pSPC18,
a derivative of the pUC18 vector with the ampicilin resistance gene bla replaced by the
spectinomycin resitance gene aad9 [52, 53]. The final product (pGCP458) contains a
promoter-less sfGFP lacking the start ATG and a 5’ BamHI restriction site for direct
cloning of the 3’ ends of ORFs to create C-terminal tag protein fusions upon
chromosomal integration. Amplification of 300 nucleotide C-terminal fragments, absent
the stop codon, from mraY, murN and yajC using the primer pairs MraY2 Fwd/MraY2Rev, MurN Fwd/MurN Rev and GP532/GP533 respectively, followed by double
restriction

digest

(BamHI/PstI)

and

ligation

generated

pSPC18:MraY-sfGFP

(pLAV5912) and pSPC18:MurN-sfGFP (pLAV51012) and pSPC18:YajC-sfGFP
(pGCP477).
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PlyC expression and purification: Recombinant PlyC, a lysin produced by streptococcal
phage C1, was expressed and purified as previously described [54, 55], with certain
modifications. Both subunits of the lysin (PlyCA and PlyCB) were 6-X-His C-terminally
tagged, and co-purified on Talon® metal affinity resin (Cat#: 635503, Clontech) from
lysates of separate strains (pPlyCA, pPlyCB). Specific activity of the purified enzyme
was measured according to established protocols [55].

Analysis of Viability: Viability was assessed by staining with a fluorescent vital dye
(LIVE/DEAD®, BacLighttm) as recommended by the manufacturer (Invitrogen). Viability
was quantitated by examination using a fluorescent microscope (Leica model DM IRE 2)
with enumeration of the percentage of live bacteria in randomly chosen microscopic
fields totaling >1000 cells for each condition examined. Data reported represent the mean
and standard error of the mean derived from a minimum of 3 independent experiments.
Differences between calculated means were evaluated for significance using a one-way
Analysis of Variance (ANOVA).

Cellular staining and fluorescent microscopy: Streptococcal cultures were challenged
with polymyxin B or lantibiotics as described above, stained with various fluorescent
reagents and then analyzed by fluorescent microscopy as follows:

Analysis of the

location and integrity of a membrane microdomain enriched in anionic phospholipids was
assessed by staining with sub-lethal concentrations of fluorescent polymyxin B
derivatives including dansyl-polymyxin B (10µM, cat. #P13238, Invitrogen) and
polymyxin B BODIPY®FL conjugate (10µM and 60µM, cat. #P13235, Invitrogen).
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Samples were examined using a Leica model DM IRE 2 fluorescent microscope and
images captured using a QImaging Retiga 1350 EX charged-coupled device camera and
Openlab software (Improvision). Where indicated, simultaneous treatment with 2
reagents was conducted in order to assess co-localization of staining.

In these

experiments streptococcal cells walls were visualized by staining with FL-vancomycin (1
µg ml-1, cat. #V34850, Invitrogen), or Wheat Germ Agglutinin (WGA) Alexa Fluor 488
or 350 conjugates (5 µg ml-1, cat. #W11261, #W11263 Invitrogen) and neutral membrane
lipids were visualized by staining with Nile Red (2.5 ug ml-1, cat. #N1142, Invitrogen).
Images were processed for publication using Adobe Photoshop CS3.

Immunofluorescent microscopy: The localization of SecA and HA-tagged HtrA protein
was detected by immunofluorescent microscopy, as described [6]. Aliquots from cultures
of intact cells, protoplasts, as well as untreated or lantibiotic-treated (1µM gallidermin)
challenge assay cultures (see above) were treated and fixed according to the method of
Raz and Fischetti [11]. Antisera used included a polyclonal rabbit anti-SecA antiserum (a
generous gift from Donald Oliver) used at a dilution of 1:100 that was detected using an
AlexaFluor 488-labeled goat anti-rabbit IgG (Invitrogen) at 1:500 and an AlexaFluor
594-conjugated rabbit IgG anti-HA epitope antiserum (Invitrogen) used at 1:500. Wheat
germ agglutinin (WGA)-AlexaFluor 350 (Invitrogen) at a final concentration of 5 µg ml-1
was used to visualize the streptococcal cell walls, and polymyxin B BODIPY®FL
conjugate (10µM) was used to visualize anionic lipids. Slides were mounted in an antifade reagent (Prolong Gold, Invitrogen) and images captured.
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Immunogold electron microscopy: Localization of sfGFP-tagged MraY and MurN and
YajC along with polymyxin B binding was examined by electron microscopy, as follows:
Cultures were grown as indicated above, aliquots were removed and prepared for
immunoelectron microscopy as described [5, 6]. Sections were stained using a
streptavidin-gold conjugate (20nm, BBI International) and examined by electron
microscopy as detailed [5, 6].

Localization of MraY and MurN and YajC was

determined at early- and mid-logarithmic phase [5, 6]. Co-localization of MurN and SecA
was assessed by staining using streptavidin-gold conjugated beads of different sizes
(12nM and 18nM, BBI International).

Analysis of protein expression and secretion: Supernatant and lysate fractions from
cultures challenged with gallidermin and polymyxin B were prepared and analyzed for
the presence of SpeB, SLO and SecA by Western blotting as described [56]. Lysate
fractions from strains expressing sfGFP-tagged MraY, MurN and YajC were similarly
examined for the presence of the sfGFP tag. Blots were developed using a Chemidoc
XRS imager (BioRad) and relative protein concentrations determined using Quantity One
software (BioRad, version 4.6.7).
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Table 1. Primers utilized for construction of fluorescent protein tagged constructs.
Primer

Sequence1

MraY2 Fwd

CCCCTGCAGCTTGGAGCTATGTTGGCTGC

MraY2 Rev

CCCGGATCCGAAGACGTATAAGATAGCTAAAACTAGTAAACTAGC

MurN Fwd

CCCCTGCAGTTTATCTATACCGAACAAGAGGCC

MurN Rev

CCCGGATCC ATAGCGGTTTAATAGCTTTTTTGC

GP526

gcaggtcgactctaga ggatcc AGCAAAGGAGAAGAACTTTTCAC

GP527

cacacaggaaacagctatgacat CCCGGG TTATTTGTAGAGCTCATCCATGC

GP532

GATACTGCAGTGGTTTATGCAACGTCAAC

GP533

GATAGGATCCATGGCTTTCAATGGCAC

1

Restriction sites underlined, and for GP526, GP527 lower case denotes pSPC18
sequence and the uppercase denotes sfGFP sequence.
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Chapter IV

Work In Progress: Characterizing ExPortal Substrates
and Factors Contributing to its Organization
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ABSTRACT
Further characterization of ExPortal organization will entail multiple genetic and
molecular approaches to isolate the precise factors involved in its establishment and
maintenance. These approaches include molecular screens to identify substrates in
addition to SpeB and SLO requiring the spatial coordination of secretory translocons and
accessory factors for efficient biogenesis and export, as well as targeted mutagenenesis of
additional cell wall synthesis proteins (i.e. transglycosylases, transpeptidases and cell
wall hydrolases) to characterize their involvement in ExPortal maintenance. Preliminary
data resulting from such efforts is presented here. A proteomics screen for polypeptides
other than SpeB or SLO with altered secretion profiles in response to CAP exposure
identified the virulence protein EndoS as a potential ExPortal substrate. Identification of
putative cell wall hydrolases encoded in the Streptococcus pyogenes genome and initial
characterization of their involvement in ExPortal maintenance by mutagenic approaches
revealed that though the Isp polypeptide co-localizes on the streptococcal surface with the
anionic lipid microdomain of the ExPortal, Isp and its homolog Isp2 are not required for
maintenance of said microdomain. Additionally Isp is unaffected in its expression or
localization following exposure of streptococci to polymyxin B, indicating further work
is necessary to determine what role, if any, these putative hydrolases have in ExPortal
organization.
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INTRODUCTION
One approach to elucidating the mechanism(s) by which the ExPortal coordinates
protein secretion and processing is to identify and characterize its secreted substrates.
Understanding how these substrates are expressed and what post-translational
modifications they undergo in order to be processed into their biologically active forms
can reveal a great deal about ExPortal function. Not all proteins secreted by streptococci
require the spatial coordination of accessory factors and the secretory translocons, as
indicated by the effect exposure to sub-lethal levels of CAPs had on ExPortal
organization and protein secretion. Since sub-lethal polymyxin B concentrations
selectively inhibited secretion of those proteins requiring an intact ExPortal, I undertook
a preliminary analysis of what other secreted proteins of streptococci are affected in their
biogenesis by exposure to sub-lethal levels of a CAP. This analysis identified EndoS, a
secreted 108kDa protein with specific endoglycosidase activity that cleaves human
Immunoglobulin G [1], as a potential ExPortal substrate affected by CAP-mediated
disruption of its secretory activity.
Data presented in Chapter III demonstrates that cell wall biogenesis is involved in
organizing the ExPortal and suggests localization of the secretory organelle is
coordinated with the site of peptidoglycan precursor (lipid II) synthesis. In coccoid
bacteria like S. pyogenes, cell wall synthesis primarily occurs at the site of cell division
and involves the action of transglycosylases, transpeptidases and cell wall hydrolases [2].
Activity and regulation of these may be important to ExPortal organization as well as cell
growth and division. Eukaryotic-type Ser/Thr kinases (STK) reported in bacteria,
including GAS, can regulate cell division, growth, and virulence. Recent research
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demonstrated that S. pyogenes STK -controlled cell division is mediated under the
positive regulation of a secreted protein termed CdhA that possesses a cysteine and
histidine-dependent aminohydrolase/peptidase (CHAP) domain with functional cell wall
hydrolase activity [3]. Disruption of the CdhA-encoding gene resulted in severe cell
division and growth defects, while a mutant expressing CdhA absent the CHAP domain
was solely attenuated for virulence and highly susceptible to cell wall-acting
antibiotics[3]. CdhA was thus characterized as a multifunctional protein with a Nterminal region involved in cell division plane-recognition and a C-terminal CHAP
domain involved in virulence[3]. Characterization of CdhA suggests that localization of
the macromolecular machineries involved in cell division and cell wall synthesis at their
site of action in streptococci requires accessory proteins. CdhA and/or related proteins
then may also act directly or indirectly, through their involvement in regulation of cell
wall synthesis, on ExPortal organization. Thus, I hypothesize that CdhA or orthologous
proteins associated with cell wall assembly and involved in determining the plane of cell
division in GAS, may also play a role in ExPortal organization.
The work of Pancholi et al indicates the functional CHAP domain of CdhA is not
involved in the protein’s role of cell division plane-recognition, given that the absence of
this domain does not produce the same division and growth defects that disrupting
expression of the whole CdhA polypeptide does. Additional cell wall hydrolases may
compensate for the absence of CdhA enzymatic activity and the role of recognizing the
plane of cell division could involve interaction of CdhA with these hydrolases in the cell
wall or with other factors at the cytoplasmic membrane. Two additional proteins of GAS
contain a C-terminal CHAP domain closely resembling that of CdhA. Identified as Isp
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(Immunogenic secreted protein) and Isp2, they are highly homologous to one another, are
encoded as part of the mga regulon, but have no assigned cellular function [4, 5]. Since
the CHAP domain of CdhA was shown to still be important for virulence and antibiotic
resistance, I hypothesize Isp and Isp2 function in conjunction with CdhA to modulate cell
wall assembly, while targeting to their site of action by CdhA influences localization of
the cell division plane and the ExPortal. Thus, I proceeded to characterize the function of
Isp, Isp2 and CdhA in cell division and ExPortal organization. Preliminary data shows
that lack of isp alone, or in combination with the absence of isp2, does not recapitulate
the effects on cell division and morphology observed by disruption of CdhA. The absence
of isp and isp2 also did not affect localization of the ExPortal anionic lipid microdomain
nor secretion of the SpeB protease. Attempts to generate an in-frame deletion of CdhA or
its CHAP domain in the strains lacking isp and/or isp2 have thus far proven unsuccessful,
which hints at a dependence of theses factors on each other for cell viability.
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RESULTS
EndoS. Proteins in supernatants harvested from stationary phase streptococcal cultures
that were treated with a sub-lethal concentration of polymyxin B were compared to those
from untreated cultures. Proteins found in both samples were isolated by gel
electrophoresis and subjected to trypsinization and subsequent analysis by mass
spectrometry at the Siteman Cancer Center Proteomics Core Laboratory (Barnes-Jewish
Hospital/Washington

University

School

of

Medicine,

http://proteomics.wustl.edu/siteman/Proteomics_page3_new.htm). The results obtained
were examined using ScaffoldTM 2 Proteome software (ScaffoldTM Version_2.1.03,
Proteome Software Inc.). Spectrometry analysis confirmed that SpeB was absent from
supernatants of streptococcal cultures exposed to polymyxin B and identified additional
proteins absent or in lower relative amounts in treated cultures. Among these, one protein
of interest for which no trace was detected in peptide treated samples, was the EndoS.
Further characterization of EndoS as an ExPortal substrate was conducted by examining
expression of the endoglycosidase in the presence of polymyxin B. Previous research
indicates that, like SpeB, EndoS expression is growth phase regulated, with peak
expression occurring in stationary phase [6]. Western analysis of supernatants from CAPtreated and untreated cultures harvested under the same conditions as indicated for SpeB
in Chapter I, revealed a dose-dependent reduction in the amount of secreted EndoS
protein resulting from exposure to polymyxin B (Fig. 1A) and HNP-1 (Fig. 1B). This
effect on levels of secreted EndoS was observed in both HSC5 and SF370 (Fig. 1C, D)
strains. Transcriptional analysis however, showed that levels of EndoS transcript were
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also affected by exposure to polymyxin B (Fig. 1E). These results suggest that disruption
of the ExPortal can also affect transcription of streptococcal virulence proteins.

Figure 1. High sub-lethal challenge with polymyxin B and HNP-1 inhibits secretion of
EndoS. Expression of the EndoS endoglycosidase in cultures of S. pyogenes HSC5 (A, B) and
SF370 (C, D) was determined following challenge with the indicated concentrations of
polymyxin B and HNP-1 by Western blot analysis of culture supernatant (A-D) and by real-time
RT-PCR analysis of endoS transcript abundance (E). All samples for EndoS analysis were
harvested at 2 hrs post-challenge.
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CdhA, Isp/Isp2. Penicillin binding protein (PBP) transglycosylases, transpeptidases and
cell wall hydrolases are hypothesized to primarily localize as a multienzyme complex or
holoenzyme to the sites of peptidoglycan synthesis in bacteria (for a review see [7]). Cell
wall hydrolase activity serves to remodel peptidoglycan strands as new subunits are
added to the polymer during growth, cell separation following division and cell wall
turnover [8-10]. CdhA was demonstrated to have functional hydrolase activity, and given
that Isp contains a C-terminall CHAP domain similar to that of CdhA, Isp is potentially a
previously unidentified streptococcal cell wall hydrolase. Thus in order to further
characterize the role of peptidoglycan biogenesis in ExPortal organization, I examined
how Isp localizes in the streptococcal cell. Isp localization was monitored by Cterminally tagging Isp using a hemaglutinin (HA)-mCherry tandem tag. The purpose of
the tandem tag was to examine localization of the protein by both fluorescent and
immunofluorescent microscopy as well as expression by Western analysis. Fluorescent
microscopy revealed that Isp localizes to discrete regions on the streptococcal surface in
both HSC5 (Fig. 2A) and SF370 strains (Fig. 2B). These regions are observed as either
unique foci or as hemispherical domains between cells, mirroring the observed
localization of HNP-1 in GAS (see Fig. 6, Chapter II).
The disruption of anionic lipid microdomains by CAPs does not appear to disrupt
cell growth and division, as indicated by data presented in Chapter I. The converse, that
disruption of the cell wall and of peptidoglycan synthesis affects anionic lipid
microdomain localization, appears to be the case, as supported by data described in
Chapter III. I examined then whether exposure to a CAP alters localization of Isp. Neither
low nor high sub-lethal concentrations of polymyxin B appear to affect localization of Isp
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(Fig. 2C, D). The lack of an effect on Isp localization as a result of exposure to an
ExPortal-disrupting CAP was observed in both the HSC5 (Fig. 2C, D) and SF370 strain
(data not shown). Next I determined whether loss of Isp expression affects localization of
the ExPortal anionic lipid microdomain. Low sub-lethal amounts of a fluorescently
labeled polymyxin B derivative (dansyl-polymyxin B) shown to target the ExPortal (see
Fig., Chapter I) in wild-type streptococci similarly localized to unique foci in a mutant
strain containing an in-frame deletion of Isp (Fig. 2E). Deletion of both Isp and its
homolog Isp2 did not alter localization of dansyl-polymyxin B either (Fig. 2F),
suggesting that individually or together these putative cell wall hydrolases do not
influence ExPortal localization. Lastly I examined the localization of Isp on the
streptococcal cell surface relative to the ExPortal. Fluorescence microscopy shows that
the fluorescently-labled Isp polypeptide and the anionic lipid microdomain of the
ExPortal labeled with polymyxin B localize adjacent to one another (Fig. 2G, H). This
could be the result of both targeting to sites of active peptidoglycan synthesis and does
not imply that localization of one is dependent on the other given the previous data
described.
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Figure 2. Characterization of Isp and Isp2 putative cell wall hydrolases and their role in
ExPortal organization. Localization of Isp and Isp2 on the streptococcal surface and their
involvement in organization of the ExPortal was examined by fluorescence microscopy.
Localization of C-terminally mCherry-tagged Isp protein was revealed by fluorescence
microscopy in HSC5 (A) and SF370 (B) strains. Localization of Isp-mCherry was unaltered by
polymyxin B challenge of streptococci with low (C) and high (D) sub-lethal levels of the cationic
peptide. Localization of anionic lipids was examined by fluorescence microscopy using dansylpolymyxin B to label membranes of HSC5 mutant strains containing in-frame deletions of isp (E)
and both isp and isp2 (F). Co-localization of the ExPortal anionic lipid microdomain and Isp
protein was determined by fluorescence microscopy in dansyl-polymyxin B-stained (blue) HSC5
strains expressing mCherry-tagged Isp (red) (G) and quantitated (H). Fluorescence, phase and
merged images are shown. Scale bar = 1µm. Numbers of polymyxin B and mCherry
fluorescence-labeled streptococci were derived from examination of at least 1000 stained cells.
All data presented represents the mean and standard error of the mean derived from at least 3
experiments.
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DISCUSSION
The observed effects of polymyxin B on expression of EndoS indicate that
disruption of ExPortal integrity by the CAP can also alter expression of streptococcal
virulence factors at the level of gene transcription. This suggests that localization of
anionic membrane lipids and associated ExPortal proteins also affects gene regulation.
One possible mechanism by which polymyxin B may be affecting EndoS expression is
disruption of one of the multiple two-component signal transduction systems identified in
GAS that regulate virulence gene expression in response to environmental cues [11]. The
CAP itself could be interacting with such a two component regulator, as is hypothesized
in the case of cathelicidin induced stimulation of the hasABC operon described in
Chapter I [12, 13]. Another possibility is that ExPortal disruption inhibits the function of
an accessory factor required for activation or de-repression of EndoS transcription.
Function of such a factor could be dependent on lipid-protein or protein-protein
interactions at the site of protein secretion, similar to how phosphatidylglycerol has been
shown to be involved in optimal protein translocation via the Sec pathway by influencing
interaction of SecA with the SecYEG translocon [14, 15]. Whatever the case, the
identification of EndoS as a virulence factor of streptococci affected by CAP activity on
the ExPortal opens up an additional avenue of investigation into the role of ExPortal
function in streptococcal virulence.
Further characterization of Isp, Isp2 and CdhA localization and activity is
evidently necessary in order to determine whether these are all indeed functional cell wall
hydrolases involved in peptidoglycan synthesis and if and how their activity affects
ExPortal organization. The experimental data published by Pancholi et. al. strongly
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suggest that CdhA does play a role in proper cell wall assembly during cell division. If
Isp and Isp2 have functional cell wall hydrolase activity, then the phenotype of the
∆isp/∆isp2 suggests a functional CHAP domain in CdhA is necessary and sufficient for
cell division and growth. It will be most interesting to examine whether deletion of the
CHAP domain of CdhA in an ∆isp/∆isp2 background recapitulates the ∆CdhA
phenotype, as this would strongly indicate that interaction of all three CHAP-domain
proteins is required or the division-plane localizing role of CdhA, with the N-terminal
domain of CdhA acting as the targeting factor for all three proteins and the associated Isp
and Isp2 activity involved in the role of CdhA in virulence and beta-lactam resistance.
Other as of yet unidentified factors may also be involved, highlighting the importance
and novelty of this research. Characterization of the ExPortal in the CdhA-disrupted
strain is pending collaboration with Pancholi et al, as my attempts to generate a CdhA
null mutant have been unsuccessful. Further mutagenesis and characterization of CdhA,
Isp, Isp2 and other components of cell wall synthesis is needed to assess their
involvement in ExPortal organization.
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EXPERIMENTAL PROCEDURES
Strains, media and growth conditions: As indicated, experiments utilized S. pyogenes
HSC5 [16] or SF370 [17] and all references to genomic loci are based on the genome of
SF370 [17]. Localization of Isp was analyzed in HSC5 following transformation by pIspHA-mCherry (pLAV41312), which expresses a Hemagglutinin (HA)-mCherry-tandemtag derivative of Isp. Localization and integrity of the ExPortal anionic lipid
microdomain was assessed in HSC5 following in-frame deletion of isp and isp2 coding
regions. Routine culture was at 37°C in Todd-Hewitt broth (BBL) supplemented with
0.2% yeast extract (Difco) (THY medium). Localization and functional assays utilized
cultures grown in unmodified C medium as described previously [18], supplemented with
spectinomycin (100ug ml-1, Sigma #S4014) when indicated. To produce solid media,
Bacto Agar (Difco) was added to a final concentration of 1.4%. Liquid cultures were
grown without agitation in closed containers and solid cultures were incubated under
anaerobic conditions using a commercial gas generator (GasPak, cat. #260678, BBL) as
described [18]. In selected experiments, media were supplemented with the cationic
antimicrobial peptide polymyxin B (cat. #P0972-50MU, Sigma).

DNA techniques: Plasmid DNA was isolated via standard techniques and used to
transform S. pyogenes as described previously [19]. Restriction endonucleases, ligases
and polymerases were used according to manufacturer’s recommendations.
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Construction of S. pyogenes deletion mutants: All references to genomic loci are based
on the genome of S. pyogenes SF370 [17]. The construction of mutants containing inframe deletions in isp (spy2025) and isp2 (spy1801) was performed by allelic
replacement [20] using the primers listed in Table 1. The in-frame deletions were
constructed as follows. Flanking regions of isp and isp2 were amplified from HSC5
genomic DNA using the corresponding primers indicated in Table 1 to generate
fragments 500 nucleotides in length with a 5’ XhoI upstream restriction site, an SphI
restriction site in common at the 3’ end of the upstream flanking region and 5’ end of the
downstream flanking region and an XbaI downstream restriction site at the 3’ end of the
downstream flanking region. The amplified flanking regions were ligated following
restriction digestion of the shared SphI site. The resulting products were amplified using
the 5’ upstream and 3’ downstream primer pairs (Spy_2026/Isp4 Fwd-Isp/Spy_2023 Rev
and Spy_1802/Isp2 Fwd- Isp2/Spy_1798 Rev) to generate fragments containing in-frame
deletions of the regions of isp and isp2 encoding L11-P542 and M11-N493 respectively.
These deletion fragments were cloned into the pJRS233 shuttle vector using the XhoI and
XbaI restriction sites to generate pJRS233-∆Isp (pLAV4910) and pJRS233-∆Isp2
(pLAV11510). HSC5 strain streptococci were transformed as previously described [20]
with pLAV4910 to generate HSC5:∆isp, which was subsequently transformed using
pLAV11510 to generate HSC5:∆isp/∆isp2. In frame deletions were confirmed by PCR
and sequence analysis using the appropriate primers.

Epitope/fluorescent protein-tagged constructs: Epitope and fluorescent-tagged proteins
examined in this study were expressed in the HSC5 strain by chromosomal integration of
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the C-terminal tags. Cloning primers are detailed in Table 1. To generate the HAmCherry-tandem-tagged constructs, the coding sequence for mCherry was first amplified
from pmCHerry-ATG5 (Addgene) using primers IspmCherry2 Fwd/Rev. The amplified
mCherry sequence was then directly cloned using BamHI/SacI restriction sites into
pSPC18, a derivative of the pUC18 vector with the ampicilin resistance gene bla replaced
by the spectinomycin resitance gene aad9 [21, 22]. The final product (pLAV8510)
contains a promoter-less mCherry lacking the start ATG and a 5’ BamHI restriction site
for direct cloning of the 3’ ends of ORFs to create C-terminal tag protein fusions upon
chromosomal integration. Amplification of a 500 nucleotide C-terminal fragment from
isp, absent the stop codon and including a 3’ HA-tag nucleotide sequence, using the
primer pair Isp-HA Fwd/Rev followed by double restriction digest (BamHI/PstI) and
ligation generated pSPC18:Isp-HA-mCherry (pLAV41312).

Cellular staining and fluorescent microscopy: Analysis of the location and integrity of a
membrane microdomain enriched in anionic phospholipids was assessed by staining with
sub-lethal concentrations of a fluorescent polymyxin B derivative (dansyl-polymyxin B,
10µM, cat. #P13238, Invitrogen). Samples were examined using a Leica model DM IRE
2 fluorescent microscope and images captured using a QImaging Retiga 1350 EX
charged-coupled device camera and Openlab software (Improvision). Co-localization of
Isp with fluorescent polymyxin B derivatives was quantitated as the percentage of
polymyxin B -stained cells that exhibited focal staining with each individual reagent
where the two foci were superimposable. Data presented for each condition represents the
mean and standard error of the mean derived from at least 3 independent experiments and
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examination of a minimum of 1000 stained cells. Images were processed for publication
using Adobe Photoshop CS3.

Analysis of protein expression and secretion: Supernatant fractions from cultures
challenged with polymyxin B were prepared and analyzed for the presence of EndoS by
Western blotting as described [23]. Blots were developed using a Chemidoc XRS imager
(BioRad) and relative protein concentrations determined using Quantity One software
(BioRad, version 4.6.7). Antibody against EndoS was a generous gift from Mattias Collin
(Lund University, Sweeden).
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Table 1. Primers utilized for construction of epitope/fluorescent-tagged constructs and in-frame
deletions.

Primer

Sequence1

Description

IspmCherry2 Fwd

CCCGGATCCGTGAGCAAGGGCG
AGGAG
CCCGAGCTCCTACTTGTACAGCT
CGTCCATGC
CCCCTGCAGATATCATGACCAAA
CTAGACCAAT
CCCGCATGCTTAAGCATAATCTGG
AACATCATATGGATATGGTCTTGG
GAGTTTGTCCCC
CCCCTCGAGTATCAATCTCGAAG
AACAATTCGTCAA

5’ amplification primer for
mCherry
3’ amplification primer for
mCherry
5’ primer for insertion of HA
epitope tag
3’ primer for insertion of HA
epitope tag

IspmCherry2 Rev
Isp-HA Fwd
Isp-HA Rev
Spy_2026/Isp4 Fwd
Spy_2026/Isp Rev
Isp/Spy_2023 Fwd

CCCGCATGC
TGTTACTGCTAACAATTTCCTTTT
CTTCAT
CCCGCATGCGTCGTAGGGGACAA
ACTCCCAAGACCATAA

Isp/Spy_2023 Rev

CCCTCTAGATGAGAAAACAGGGC
TTTGGGTTCTATTTTG

Spy_1802/Isp2 Fwd

CCCCTCGAGGGTTCTGATCTAAG
CTTACCATTTC

Spy_1802/Isp2 Rev

CCCGCATGCGGCAACTCTTAATA
GTTTGTTTTTATT

Isp2/Spy_1798 Fwd

CCCGCATGCAACATATGTTAT
TGGCAAGAGTAAAAA

Isp2/Spy_1798 Rev

CCCTCTAGATCTATCACTTTG
TGATTATTTTGTCAA

1

5’ primer for amplifying the
upstream flanking region of
isp
3’ primer for amplifying the
upstream flanking region of
isp
5’ primer for amplifying the
downstream flanking region
of isp
3’ primer for amplifying the
downstream flanking region
of isp
5’ primer for amplifying the
upstream flanking region of
isp2
3’ primer for amplifying the
upstream flanking region of
isp2
5’ primer for amplifying the
downstream flanking region
of isp2
3’ primer for amplifying the
downstream flanking region
of isp2

Restriction sites underlined, Hemagglutinin (HA) tag italicized.
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Chapter V

An Emerging Model for Spatial Coordination of Protein Biogenesis and Secretion:
the Role of Lipid Segregation and Cell Wall Synthesis in ExPortal Organization
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INTRODUCTION
Previous work discovered the co-localization of secretory translocons with an
accessory factor for protein biogenesis at an anionic lipid microdomain, which defined
the ExPortal as a secretory organelle dedicated to coordinating protein processing with
secretion. My thesis research sought to further understanding of how such spatial
coordination in the membrane is achieved and maintained, and what its relevance is to
streptococcal pathogenensis. The experimental data resulting from this research
constitutes a meaningful and exciting contribution to both of these aims.
Investigation of cationic antimicrobial peptide (CAP) interaction with the
ExPortal increased knowledge of an aspect of streptococcal pathogenesis that is not often
examined. As effectors of innate immunity, CAPs have traditionally been considered to
primarily act as membrane permeabilizing factors against which bacteria have little
resistance. However, the work presented here demonstrates in a physiological model
what has, for the most part, been investigated in model lipid membranes. That is, CAPs
interact with the cytoplasmic membranes of bacteria via mechanisms that do not result in
membrane permeabilization, but can have substantial effects on cell viability nonetheless.
In Streptococcus pyogenes, CAPs influenced the secretion of virulence factors that have
been demonstrated to be of great importance to pathogenicity, opening up a new area for
investigation into how CAPs may participate in colonization of a human host by GAS.
The results presented also support a tentative model for ExPortal organization.
According to this model, anionic lipids in the streptococcal membrane play a central role
in the localization of secretory translocons and accessory factors in the membrane.
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Segregation of these charged lipids to a microdomain in the membrane appears to be
mediated by, or at least involve, interaction with the cell wall and with peptidoglycan
production. Further testing of this model will include characterization of the involvement
in ExPortal organization and function of cell division proteins required for directing cell
wall synthesis and growth. This makes S. pyogenes an emerging model organism for
examining the intersection of multiple cellular processes in the membrane of Grampositive pathogens.

Figure. 1 An emerging model of ExPortal organization. Spatial coordination of anionic lipids,
peptidoglycan biogenesis proteins and secretory translocons in the ExPortal to effect efficient
secretion and processing of streptococcal virulence factors.
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CONCLUSIONS
The model of ExPortal organization and maintenance supported by the
experimental results presented can be described as follows and is schematically
represented (Fig. 1). Interaction of anionic lipids with the Sec translocons, accessory
factors (HtrA), and secreted substrates requiring post-translational processing (SpeB,
SLO) appears to target and maintain these polypetides at the ExPortal. I have shown that
without segregation of anionic lipids to unique microdomains in the streptococcal
membrane, targeting and maintenance of these ExPortal proteins at their cellular site is
lost, meaning lipid segregation in the membrane is central to ExPortal organization. Thus
segregation of anionic lipids, mainly phosphatidylglycerol, constitutes the primary
mechanism for targeting protein components to the site of the ExPortal. Identification of
the peptide sequences involved in the lipid-protein interactions localizing these proteins
is therefore an area of interest for further research. The establishment and maintenance of
anionic lipid microdomains is in turn dependent on the presence of extracellular
peptidoglycan and its biogenesis. Production of the peptidoglycan precursor lipid II is
localized to the same membrane site as the ExPortal, and loss of peptidoglycan disrupts
anionic lipid and ExPortal protein localization in the membrane. Lipid II production at
the site of the ExPortal may also be dependent on the presence of an anionic lipid
microdomain to which membrane-associated lipid II-synthetic proteins are targeted.
However, the observation that a lipid II-binding lantibiotic (gallidermin) disrupts
ExPortal lipid and protein localization favors a mechanism whereby targeting of the
peptidoglycan precursor influences lipid segregation in the membrane, rather than the
converse. The experimental results presented support a model in which cell wall outside
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the membrane restricts localization of anionic lipids by determining the site of lipid II
synthesis. Without an intact cell wall in which PBPs assemble peptidoglycan, lipid II in
the outer leaflet of the cytoplasmic membrane is deprived of acceptors for its
glycopeptide cargo. This can prevent recycling of its prenyl-phosphate anchor and inhibit
further lipid II production, thus disrupting ExPortal organization and inducing
morphological defects if peptidoglycan synthesis is completely arrested (see Fig. 3
Chapter I). There is experimental precedent that supports such a model in the substrate
recognition mechanism of PBP recruitment to division septa. A

D-Ala-D-Ala

carboxypeptidase (PBP3) of S. pneumoniae, encoded by the dacA gene also present in
GAS, degrades the substrate of PBP transpeptidases by trimming the lipid II peptapeptide
[1-3]. S.pneumoniae mutants disrupted in PBP3 display defects in division [4] and in colocalization of PBPs with the FtsZ ring [2]. PBP3 appears distributed over the whole cell
surface except the mid-cell region before division starts [2], meaning pentapeptides are
only available at equatorial peptidoglycan, where PBPs would be recruited to by affinity
for their substrate. This cooperation between PBP substrate affinity and availability lends
support to the hypothesis that the cell wall restricts localization of peptidoglycan
synthesis through the activity of PBPs and the availability of sites for peptidoglycan
polymerization in intact cell wall. According to this model then, the site at which cell
wall synthesis primarily occurs determines where lipid II is produced and in so doing
affects ExPortal localization. In summary, my thesis work has expanded our model of
ExPortal organization, by demonstrating that anionic lipid segregation is central to
targeting ExPortal proteins to their membrane site and that this lipid microdomain is
maintained by the cell wall and depends on lipid II biogenesis localized at the ExPortal.
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This model of ExPortal organization proposes that spatial coordination of protein
secretion and processing results from cooperation of multiple cellular mechanisms in a
highly interdependent manner. The individual contributions cell wall biogenesis, lipid
segregation and protein interaction make are each necessary but not sufficient by
themselves to either establish or maintain the spatial coordination of secretory
translocons and accessory factors. This suggests further dissection of the specific roles
each plays in ExPortal organization may prove difficult. However, it is that much more
important for the discovery of highly effective antimicrobials, as it makes the ExPortal a
useful target for the development of novel antibiotics that can disrupt multiple cellular
processes.

Mechanism of CAP activity on the ExPortal. One aim of my thesis research was to
investigate involvement of the ExPortal in streptococcal pathogenesis. Previous research
suggested that CAP activity is an aspect of host immunity that would interact directly
with the ExPortal. As described in Chapter I, the principal mechanism of CAP activity is
the permeabilization of the cytoplasmic lipid membrane. Interaction of membrane lipids
with multimeric protein complexes is central to the biological processes of membrane
biogenesis, cell wall synthesis, and responding to environmental challenges (i.e. cell
signaling, secretion of virulence factors). Integrity of the cytoplasmic membrane is
therefore crucial to bacterial survival. Hence the prominence and effectiveness of CAPs
as antimicrobials against which bacterial pathogens have limited resistance. The
experimental data presented here indicate that CAPs affect their bacterial target in a
manner other than by altering membrane permeability. A readily available CAP
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(polymyxin B) and a physiologically important one (HNP-1) were shown to interact
directly with the ExPortal and disrupt its organization and function in the absence of
membranolytic activity. These findings contribute novel observations in a physiological
model to emerging research that is elucidating the mechanisms of non-membranolytic
interaction by which CAPs influence pathogens.
Several factors modulate how CAPs partition into membranes, the most important
of which are membrane electrical potential, curvature strain of the membrane and
hydrophobic interactions with the lipid acyl chains [5]. Electrical potential is dictated by
the electrostatic interactions between the lipid headgroups and the peptides’ charged
residues. Cell membranes rich in lipids with a net negative charge at physiological pH,
like phosphatidylglycerol (PG), cardiolipin (CL) or phosphatidylserine [6], tend to be
highly electronegative, making them preferentially targeted for interaction with CAPs.
Unlike unsaturated lipids that promote negative curvature strain in monolayers, PG
generates no such strain given its cylindrical geometry. Interaction of CAPs with the acyl
chains of lipid molecules occurs via van der Waals and hydrophobic interactions that can
frustrate lipid packing in the membrane, inducing membrane thinning and/or lipid phase
segregation. These properties of PG/CAP interaction explain the preferential localization
of CAPs like polymyxin B and HNP-1 at the ExPortal. The electronegativity of an
anionic lipid microdomain such as that of the ExPortal promotes interaction with the
CAPs, and the reduced membrane strain in a region enriched for the cylindrical topology
of PG facilitates insertion of the peptides into the bilayer and interaction with the
hydrocarbon acyl chains.
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Hydrophobicity and a net cationic nature are common to all CAPs however, but
not all CAPs tested showed a propensity to affect ExPortal secretory function. One
explanation is that varying degrees of hydrophobicity and net charge have great influence
on the affinity of CAPs for membranes of varying composition. A study of
diastereomeric peptides composed of varying ratios of lysine and leucine revealed that
highly hydrophobic peptides had lytic activity against anionic and zwitterioinic
phsopholipid vesicles alongside hemolytic and antibacterial activities, whereas highly
cationic peptides only permeabilized acidic phoshpolipid vesicles and lysed bacteria [7].
Though composed of the same two amino acids in different proportions, these
proportions had a marked effect on the activity of the synthetic CAPs. Given the
enormous diversity in the amino acid sequences of CAPs, not all will target the ExPortal
as effectively.
Binding to the streptococcal membrane was not directly examined in all the CAPs
studied, thus it is possible that those CAPs that did not affect ExPortal secretory function
do bind anionic lipids at the ExPortal, but their initial interaction with the membrane
surface did not have any appreciable disruptive effects on its organization. This could be
because these peptides do not exert any effects beyond a membranolytic activity on their
bacterial targets or that the sub-lethal concentrations tested don’t reflect the threshold
concentration of the peptides under the experimental conditions used. Below this socalled threshold concentration CAPs fold and remain adsorbed parallel to the bilayer [811]. As the ratio of peptides to lipid increases, peptides orient perpendicular to the
membrane [12], insert and partition into the hydrophobic core of the bilayer. Aspects
influencing partitioning are peptide concentration, the propensity of a CAP to
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oligomerize, composition of the membrane, fluidity, chemistry and size of the
phospholipid headgroups, transmembrane electrical potential and pH [8, 11, 13-15].
Thus, CAPs that did not have disruptive effects on the ExPortal might not have achieved
the threshold concentrations necessary to influence its organization or they had a
propensity to only adsorb at the surface unless they achieved the threshold concentration
that induces permeabilization of the membrane by one of the mechanisms described in
Chapter I.
As described in chapter III, different lipid phases can coexist within a single
membrane plane, delimited by a plane boundary, giving rise to lateral phase segregation
and formation of the lipid microdomains observed in bacterial cytoplasmic membranes.
The properties of these lipid phases determine the orientation, mobility and interaction of
proteins and lipids contained therein and thus directly influence the biological
functionality of the domains. Research using synthetic amphipathic α-helical peptides
showed that formation of lipid phases can be influenced by peptides of this kind, which
also exhibited antimicrobial activity [16]. Peptides affecting lipid phases have been
observed to perturb the membrane by forming specific lipid-peptide domains, by lateral
phase segregation of zwitterionic from anionic phospholipids and by inducing nonlamellar phases at physiologically relevant concentrations [5]. One demonstration of such
modes of action was the observation of anionic phospholipids de-mixing in Grampositive model membranes exposed to peptides with this kind of activity [17]. Peptide
induced lipid segregation then appears to be the mechanism employed by those CAPs
that have disruptive effects on the ExPortal. The activity of CAPs like polymyxin B and
HNP-1, which target PG and/or lipid II localized in an anionic lipid microdomain of the
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streptococcal membrane, most likely disrupts the physiological role of the ExPortal by
causing lipid phase boundary defects through peptide-induced reorganization of
membrane lipids. The possibility that polymyxin B and HNP-1 act on other or additional
polypeptide targets to influence ExPortal organization and biogenesis of secreted factors
requires further investigation as previously described in Chapter I and therefore cannot be
entirely ruled out. However, the data presented here as well as investigation conducted in
other bacterial organisms strongly suggests that lipid segregation by CAPs promotes
dissolution of lipid-protein complexes in the membrane and abrogates their functionality.

Challenges to the ExPortal model of coordinated protein secretion and processing. A
great deal of data, published and unpublished, has been presented here to support a
mechanism of localized protein secretion and maturation in S. pyogenes. However,
experimental data has been published that disputes the spatial coordination of secretory
translocons and accessory factors at a unique site in the streptococcal membrane. One
study indicated that M protein and Protein F (SfbI) localized at the cell surface of GAS at
distinct and separate sub-cellular regions: M protein directed at septa and SfbI at polar
domains [18]. Swapping of N-terminal signal sequence domains between the two proteins
switched their localization patterns, with SfbI observed at septa and M protein at polar
domains [18], suggesting that differences in signal sequences is determinant in targeting
of streptococcal factors to their extracellular site. Analysis of sortase-mediated anchoring
of M protein and SfbI to their respective cellular surface locations revealed that the two
proteins are anchored simultaneously throughout the cell cycle, with M protein rapidly
anchored at the septum and SfbI accumulating gradually on peripheral peptidoglycan,
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culminating in mainly polar localization at the old cell poles [19]. However, disruption of
sortase function did not impede the appearance of M protein and SfbI at their respective
cellular sites, suggesting that these secreted factors were not translocated at a shared,
unique microdomain and then sorted to their extracellular site, but directly translocated at
their site of localization [19]. Though these data appear to call into question the existence
of an ExPortal for coordinated protein secretion and biogenesis, alternative mechanisms
for this differential targeting of secreted proteins in GAS should be considered and
investigated. For example, the data indicates that these proteins target differently on the
streptococcal surface, whether by sortase-mediated anchoring or immediately following
translocation. It is possible that the signal sequences, which as demonstrated by Carlsson
et. al. are the determinants of localization, serve to segregate the secreted proteins in the
membrane immediately following translocation and prior to the action of sortasemediated anchoring to the cell wall, in order to efficiently distribute M protein and SfbI
to their final surface destination. One experimental approach to determine if this is the
case would be to swap signal sequence domains of M protein and SfbI with those of
known ExPortal substrates (SpeB and SLO) to assess localization upon translocation.
Efforts to directly tag the SecYEG translocon in the streptococcal membrane have thus
far proven unsuccessful, but if accomplished, direct labeling of SecYEG in the
cytoplasmic membrane will greatly help resolve these conflicting results.
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FUTURE DIRECTIONS
Further characterization of ExPortal organization and refinement of this model
will include examination of the role cytoskeletal and cell wall synthesis proteins play in
ExPortal maintenance. Due to their ellipsoid shape and pattern of division in successive
parallel planes perpendicular to the long cell axis, GAS are morphologically described as
ovococci along with other streptococci and enterococci [20]. Ovococci synthesize the cell
wall primarily at the division site, with new hemispheres of the daughter cells synthesized
between the old hemispheres of the parent cell, as demonstrated by labeling of S.
pnemoniae cells mostly at mid-cell with fluorescent-vancomycin [21]. Ultrastructural,
mutational and drug treatment studies in streptococci indicate that PBPs are arranged into
two synthetic machineries co-localized at a single cellular site [22, 23]. One machinery
synthesizes peptidoglycan at mid-cell on the inner face of the cell wall concomitant with
splitting of the new wall, resulting in the observed initial phase of longitudinal growth.
[20]. This is followed by activity of the second PBP machinery which builds the septal
cross-wall ahead of septal splitting of the wall in order to produce the cross-wall observed
in ovococci. High molecular weight (HMW) PBPs localize mid-cell at the site of FtsZ
ring formation at the onset of cell division, suggesting a mechanism of FtsZ triggered cell
wall synthesis [20]. Thus, most activity of PBPs in ovococci involves polymerization of
peptidoglycan during cell division-associated growth.
One hypothesis of interest for future work to test then, is that the multimeric cell
division machinery (divisome) of streptococci is involved in localizing the ExPortal, most
likely by determining the site of peptidoglycan synthesis. As mentioned in Chapter III,
GAS lack cell wall elongation-associated divisome proteins (RodA, MinCD), but express
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other peptidoglycan synthesis-related divisome factors: DivIB, DivIC, DivIVA, and
EzrA. DivIB and DivIC are bitopic membrane proteins with major extracellular domains
that in other ovococci are often encoded in operons along with genes involved in lipid II
synthesis [20]. In S. pyogenes DivIB is encoded directly downstream of a lipid II
synthase gene (murG) and immediately upstream of a Z-ring accessory factor gene (ftsA),
while DivIVA is encoded a not very far downstream of the latter [24]. In S. pneumoniae
and E. faecalis, loss of DivIVA expression produces aberrant cell shapes, incomplete
septa and cells devoid of nucleoid [25, 26] and in S. aureus DivIVA has been shown to
primarily localize at division septa [27]. The integral membrane protein EzrA regulates
timing and positioning of FtsZ rings in B. subtilis [28] and can directly bind to and
regulate assembly of FtsZ polymers in vitro [29]. EzrA is also required for recruitment of
PBP1 to the cell division site in B. subtilis as part of the septal wall synthesis machinery
[30]. While not essential in S. aureus, EzrA is important for regulation of cell size and is
likewise required for localization of PBP1 [31].
Given all this experimental evidence of the close relationship between divisome
proteins and cell wall synthesis in ovococci like GAS, one approach to examine the role
of said proteins in ExPortal organization would be to generate in S. pyogenes mutants
disrupted in DivIB, DivIVA and EzrA. Attempts to generate in-frame deletion mutants as
well as targeted disruptions of DivIB, EzrA and its associated PBP (PBP1) have thus far
been unsuccessful. A method of targeted gene disruption using synthetic inducible
riboswitches, developed by Topp et al. [32] and applied in GAS by Bugrysheva et al. in
controlling expression of an essential gene [33], is an alternative approach to consider for
generating the desired disruption of EzrA, DivIB and PBP1. Examining localization of
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these proteins and the effect of their disruption on the distribution of lipid and
proteinaceous ExPortal components constitutes an important next step in understanding
organization of this secretory organelle.
Given the diversity and ubiquity of CAPs throughout all realms of life, it should
come as no surprise that bacterial pathogens have developed resistance mechanisms
against them. As described in Chapter I, a great deal of research has gone into identifying
and characterizing these mechanisms in order to develop therapeutic strategies that
enhance the inherent ability and efficiency of CAPs at killing pathogens. One avenue of
research that resulted from the investigation of CAP interaction with the ExPortal
undertaken in this thesis work was the development of a screen to isolate spontaneous
mutations rendering S. pyogenes impervious to the inhibitory effect of CAPs on ExPortalmediated protein secretion. The aims of such a screen are to further understanding of
host-pathogen interactions by dissecting how GAS coordinate the protein secretion and
processing that is central to their pathogenesis and to gain insight into how streptococci
might overcome the action of host antimicrobials. Initial characterization of mutants
isolated in this screen has validated the experimental approach by identifying mutants
encoding between 1 and 4 single nucleotide polymorphisms that map to molecular
pathways involved in secretion, lipid biosynthesis and protein processing. Efforts to
recreate the identified mutations by directed mutagenesis and characterize their
phenotypes are currently underway and show great promise.
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ABSTRACT
The signal recognition particle (SRP) pathway is a universally conserved pathway
for targeting polypeptides for secretion via the co-translational pathway. In particular,
the SRP pathway is thought to be the main mechanism for targeting polypeptides in
Gram-positive bacteria, including a number of important human pathogens. Though
widely considered to be an essential cellular component, recent advances have indicated
this pathway may be dispensable in Gram-positive bacteria of the genus Streptococcus
under in vitro conditions. However, its importance for the pathogenesis of streptococcal
disease is unknown. In this study, we investigated the importance of the SRP pathway
for virulence factor secretion in the human pathogen Streptococcus pyogenes. While not
essential for viability in vitro, SRP mutants demonstrated a carbohydrate-specific growth
defect. We also observed that a distinct subset of virulence factors were dependent upon
the SRP pathway for secretion, whereas others were completely independent of this
pathway. Significantly, deletion of the SRP pathway resulted in mutants that were highly
attenuated in both a zebrafish model of necrotic myositis and a murine subcutaneous
ulcer model, highlighting the importance of this pathway in vivo. These studies
emphasize the importance of the SRP pathway for the in vivo survival and pathogenesis
of S. pyogenes.
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INTRODUCTION
The important human pathogen Streptococcus pyogenes is able to establish
infection and cause disease in a wide variety of tissues in the host including the pharynx
(eg. “strep throat”) and the epidermis (eg. impetigo, erysipelas), as well as deeper tissues
like the dermis, fascia and muscle (eg. cellulits, necrotizing faciitis, myositis). Crucial to
the establishment of infection is the production of a multitude of virulence factors that are
secreted across the single cellular membrane of this Gram-positive pathogen (14).
Understanding how these various factors are trafficked to their appropriate destinations,
including the streptococcal cell membrane, its cell surface, the extracellular spaces and
host cells, will be important for elucidating the role of protein secretion in streptococcal
virulence. An unexplored question is how intracellular routing of a nascent polypeptide
contributes to its trafficking fate.
Protein secretion by Gram-positive bacteria has recently been revealed to be a
complex, organized process with specific domains dedicated to protein secretion and
folding (11, 42, 43). However, the pathways used to route presecretory proteins to the
sites of translocation across the membrane are not well understood. As Gram-positive
bacteria lack a discernable homolog of SecB, a chaperone involved in the post-translation
targeting pathway, most polypeptides are presumably targeted co-translationally via the
signal recognition particle (SRP) pathway (45). This is supported by the fact that most
Gram-positive signal sequences tend to be longer and more hydrophobic than their Gramnegative counterparts, which are features thought to be important for efficient routing of
the presecretory protein to the SRP pathway (12). Many studies in model bacterial
species, including Escherichia coli and Bacillus subtilis, have highlighted the essential
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nature of the SRP pathway for bacterial viability (25, 41). However, more recent studies
of bacteria in the genus Streptococcus have indicated that SRP essentiality may not be a
universal characteristic of all bacteria (23).
The SRP itself is a ribonucleotide-protein complex composed of a protein, the
fifty-four homolog (Ffh) and an RNA known as the small cytoplasmic RNA
(scRNA)(45). The SRP binds to signal sequences as they exit the ribosome and targets
them to the bacterial membrane by binding the membrane-associated receptor, FtsY,
which then releases the signal peptide to the Sec translocon (30). Recent cyro-electron
micrographs revealed the details behind this process whereby the interaction between
FtsY with the ribosome and Ffh results in a conformational change in the ribosome to
promote binding to the translocation machinery (21). Crucial for proper function of SRP
is the GTPase activity of both Ffh and FtsY, which is shared in a common catalytic
chamber of this heterodimeric complex (17). The SRP receptor interacts directly with the
SecYEG translocon, highlighting the close association between these two protein
complexes (3).
Interestingly, deletion of the genes encoding Ffh, FtsY and scRNA singly or in
combination in Streptococcus mutans is not a lethal event for growth on complex media
(23). Under non-stress conditions, the SRP- mutants have growth yields similar to wild
type, although with somewhat longer doubling times during logarithmic growth (23).
The SRP mutants do have a reduced capacity to resist certain stresses, most prominently
osmotic and acid shock (20) and fail to form biofilm (24).

However, a decreased

resistance to stress is not a global phenotype as the mutants do retain an ability to adapt to
acidic environments under conditions that more gradually expose them to decreased pH
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(13). Also, their growth patterns are not altered in response to many other stresses
including high and low temperature (23).

The importance of the SRP for the

pathogenesis of S. mutans disease remains to be determined.
Studies in E. coli have suggested that the SRP pathway is the major pathway for
targeting secretion of integral membrane proteins, which typically lack cleavable signal
sequences (44).

Similarly, analysis of membranes of S. mutans SRP- mutants

demonstrated that approximately 17 proteins were either absent or were present at
significantly reduced levels (24). This latter class included the β-subunit of the F1F0
ATPase, which is known to be a SRP substrate in other bacterial species (47). Since this
proton pump plays a central role in the ability to adapt to acidic conditions (5), this defect
may explain the enhanced sensitivity of these mutants to acid stress. Other proteins with
altered membrane abundance included several glycolytic enzymes and LuxS, which is
responsible for synthesis of an autoinducer known to be important for formation of
streptococcal biofilm (46, 48). However, most of these proteins lack clearly identifiable
signal sequences, so the global importance of the SRP for the trafficking of polypeptides
with both cleavable and non-cleavable signal sequences in the streptococci is unknown.
The objectives of the present study were to examine whether the non-essentiality
of the SRP can be generalized to other pathogenic streptococcal species, and if so, what
role the SRP pathway may play in the secretion of virulence factors and whether the SRP
is required for virulence. Our analysis of an Ffh-deficient mutant of S. pyogenes revealed
that a distinct subset of virulence factors with cleavable signal sequences was dependent
upon the SRP pathway for secretion. Furthermore, SRP- mutants were highly attenuated
in animal models of necrotic myositis and subcutaneous infection. These data provide
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insight into the conservation of the SRP pathway function in the streptococci, and suggest
that while it is not essential for growth, it is essential for virulence.
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MATERIALS AND METHODS
Strains, media, culture conditions. Strains used included, Escherishia coli DH5α and S.
pyogenes HSC5 (22). Routine culture of S. pyogenes was at 37oC and employed ToddHewitt medium (BBL) supplemented with 0.2% yeast extract (Difco). Culture of E. coli
utilized Luria-Bertanini (LB) broth at 37oC with shaking. Proteolytic assays employed
strains grown in C-medium that were cultured under the conditions previously described
(32).

When required, antibiotics were used at the following concentrations:

erythromycin, 750 µg/ml for E. coli and 1 µg/ml for S. pyogenes.
DNA and computational techniques. Plasmid DNA was isolated via standard
techniques and used to transform S. pyogenes as described previously (10). Restriction
endonucleases, ligases, and polymerases were used according to manufacturer’s
recommendations. The fidelity of all constructs derived by PCR were confirmed by
DNA sequencing analyses. All references to genomic loci are based on the genome of S.
pyogenes strain SF370 (15). Gene assignments were based on the information available
in the Kyoto Encyclopedia of Genes and Genomes (www.genome.jp), and were
supported by subsequent interrogation of the SF370 genome using BLAST (2) and query
sequences derived from Bacillus subtilis gene products with experimentally confirmed
activities, as noted in the text.
Construction of Mutants. An in-frame deletion was constructed by an inverse PCR
technique (31) to delete an internal fragment encompassing 500bp of the central portion
of ffh (Spy1200). Allelic replacement proceeded as described previously (31), with
confirmation of mutant genome structure by PCR using primers of the appropriate
sequences. Primers for the deletion included Ffhdeletion1 AAC CTA GGG GGC CTA
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TGG AAG ACC TCT TGA AAA TGA TTC CAG G and Ffh deletion 2 AAC CTA GGC
AAA CCT TTT CTG ACA ATA TCG ACT GC. The resulting fragment of ffh has a
deletion from amino acids spanning positions 180 to 340.
Cellular fractionation and preparation of membranes. Protoplasts were prepared as
previously described (40) and then lysed by multiple freeze-thaw cycles (-80oC/37oC)
followed by agitation with glass beads (106 µm, Sigma) using a reciprocating shaking
device (FastPrep®, Q.biogene) at a speed setting of 4.5 for 45 seconds, repeated 4-5
times. Membranes were collected by centrifugation (120,000xg, 4˚C, 60 minutes) and
resuspended in distilled water. SDS sample buffer was added to the membranes followed
by a 10 minute boil. Membrane fractions were then separated by SDS-PAGE, transferred
to Immobilon-PSQ membrane, and stained with Coomasie Brilliant blue R. Protein
identification was performed by N-terminal sequencing of Coomasie-stained bands
(Midwest Analytical, St. Louis, MO).
Analysis and identification of proteins. Cell wall fraction, membrane, and cytosolic
fractions were prepared from cultures as previously described (43). Cell free supernatants
were subjected to TCA precipitation for protein concentration. Cell wall fractions from
protoplast preparations were utilized for M protein analysis while culture supernatants
were utilized for SpeB, SLO, and SPN. Other fractions were consistently negative for the
presence of these proteins. Protein samples were separated by SDS-PAGE and transferred
to PVDF membranes. Blocking and antibody binding was done in PBS-T with 5% nonfat dry milk. Antisera against SLO and SpeB have been described previously (31, 35).
An anti-peptide antiserum that recognizes multiple serotypes of M protein was generated
as described (16). An antiserum that specifically reacts against SPN was generated using
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purified SPN (C. Smith, M. Caparon, S. Hultgren; unpublished). Analyses of culture
supernatant fluids for SpeB proteolytic activity and SLO hemolytic activity were
conducted as described (32, 35).
Analysis of transcription. RNA from various streptococcal strains was isolated and
analyzed as described previously (7, 29). Briefly, overnight growth in THY medium was
diluted 1:100 in fresh THY medium followed by growth at 37°C to mid-logarithmic
phase (OD600 = 0.500). RNA was then isolated by using glass beads (Lysing Matrix A,
Q/BioGene) and a high-speed reciprocating shaking device (FP-120, Savant Instruments).
RNA was further purified (RNeasy Mini Kit, Qiagen) and contaminating DNA was
removed by DNase treatments according to the manufacturers instructions (RNase free
DNase set, QIAGEN and DNase I, amplification grade, Invitrogen). The A260/A280 ratio
was used to determine the RNA concentration and purity. For cDNA synthesis, 5 µg total
RNA was treated with 200 U Superscript II Reverse transcriptase (Invitrogen) using 250
ng of oligonucleotide random primers (Invitrogen). Real time RT-PCR was performed
employed an iCycler thermocycler (Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad)
and the methods and primers described previously (29). Transcript abundance was
normalized to recA as previously described (29) and data presented represent the mean
and standard deviation derived from at least two independent experiments that were
performed on different days, with each individual sample analyzed in triplicate.
Zebrafish infections. Bacterial strains were back-diluted 1:100 from overnight culture
and grown in THY broth until OD600=0.30. Bacteria were then subjected to brief
sonication to disrupt bacterial chains and used for intramuscular injection of zebrafish, as
described previously (39). Experimental groups consisted of 10 zebrafish, each of which
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was injected with 105 CFU in a volume of 10 µl or with an equivalent volume of sterile
medium alone in the case of Mock infection. Survival was monitored for 5 days and any
differences in survival between groups infected with wild type or mutant strains tested for
significance as described (7).

Data presented are pooled from 3 independent

experiments, each of which was conducted on a different days.
Mouse subcutaneous infections. Bacterial strains were grown and prepared as outlined
above, then used to infect mice subcutaneously as previously described (8). Experimental
groups consisted of 5 mice, each of which received a subcutaneous injection into the right
flank of 108 CFU in a volume of 100μl. Lesion development was monitored over a period
of 96 hours and recorded as described elsewhere (8). Differences between groups in
lesion area and in the number of mice developing an ulcer were tested for significance by
the Mann-Whitney U test and the Chi-square test with Yates’ correction, respectively (8).
For all test statistics, the null hypothesis was rejected when P < 0.05. Data presented are
pooled from two independent experiments that were conducted on different days.
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RESULTS
Ffh is not essential in Streptococcus pyogenes. Disruption of the SRP pathway leads to
a variety of phenotypes in the various bacterial species examined. In E. coli and B.
subtilis deletion of Ffh is lethal (41). Furthermore, conditional depletion of Ffh and FtsY
in B. subtilis results in a marked impairment of protein secretion (25), although the effect
on the secretome may be more modest when the bacteria are cultured in rich media (49).
In Streptococcus mutans, disruption of Ffh was first revealed in a screen for acidsensitive mutants (19). It was subsequently shown that all components of the SRP
pathway could be extensively disrupted in S. mutans with few phenotypic consequences
apart from sensitivity to certain stresses (13). Interestingly, disruption of both the SRP
and one of its two homologs of YidC (YidC2) resulted in S. mutans cells which were
severely impaired in growth (23).

We sought to ascertain whether SRP was also

dispensable for the growth of S. pyogenes and the effect of SRP disruption on the
secretion of several important virulence factors. An in-frame deletion allele of the gene
encoding Ffh was constructed to remove 500 bp from the central portion of the Ffh open
reading frame, which includes the region encoding conserved residues necessary for
GTPase activity that are crucial for function (17). The resulting allele (ffhΔ180-340) was
successfully used to replace the wild type gene in S. pyogenes HSC5 (Fig. 1A) and the
resulting mutants grew normally and produced colonies on THY agar plates that were
indistinguishable from wild-type.

Thus, similar to S. mutans, the SRP pathway is

dispensable for viability of S. pyogenes.
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A medium-specific growth defect. The method for allelic replacement generates a
tandem duplication of wild type and mutant alleles that resolves by homologous
recombination to produce strains carrying either the wild type or mutant allele (9). One
Ffh- mutant (FFH1) was chosen for further analysis and its ability to grow in liquid media
under various nutrient conditions was examined when compared with a matched wild
type revertant (WTrev). When grown in standard THY broth, a complex medium rich in
glucose (18) the mutant showed a modest defect in its growth rate, but obtained an
equivalent growth yield as compared to wild type on the basis of culture densities (Fig.
1B). When grown in C-medium, a more minimal medium rich in peptides but low in
glucose, the Ffh- mutant presented a pronounced defect in both growth rate and yield,
with cultures reaching a final density that was less that 50% of that obtained with a strain
with the wild type gene (Fig. 1C). However, this defect could be rescued by the addition
of additional glucose to C-medium, which produced a growth profile that was
indistinguishable from that of THY medium (Fig. 1, compare 1D to 1B). Addition of
NaCl (up to 150 mM) did not restore growth; however, buffering the pH of the medium
to between pH 6.0 to pH 6.5 had the same effect as the addition of glucose, and restored
growth of the mutant to levels identical to THY medium (data not shown).

Stress Response Activated. Membrane protein profiles of the wild type revertant and
Ffh- mutant were compared. Consistent with the relatively normal growth characteristics
of the mutant in THY broth medium, these profiles were remarkably similar (Fig. 2). An
exception was the presence of two bands that were consistently more intense in
membranes of the mutant when compared with the wild type revertant. Subjecting these
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bands to N-terminal sequencing revealed them to be DnaK and GroEL (Fig. 2). These
proteins play prominent roles in several stress responses, particularly under conditions
where misfolded proteins accumulate (38, 49). This observation suggests that despite
near normal growth characteristics in this medium, that the mutant is accumulating some
mis-folded proteins.

Selective defects in secretion of proteins with cleavable signal sequences.

A

prominent characteristic of S. pyogenes is its ability to secrete a large number of proteins
during growth in culture and in tissue that have cleavable signal sequences. The fate of a
subset of these proteins, including the M protein, is to become covalently associated with
the cell wall (34). Others have well-characterized toxic activities and are known to have
distinctly different trafficking fates when the bacterium is growing while attached to
surface of host cells. For example, many secreted proteins, such as the SpeB cysteine
protease, are trafficked into the extracellular spaces. At least one, the S. pyogenes NADglycohydrolase (known as Nga or SPN), is translocated across the host cell membrane
into its cytosol by a process that involves a second secreted translocator protein,
streptolysin O (known as SLO), that is itself delivered to the host cell membrane (33, 35,
37).

Since M protein, SpeB, SPN and SLO have different trafficking fates, the

consequence of the loss of Ffh on their secretion was assessed. Following its secretion
via the Sec pathway, the signal sequence of the M protein is cleaved and then it is
subsequently processed at a site towards it carboxy-terminal end and covalently crosslinked to peptidoglycan by the enzyme sortase (4). Examination of cell walls revealed
that the amount of M protein in the mutant was as similar or lower than the amount of M
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protein in the wild type parental strain (Fig. 3) indicating that Ffh is not essential, for the
secretion of M protein and its delivery to the sortase pathway. In contrast, the loss of Ffh
had marked effects on the secretion of SPN and SLO. Analysis of culture supernatants
revealed that SPN and SLO were undetectable even after the proteins in these
supernatants were concentrated by TCA precipitation (Fig 3). Additionally, culture
superntants from Ffh- mutants lacked detectable SLO hemolytic activity and SPN NAD
glycohydrolase activity (Table 1), confirming a defect for secretion of these proteins.
The genes encoding SPN and SLO are co-transcribed from a common promoter (36) and
the failure to observe the secreted forms of either protein was not due to a defect in
transcription from this promoter as analysis of the slo and spn transcript by real time RTPCR at the time of maximal expression in logarithmically-growing cultures indicated that
it was as abundant in the mutant as it was in the wild type revertant (Table 1). A similar
analysis of the transcript levels of the gene encoding M protein at a time point
corresponding to the period of its maximal expression also showed no differences
between the Ffh- mutant strain in comparison with the wild type revertant (Table 1). No
intracellular pool of SLO was detected when the mutant was subjected to lysis at this
time point (data not shown), suggesting that the polypeptide was rapidly degraded in the
absence of secretion. ). Taken together, these data show that the SRP pathway does make
a critical contribution to secretion of at least a subset of the exported virulence factors of
S. pyogenes that possess cleavable signal sequences.

Medium-dependent effect on secretion of SpeB. The absence of Ffh had a different
effect on secretion of SpeB, as it was observed that the Ffh- mutant secreted the SpeB
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polypeptide at levels higher than those observed for the wild type revertant during growth
in THY medium (Fig. 3). However, this increased level of SpeB protein did not result in
greater expression of protease activity in the Ffh- mutant, as SpeB-dependent cysteine
protease activity in culture supernatant from the mutant was somewhat reduced from
levels observed for the wild type revertant (Table 1). This phenotype was mediumdependent, as the supernatant fluids from the Ffh- mutant lacked both detectable cysteine
protease activity (data not shown) and detectable levels of the SpeB polypeptide
following culture in the glucose-deficient C medium, which is a medium that supports
robust expression of SpeB by the wild type reveratant (Fig. 4). This defect was not due
to a failure of the mutant to express SpeB, as the intracellular fraction of the mutant
contained detectable levels of the SpeB polypeptide (cytoplasmic, Fig. 4). Glucose has a
repressive effect on expression of SpeB (28, 29) and as expected, supplementing C media
with glucose resulted in repression of SpeB expression in the wild type revertant
(compare WTrev supernatant, C medium + Glc to C medium, Fig. 4). However, the
addition of glucose resulted in increased SpeB expression in the Ffh- mutant, as levels in
the supernatant fraction for both the SpeB polypeptide (C medium + Glc, Fig. 4) and
cysteine protease activity (data not shown) were elevated to the levels observed in the
wild type revertant in unsupplemented C medium. Similar to their effects on growth in C
medium (see above), buffering to pH 6.5, but not the addition of NaCl, resulted in
enhanced levels of SpeB in the supernatant fluids of the mutant (data not shown).

The SRP pathway is required for pathogenesis in a zebrafish model of necrotic
myositis. Since the Ffh- mutant had a both a medium-specific growth defect and a
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selective deficiency in its ability to export several toxins, it was of interest to determine if
the mutant was also altered in its ability to cause disease. The virulence of the Ffhmutant was evaluated in a zebrafish model of necrotic myositis that reproduces several
features commonly observed in streptococcal infection of human muscle, including local
growth in muscle tissue, extensive necrosis of the infected tissue and diminished
inflammation (39). Infection of zebrafish with the wild type revertant at approximately
10-fold the LD50 produced characteristic survival curves in which greater than 90% of
infected zebrafish did not survive past day 3 post-infection (Fig. 5). Also, all fish
infected with the wild type revertant demonstrated a characteristic discolored lesion at the
site of infection apparent 24 hrs post-infection that reflects the extent of the underlying
necrosis in muscle (39) and all zebrafish that developed a lesion did not survive. In
contrast, greater than 95% of zebrafish infected with the Ffh- mutant were still viable at
Day 3 (Fig. 5) demonstrating that the loss of the SRP rendered S. pyogenes significantly
less virulent (p < 0.0001). Although not as intense or of equivalent area as in zebrafish
infected with the wild type revertant, approximately 25% of the zebrafish infected with
the mutant did develop lesions by Day 2, and these animals typically survived and their
lesions resolved. Lesion development had not been associated with any of the attenuated
mutants analyzed previously (8, 39).

The SRP pathway is required for pathogenesis in a murine model of subcutaneous
infection.

Virulence of the Ffh- mutant was also examined in a murine model of

subcutaneous infection, in which challenge with S. pyogenes HSC5 has been observed to
cause visible ulcer-like lesions following injection into subcutaneous tissue (8).
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Consistent with previous reports, all mice injected with the wild type revertant had visible
lesions by 48 hrs post-infection, while most mice infected with the Ffh- mutant failed to
develop any evidence of a visible ulcer even following 72 (Fig. 6) and 96 hours of
examination (data not shown), demonstrating that the mutant was significantly less
virulent (P < 0.02). A subset of mice infected with the mutant did develop ulcers (Fig.
6). However, the wild type reverant caused lesions that were significantly larger in size
compared with the mutant when compared at a time when lesion formation by the wild
type revertant had reached a maximum (72 hrs, P < 0.005, Fig. 6) and at subsequent time
points over the duration of the experiment (96 hrs). These data provide additional
evidence to suggest that Ffh play an important role in S. pyogenes virulence.
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DISCUSSSION
These data suggest that the non-essentiality of the SRP pathway may be a general
feature of the streptococci. However, the SRP does contribute to a number of important
functions of S. pyogenes, including the ability to efficiently utilize carbohydrates for
growth, to secrete several proteins involved in host cell-pathogen interactions, and to
cause disease in multiple animal models of streptococcal infection. The fact that the SRP
is not required for growth should allow more refined molecular studies of this important
pathway for targeting presecretory proteins that should provide insight into the pathway
in other bacterial species where the SRP is essential. Further analyses of the SRP
pathway in S. pyogenes should also be useful for understanding how targeting pathways
may influence the trafficking fate of secreted proteins during infection.
While it is clear that the signal sequence is important for recognition by the SRP,
the specific features of the signal sequence that dictate whether the nascent presecretory
protein will be routed to the SRP pathway or to another pathway are not clear. Signal
sequences themselves canonically have 3 regions, including an amino-terminal region
enriched in positively charged residues (N region), a central region consisting of
hydrophobic residues (H region) and moderately polar carboxy-terminal domain (C
region) (Fig. 5). Studies in E. coli have suggested that while it is not an exclusive signal,
that the probability of SRP recognition of any one signal peptide does correlate with its
degree of hydrophobicity (26, 27).

Preliminary results from our analysis using the

computational method of Huber et al (26) failed to identify any correspondence between
hydropobicity and whether the signal sequences of the 4 protein analyzed in this study
were routed to the SRP pathway. A complication is that the longer hydrophobic regions
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typical of Gram-positive signal sequence generally renders them quite hydrophobic
overall. The signal sequences of SLO, SPN, M protein and SpeB are unremarkable in
this regard and have H regions encompassing 17-18 residues (Fig. 5). It has also been
suggested that the presence of glycine residues in the H region can destabilize formation
of an alpha-helix that results in an inability to interact with the SRP (1). An examination
of the four streptococcal signal sequences shows their H regions all contain multiple
glycine residues (Fig. 5). Thus, there are no obvious characteristics of these signal
sequences that distinguish between their routing pathway.
Evidence suggests that an important function for the SRP pathway is in the
insertion of integral membrane proteins (44). Since nutrient transporters typically include
an integral membrane component, the loss of a transporter could explain the mediumspecific growth defect of the S. pyogenes Ffh- mutant. As the growth and SpeB secretion
defect could be reversed by the addition of glucose, it is possible that an important
peptide transporter requires the SRP for its insertion into the membrane, making the
mutant more dependent on carbohydrates for growth and the secretion of virulence
factors. A differential dependence of nutrient transporters on the SRP pathway may also
explain recent studies that shown that depletion of the SRP in B. subtilis results in a
pronounced secretion defect when cells were grown in minimal media that was much less
severe when cell were grown under rich media conditions (49). Likewise, the viable SRP
null mutants of S. mutans are typically grown in complex rich media (23). An increased
requirement for glucose could help to explain the S. pyogenes Ffh- mutant’s attenuated
ability to cause disease. Analysis of the transcriptome during infection has shown that S.
pyogenes experiences a significant starvation for carbohydrates in well-developed
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necrotic lesions (29). This idea is supported by evidence that suggests that the nutritional
environment experienced by S. pyogenes in a necrotic lesion is similar to the nutritional
landscape presented by unsupplemented C medium during growth in culture (29) and this
medium had the most restrictive effect on the Ffh- mutant’s growth and secretion of the
several media evaluated.
Alternatively, the Ffh- mutant’s requirement for glucose for growth and for
secretion of SpeB in C medium may reflect the complex transcriptional regulatory
networks that control expression of SpeB. It is known that transcription of the gene that
encodes this protease is highly regulated and sensitive to several different regulatory
pathways, including those that respond to nutritional cues (29).

For example,

transcription of speB is repressed by a culture pH higher than pH 6.5, and glucose and
NaCl concentratins of 100 mM and 140 mM or greater, respectively (29). Interestingly,
the Ffh- mutant expressed higher levels of SpeB, and hyperexpression was not sensitive
to repression by glucose or pH. Also, while the mutant grew poorly in unsupplemented C
medium, it did express SpeB, although failed to secrete the protease. A failure to secrete
the protease could be a factor that contributes to poor growth in unsupplemented medium
as SpeB proteolytic activity in the cytoplasmic compartment of the cell would likely be
deleterious. In addition, since the effect of supplementation does not appear to be a
repression of speB expression, but rather, a rescue of the secretion defect, it is possible
that there is an accessory secretion factor required for high level secretion that is
regulated by pH and glucose. Accessory factors secretion factors that promote high
levels of secretion have been described for other Gram-positive bacterial species (for
review, see Ref # 45).
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Analysis of the trafficking of thioredoxin in E. coli has suggested that proteins
exported by SRP-dependent signal sequences are those that have the ability to fold
rapidly in the cytoplasm (26). If allowed to accumulate in the cytoplasm for any length
of time, it is likely that these proteins would jam the translocons if an attempt was made
to secrete them in a partially-folded state, a situation that can be by-passed by cotranslational secretion (26). Support for this function for the SRP pathway comes from
the observation that SPN depends on the SRP for secretion. As an NAD glycohydrolase,
SPN is indiscriminate in its source of substrate and is toxic to both streptococcal and host
cells. In fact, the ability of S. pyogenes to produce SPN is absolutely dependent on coexpression of an immunity factor known as IFS (36). This immunity factor acts as a
competitive inhibitor of SPN’s NAD substrate to ameliorate its toxicity (36).
Interestingly, IFS resides exclusively in the streptococcal cytoplasm, suggesting that even
if a few molecules of SPN go off-pathway and fold rapidly in the cytoplasm, the result is
an inability to sustain viability. Secretory stress induced by partially folded proteins
could also explain the fact that even under conditions where it is growing robustly, that
the mutant appeared to be experiencing a stress response as evidenced by the enhanced
association of DnaK and GroEL with membranes. A similar stress response has been
observed in Ffh-depleted B. subtilis (49) and in S. mutans mutants (24).
Our analysis has contributed to the emerging picture that protein secretion by S.
pyogenes and other Gram-positive bacteria is a complex and organized process. For
example, S. pyogenes has been shown to have a distinct membrane microdomain
dedicated to protein secretion known as the ExPortal (42), which may serve as a protein
folding organelle by promoting the interaction of unfolded nascent secretory proteins
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with accessory maturation factors (43).

Secreted proteins that are substrates of the

sortase pathway are not distributed randomly in the cell wall. Rather, the M protein first
appears linked to the cell wall predominantly along septum, while Protein F first appears
at higher concentrations at the cell poles (11).

These events imply that there is

considerable cooperation between the protein export and cell wall synthesis machineries
and imply that intracellular routing signals play an important role in dictating trafficking
fate. This notion is supported by the observation that exchange of signal sequences
between M protein and Protein F alters how the proteins appear in the wall (11). Thus,
while the SRP appears dispensable for growth of various species of streptococci,
understanding how the SRP pathway contributes to the secretion process will be essential
for understanding how protein secretion contributes to the pathogenic mechanisms by
which this group of bacteria cause disease.
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FIGURES

Figure 1. Deletion of ffh results in specific nutritional requirements. Successful replacement
of ffh (spy1200) in the wild type strain with a deletion allele (ffhΔ180-340) produced Ffh- strain
FFH1. (A) Analysis of PCR products generated using ffh-specific primers by agarose gel
electrophoresis revealed bands of the expected sizes for the wild type (WT) and mutant (Ffh-)
strains as shown. Open and closed arrows at the left of the DNA size standards (Std.) (TrackIttm
DNA ladder, Invitrogen) indicate the 1650 and 1000 bp bands, respectively. The growth of the
mutant (Ffh-) in liquid media was compared to a matched wild type revertant (WTrev) using THY
medium (B), C-medium (C) and C-medium supplemented with glucose (D). Data shown are
from a single experiment representative of a minimum of three independent experiments, each of
which was conducted on different days.
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Figure 2. The majority of membrane proteins are correctly targeted in the absence of the
SRP. Membranes purified from mutant (Ffh-) and a matched wild type revertant (WTrev) were
analyzed by SDS-PAGE and staining with Coomasie blue as shown. The identities of the bands
labeled on the left of the Figure were determined by N-terminal amino-acid sequencing. The
migration of several size standards is indicated to the right of the Figure.
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Figure 3. The SRP is required for the secretion of a distinct subset of virulence factors.
Analysis of the secretion of a selection of virulence factors that have both cleavable signal
sequences and distinct trafficking fates during infection is shown. Included are the sortase
pathway substrate the M protein, the SpeB cysteine protease that is released into the extracellular
compartment, SLO that is trafficked to the host cell membrane, and SPN that is translocated into
the host cell cytosol. Compared by Western blot analyses are the mutant (Ffh-) and a matched
wild type revertant (WTrev) using antisera specific for each indicated protein. Samples analyzed
for M protein were cell walls from protoplast preparations, cell-free overnight culture supernatant
fluids for SpeB, and cell-free overnight supernatant fluids that were concentrated by TCA
precipitation for SLO and SPN. The migration of the zymogen (proSpeB) and mature (SpeB)
forms of SpeB are indicated to the right of the SpeB panel.
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Figure 4. A medium-dependent secretion defect. A Western blot analysis of SpeB expression
from mutant (Ffh-) and wild type revertant (WTrev) following culture in C medium or C medium
supplemented with glucose (C medium + Glc) is shown. As indicated in the Figure, both
supernatant and cytoplasmic fractions were analyzed.
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Figure 5. The SRP is required for virulence in an animal model of necrotic myositis. Groups
of zebrafish were challenged intramuscularly with 1 x 105 CFU of mutant (Ffh-), a matched wild
type revertant (WTrev) or were injected with sterile media alone (Mock). Survival was monitored
for 72 hours and the data presented as a Kaplan-Meier plot. Data are pooled from three
independent experiments, each of which was conducted using 10 zebrafish per group. These data
indicate that the mutant was significantly less lethal than the wild type revertant (P < 0.0001).
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Figure 6. The SRP is required for virulence in the murine subcutaneous ulcer model.
Groups of female SKH1 hairless mice received a subcutaneous injection of 107 CFU of mutant
(Ffh-) or a matched wild type revertant (WTrev) into the hind flank. Following 72 hrs, the area of
any visible ucler that formed at the site of injection was determined as described (8). Data shown
are pooled from two independent experiments. Each symbol represents the area of the ulcer
observed in an individual mouse, and the horizontal bar indicates the mean value obtained for the
pooled set of 10 mice. As indicated in the Figure, lesions caused by the WTrev were significantly
larger than those caused by the Ffh- mutant.
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Figure 7. Comparison of virulence factor signal sequences. The N, H and C regions of the
signal peptides of SPN (Spy0165), SLO (Spy0167), Emm1 (Spy2018) and SpeB (Spy2038) are
shown. Positively-charged residues in the N region and the residues of the hydrophobic H region
are indicated in bold type and by grey highlighting, respectively. Helix disrupting glycine
residues in the H regions are indicated in white type. The signal peptidase cleavage site
(indicated by the arrow) predicted computationally by SignalP, version 3.0 (6) agreed with the
mature N-termini that have been experimentally determined and reported for each protein.
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